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Abstract 
Eleftheria Trampari, September 2016, John Innes Centre, University of East Anglia, 
PhD., UK 
Allosteric control of Type III secretion systems by the second messenger Cyclic-di-
GMP. 
Cyclic di-GMP (cdG) is a ubiquitous second messenger in bacteria, regulating 
transcriptional and post-transcriptional processes and allosterically controlling protein 
function. While the mechanisms of cdG metabolism are well understood, the downstream 
targets of this molecule are poorly characterised. 
To understand the role of cdG signalling in plant-associated species, cdG-capture 
compound pull-down experiments were performed to identify potential binding proteins 
in Pseudomonas fluorescens. One of the top targets identified was the flagella export 
AAA+ ATPase FliI, which was shown to bind specifically and tightly to cdG. FliI-cdG 
interaction was demonstrated for diverse bacterial FliI homologs. Excitingly, high-
affinity binding was observed for the type-III secretion system (T3SS) homolog, HrcN 
and the type-VI ATPase, ClpB2. A combination of techniques was used to predict the FliI 
cdG binding site at the interface between two FliI subunits.  
Although the addition of cdG inhibits the ATPase activity of both FliI and HrcN in vitro, 
this occurs at a non-physiological cdG concentration suggesting that this does not 
represent the in vivo role of binding. However, when cdG concentrations are artificially 
increased, the export of flagellin subunits is significantly reduced, suggesting a link 
between cdG binding and protein export. Changes in the in vitro multimerization state of 
the protein were also observed upon the addition of cdG. 
As part of this study, novel and highly specific tools for nucleotide-protein interactions 
were developed and existing biochemistry techniques were optimised. These assays were 
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employed to characterise cdG binding to four more proteins, which were identified as 
cdG binders.   
The results generated in this study broaden the existing knowledge about cdG binding 
protein diversity. The identification of FliI as a cdG binder suggests a novel cdG-
dependent control mechanism for the function of bacterial export pathways including the 
flagellum and the T3SS, through allosteric interaction with export ATPase proteins. 
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Chapter 1: Introduction 
Bacteria sense their environment using complex signalling networks, which allow them 
to receive environmental signals and translate them into cellular responses. These 
responses help the bacteria to “make different decisions”, to either avoid or take 
advantage of their surroundings. Bacterial responses are orchestrated by complex 
intracellular signalling networks, an important part of which is the cyclic di-GMP (cdG) 
signalling system.  
This study examines cdG networks in plant-associated bacteria, which can either have 
beneficial or harmful effects on plants. Pseudomonas fluorescens was selected as a model 
organism for studying the beneficial interactions between bacteria and plants, and 
Pseudomonas syringae for studying the bacterial plant infections. This work focuses on 
the identification of novel cdG targets in these Pseudomonas sp. and the characterisation 
of two particularly important cdG-binders, the ATPase complexes of the flagellum and 
the type III secretion system. Gaining more insights into the increasing importance of cdG 
networks in bacteria could have profound implications for the control of disease as well 
as the exploitation of these networks in beneficial microbes, for example, to promote more 
environmentally sustainable agricultural practices. 
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1.1 Pseudomonas fluorescens  
Pseudomonas fluorescens is a Gram-negative, rod-shaped bacterium that lives 
saprophytically in the soil, for most of the time in close association with plants. P. 
fluorescens is characterised by its ability to produce fluorescent siderophores (e.g. 
pyoverdin), which are used by these microbes to extract the available iron from their 
environment (1).  
P. fluorescens is an agronomically important bacterium due to its ability to act as a plant 
growth promoter (PGP) and a biocontrol agent. It effectively colonises roots and shoots, 
living of plant root exudates. In return P. fluorescens promotes plant growth and induces 
systemic resistence to pathogen attack in its host (2). Pseudomonas species also directly 
Figure 1.1: Representation of biological control in soil. The possible interaction between the biocontrol factors 
is described. Reprinted by permission from Macmillan Publishers Ltd: [Nature publishing group] (2), copyright 
(2005) 
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antagonise pathogens by secreting antibiotics and engaging in specific antimicrobial 
activity (Figure 1.1). 
1.2 Biocontrol and plant growth promotion 
Bacteria such as P. fluorescens that have the ability to promote plant growth are 
commonly known as plant growth-promoting rhizobacteria (PGPR). These microbes are 
able to colonise plant roots, leading to beneficial associations between the two species. 
PGPR can promote plant growth either directly, by altering plant hormone levels and/ or 
by making nutrients accessible to the plant roots, or indirectly, by fighting against 
pathogenic organisms that affect plant growth and development (3,4).  
Biocontrol is a complicated process that is based on the specific properties of beneficial 
microorganisms to control plant diseases (5). Antagonism is the most well-known 
mechanism for controlling pathogenicity. In antagonistic relationships, certain microbial 
species have the ability to produce antibiotics and other secondary metabolites that are 
toxic to their competitors and as a result, they predominate in the rhizosphere (6), the soil 
area surrounding the roots.  
In order for the biological control to be effective, two main conditions should be met. 
Firstly, bacteria need to produce a specific antibiotic, bacteriocin or other secondary 
metabolic products that will allow them to compete against other organisms in the soil 
environment successfully, and secondly, they must have the ability to colonise the plant 
root environment effectively. These two bacterial characteristics help them to efficiently 
protect plants (7).  
1.3 Plant colonisation  
The reason why microbes colonise plant roots is to exploit the secreted organic 
compounds the plant rhizosphere provides. By growing on plant root exudates, microbes 
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not only survive in a hostile environment but also develop into active microbial 
populations, which can then colonise plant surfaces (8).  In addition to the nutrients that 
plants secrete, plant surfaces provide protection to the attached microbes, which have the 
opportunity to form a safe homeostatic environment (e.g. biofilm). It is also known that 
adherent populations develop stronger resistance against environmental factors and as a 
consequence prevails against free-living soil populations (9).  
The colonising microbes benefit in multiple ways from their association with plants. 
However, plants also gain significant advantages, as bacteria both enhance plant growth 
and reduce the danger of plant disease. In addition to biocontrol activity against 
pathogenic microorganisms, PGPRs undertake several beneficial biological services for 
their plant hosts, such as phosphate solubilisation, nitrogen fixation, and the production 
of phytohormones (e.g. cytokinin and auxin) and growth stimulants such as ethylene. 
Beneficial microbes may also contribute towards natural environmental remediation, with 
some species having the ability to degrade dangerous chemical compounds in the soil 
(10).  
In order for bacteria to achieve a successful association with plants they first need to 
attach to plant surfaces and then colonise plant tissues. There are two major ways under 
which bacteria can be deposited onto plant surfaces, the passive and active deposition.  
Passive mechanisms are usually environmental factors such as wind or rainwater that 
deposit bacteria onto the plant surfaces (11). Active deposition mechanisms involve 
motility and chemotaxis, which play a fundamental role in the successful plant root 
colonisation (12–14). 
P. fluorescens colonises plant roots in a non-species specific manner and exploits root 
exudates as a carbon source. The colonisation process is highly regulated in all stages, 
from migration towards plant roots through to biofilm formation (7).  To enable the initial 
stages of plant colonisation, these bacteria orchestrate a highly complex arsenal of 
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motility systems, which include the flagellum and the type IV pili as well as biosurfactants 
to enhance swarming motility (15,16).  
1.4 Motility 
One of the most important determinants for effective plant root colonisation is bacterial 
motility. Bacterial mutants that have lost their ability to swim are incapable of colonising 
plant roots efficiently, and as a result, they lose their biocontrol ability. The central 
organelle responsible for bacterial movement is the bacterial flagellum.  
There are four distinct forms of motility (17): Twitching, requiring type IV pili (18); 
sliding motility, which is a form of passive translocation (19,20); and finally swimming 
and swarming motility, which are the most active forms of bacterial movement both 
depending on the presence of functional flagella (21,22). 
Flagella-driven motility helps bacteria to move towards more advantageous environments 
and also to avoid dangerous environmental conditions, allowing them to compete against 
other organisms in the phyllosphere successfully. 
1.5 Bacterial flagellum 
The bacterial flagellum is the main organelle responsible for bacterial movement in 
Gram-negative species. It is the flagellated version of T3SS, as they both share the type 
III export machinery, a highly-conserved transmembrane export system, which initiates 
the formation of  the flagellum filament and the injectisome needle in each system 
accordingly (23).  
Formation of the flagellum has been linked to effective bacterial adherence and host 
colonisation, as well as multiplication inside host tissues. The main flagella filament 
subunit, flagellin, has been reported to employ adhesin-like properties, helping the 
bacteria to attach better to surfaces (24). Furthermore, the importance of flagella in the 
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invasion in mammalian cells has been demonstrated several times (25,26). As a result, 
the flagellum plays a crucial role not only in beneficial microbe-host interactions but also 
in bacterial virulence. Interestingly, the flagellum has also been implicated in the 
secretion of virulence factors (27). 
The synthesis of this complex machinery requires more than 50 gene products. Regulation 
of flagellar synthesis occurs at every stage of its biogenesis, such as co-transcriptionally, 
post-transcriptionally, co-translationally and post-translationally (28–30). It is known that 
the transcription of flagellar genes is temporally-controlled and also depends on the 
environmental conditions. In certain bacteria flagella, gene expression is coordinated with 
the cell cycle (31). 
1.5.1 Flagellum structure 
The flagellum comprises of the basal body, the hook and the helical filament (32). The 
basal body includes protein rings attached to the bacterial membranes (L, P and the 
cytoplasmic C ring) and the central rod.  The cytoplasmic C-ring acts as the rotor of the 
motor, and also as the input point for signals controlling flagellar rotation (33). Each 
component of the bacterial flagellum is synthesised at the correct time for its 
incorporation into the assembling machinery (34). The assembly starts by the build-up of 
the flagellum basal body, starting with FliF protein translocation at the inner membrane. 
The stator, formed by the motor proteins MotA and MotB, surrounds an ion-conducting 
channel complex which forms the basal body (35). The stator directly interacts with the 
rotor, which comprises of FliG, FliM and FliN (see Figure 1.2). Once the basal body has 
been built, the external components of the flagellum, the filament and the linker 
components are exported through the narrow central channel formed by this point. 
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1.5.1.1 The basal body 
The basal body construction starts with the formation of the MS ring, a membrane ring 
structure attached to the rotor. The MS ring consists of 26 copies of FliF. The C ring 
formation follows, which is a second ring structure located in the cytoplasm (36). The 
next part assembled is the T3SS, which is thought to be built in the centre of the MS ring, 
a process followed by the rod assembly in the periplasmic space (37).  
1.5.1.2 The rod 
The rod consists of the proximal and the distal rod. The proximal rod is composed of 6 
subunits of FlgB, FlgC and FlgF and the distal rod from around 26 subunits of FlgG 
(38,39). The secretion of the rod subunits occurs through the Sec secretion pathway 
instead of via flagellar type III secretion. FlhE is also a protein associated with the rod 
Figure 1.2: Structural representation of the bacterial flagellum. Figure based on (23) 
 
Outer membrane 
Inner membrane 
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and is required for efficient subunit secretion (40,41). Strains missing this protein are 
defective in swarming motility (42). FlgL is located at the proximal-distal rod junction, 
and deletion of the flgL gene affects its integrity, making the flagellum susceptible to 
breaking (43).  
1.5.1.3 The motor-force generators  
For the flagellum to rotate, both rotor and stator protein complexes are required. MotA 
and MotB, which are integral membrane proteins, form ion-conducting stator complexes 
(44,45), promoting the motor rotation. The rotor is built of FliG, FliN and FliM and it 
interacts with CheY, a component of the chemosensory system, directing the motor to a 
clockwise or a counter-clockwise direction (46,47). FliG is known to interact with MotA 
as well as the MS-ring protein FliF (48–50). FliM is the protein responsible for the 
interaction with phosphorylated CheY protein (51,52). FliN is involved in the rotation of 
the flagellum and directional switching, as well as contributing to protein export by direct 
interaction with FliH, the ATPase-complex protein (53–55). It is also known that FliN 
assembles onto the FliF ring prior to the localisation of the internal membrane 
components (FliF, FlhA, FlhB, FliP, FliQ and FliR). This indicates that FliN, being a 
cytoplasmic-directed component, may be essential for the correct localisation of the 
internal membrane proteins (54).  
1.5.1.4 The hook  
The hook is composed of about 120 copies of FlgE and resembles the structure of the 
filament (56,57). The main characteristic of the hook is its flexibility, which is essential 
for effective flagella function (58).   
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1.5.1.5 Capping proteins 
FliD plays the role of the filament cap and is critical to its polymerization, enabling the 
filament proteins to polymerise by selectively allowing proteins to pass through the 
channel (59,60). The filament cap is made by five FliD molecules, forming a pentameric 
structure characterised by a flexible domain and a flat-top domain (61). FlgD is also a 
protein involved in the formation of the tip on the growing hook at an earlier stage of the 
assembly (48). 
1.5.1.6 The flagellar propeller and filament 
The rotation of the flagellar propeller is responsible for bacterial motility. The propeller 
is 20 nm thick and up to 15 µm long. The filament consists of up to 20,000 flagellin 
subunits (FliC). The rotation of this helical propeller is driven by the flagella motor. The 
direction in which bacteria move depends on the direction of the rotation, to change 
direction of movement they switch between clockwise and anti-clockwise motor rotation 
(62) (as a consequence of CheY-P interaction).  
1.5.1.7 Junction proteins 
Junction proteins are the proteins linking the flexible hook with the filament. For instance, 
when the hook is completely built, FlgD, the hook cap is discarded and three junction 
proteins take its place; FlgK and FlgL, both linking the hook with the filament and FliD, 
which links the filament with the cap. FlgK and FlgL stay in place during the assembly 
of the flagellum whereas FliD moves outwards as FliC polymerises (63–66).  
1.5.1.8 Soluble cytosolic proteins; the ATPase complex 
An important part of the flagellum export apparatus are three soluble proteins that form 
the ATPase complex. These are FliI; the main ATPase, FliH; a protein shown to 
negatively regulate ATPase activity and FliJ; a general chaperone (34,67). These three 
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proteins interact with each other forming the FliHIJ ATPase complex. It was initially 
believed that this complex was responsible for carrying substrates to the export gate of 
the flagellum, where it associated with the MS ring to secrete the proteins using the energy 
released by ATP hydrolysis. However, recent studies have shown that ATP hydrolysis is 
not essential for export, in comparison to the Proton Motive Force (PMF), but does help 
to effectively translocate the exported substrates (68,69). Recently, another potential role 
of the FliHIJ complex has been unravelled. FliI ATP hydrolysis is apparently required in 
the T3SS in pathogens for the unfolding of secretion substrates (70). These studies 
indicate that a more realistic role of the complex may lie in the correct localisation of 
substrates to be exported onto the export gate, and then unfolding them to enable their 
translocation via PMF-dependent secretion (71,72). FliJ has been demonstrated to directly 
interact with FliM on the C ring as well as FlhA of the T3SS, whereas FliH was shown 
to interact with FliN of the C ring (53–55,73). From their part, the secretion proteins 
cannot interact directly with the FliHI complex without the presence of their chaperones 
(74). FliJ on the other hand can only interact with unbound chaperones but is incapable 
of interacting with substrates only or substrates bound to their chaperones (72). Finally, 
the FliH and FliJ proteins potentially interact independently with FliI to either inhibit or 
enhance its activity (68). 
1.5.2 Flagellum function 
Both the flagellum and the T3SS are responsible for the export of substrates. This process 
is remarkably fast. For instance, for the filament growth, flagellin is transported at a rate 
of 10,000 amino acids per second (75). Similarly, the non-flagellated T3SS from S. 
typhimurium transfers several thousand copies of the effector protein SipA in a matter of 
a minutes after contacting the host tissue (76).  
The quick rate of secretion of these components cannot only be due to the ATPase activity 
of the soluble T3SS components, which leads to the conclusion that it most probably 
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depends on the PMF, which is responsible for the system’s protein translocation and 
function. The ATPase complex (FliH, FliI, FliJ) however is assumed to be responsible 
for the efficient localisation of the proteins for secretion (68,69).  
1.5.3 Transcriptional regulation of flagellar genes biosynthesis 
The transcriptional regulation of the flagellum has mostly been studied in S. typhimurium. 
The master flagellar operon, flhDC controls flagellum assembly and is regulated by 
various input signals, which lead to the inhibition or expression of the flagellar genes. 
The flhDC genes are expressed by a class I promoter (34). FlhD and FlhC proteins interact 
with each other forming a heteromultimeric complex (four molecules of FlhD and two 
molecules of FlhC), which acts as a transcriptional activator, triggering σ70-dependent 
transcription of the class II promoters (77). In turn, class II promoters are responsible for 
the transcription of the structural genes, which are needed for the hook-basal body 
assembly. When the hook and basal body are completed, σ28-dependent class III promoter 
transcription occurs (78,79). This transcriptional level of regulation is inhibited from the 
anti-σ28 factor protein FlgM. When the hook-basal body assembly is completed, FlgM is 
secreted from the cell, potentially through the unfinished machinery, and σ28-dependent 
transcription of the class III promoters starts. In that way there is a temporal control of 
the flagellar gene transcription, ensuring that each protein will be transcribed at the right 
point of assembly.  
1.5.4 Flagellum regulation by cdG 
In recent years it has become clear that regulation of flagella function is even more 
complex than initially thought. Various studies have shown that motility inhibition is 
directly associated with increased levels of the ubiquitous bacterial second messenger 
cyclic di-GMP (cdG) in the cell. Generally, high levels of cdG have been associated with 
inhibition of flagella and pilus-mediated motility. On the other hand, low levels of cdG 
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in the cell have been linked to the promotion of motility (80–83). In Pseudomonas 
aeruginosa PAO1, cdG controls the transcription of the flagellum by interacting with the 
master transcriptional regulator, FleQ (84). FleQ is an enhancer binding protein, which 
contains a AAA σ54 interaction domain and a helix-turn-helix DNA binding domain. It 
acts as an activator of the regulatory genes fleSR, as well as the genes that are responsible 
for flagellar assembly  (85). The regulation of the flagella is also under the control of 
FleN, the expression of which is under FleQ control. FleN is an ATPase protein 
containing a Walker A motif (86) which interacts with FleQ in the presence of cdG and 
inhibits FleQ activity leading to the activation of flagella gene expression (87). 
1.5.5 Flagellum and virulence 
Although the flagellum was initially regarded as an organelle responsible solely for 
bacterial movement, recent studies have shown that it has a number of other biological 
functions as well. For instance, in many bacterial species, the flagellum is a well-studied 
virulence factor, making the non-flagellated strains less virulent. Indeed, the flagellum is 
known to affect virulence several different ways (24).  
Of course, the main mechanism in which flagellum affects virulence is through the 
facilitation of motility. Among other examples, in Vibrio cholerae, lack of a flagellum 
leads to less virulent strains with reduced absorption in mice intestines (88).  
Another mechanism is through the facilitation of adhesion. The flagellum has been shown 
to mediate direct bacterial adhesion in enteropathogenic E. coli. This function is 
structural, and is not linked to the flagellar rotation - E. coli strains with inactivated FliC 
demonstrate significantly decreased adhesion, whereas strains having a non-functional 
flagellum nonetheless adhere to surfaces as efficiently as the wild type (89). 
For effective plant colonisation and persistence, it is critical that bacteria adhere 
efficiently to the plant surfaces. To do so, they employ various surface structures such as 
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the fimbriae or pili, several surface proteins (90) as well as the bacterial flagellum. The 
expression of the genes encoding for these structures is closely integrated with the 
expression of the flagellum genes. Thus, bacteria can easily switch between a motile and 
a sessile lifestyle based on the different environmental stimuli (e.g. temperature, 
osmolarity, pH, etc.), which in turn alter the expression of the flhDC flagellar operon (91). 
This regulation of the flagellum genes occurs at the transcriptional level as well as the 
assembly level (34,91). The adherent properties of the flagellum also play a crucial role 
in biofilm formation. Non-flagellated mutants showed reduced adhesion compared to the 
wild type strain and as a result, reduced biofilm formation (89,92). 
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1.6 Pseudomonas syringae  
P. syringae is closely related to P. fluorescens, but in contrast to the latter, is an aggressive 
plant pathogen with over 50 known pathovars infecting a broad range of different plant 
species. P. syringae pathovars cause plant diseases including bleeding canker, halo blight 
and tomato speck. P. syringae pv. tomato DC3000 (Pto), for instance, infects tomato 
plants and the model organism Arabidopsis thaliana (93). P. syringae is able to 
manipulate host plant cells by producing and secreting diverse phytotoxins and effector 
proteins. These induce a range of pathogenic phenotypes, including stomatal opening to 
enable bacteria access to the apoplast, chlorosis and tissue necrosis (94,95). P. syringae 
secretes and injects many of these phytotoxins and virulence factors by deploying a 
specialised organelle called the T3SS (96). Consequently, the T3SS plays a crucial role 
in P. syringae virulence (97).  
1.7 Plant infection 
Many plant pathogenic bacteria follow a traditional infectious cycle which is well- 
conserved among different bacterial species. This includes some well-determined stages 
such as the entry of the pathogen (usually through wounds on the plant tissue), 
establishment and multiplication in the apoplast, avoidance of the host defence 
mechanisms and finally the exit from the organism. Although the virulence factors differ 
from one organism to the other, many of the systems used during infection are remarkably 
conserved among different species (95). 
Once a bacterium has encountered its host, the first step for a successful infection is the 
adhesion of the bacteria to the plant surface using specific surface proteins called 
adhesins. Adhesins are bacterial cell surface components, which enable bacteria to resist 
physical forces and enable them to attach to host cells effectively. Adhesins exhibit an 
increased selectivity for specific target molecules and recognise specific motifs on the 
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host surfaces (98). These molecules are usually located at the tip of distinct bacterial 
structures such as the pili or fimbriae; alternatively, they are anchored to the bacterial 
membrane. Following adhesion to the plant surface, bacteria migrate into the apoplast. 
This step is followed by the coordinated deployment of the bacterial secretion systems, 
which are employed to fight and avoid the host’s defence mechanisms. 
1.8 Secretion systems 
Gram negative bacteria, including P. fluorescens and P. syringae, employ complex nano-
machines for the export of virulence factors directly into host cells. These virulence 
factors are usually either toxins, which are critical to pathogenesis, or effector proteins. 
Two of the most important secretion systems, responsible for the establishment and 
maintenance of bacterial infections and cytotoxicity against different cell types are the 
Type III and Type VI secretion systems. 
1.8.1 Type III secretion system (T3SS) 
The T3SS is a needle-like structure that delivers bacterial effector proteins and toxins 
directly into the host cell in a highly regulated manner. It is well conserved both 
structurally and functionally among both symbiotic and Gram-negative pathogenic 
bacteria (99). It consists of multiple protein layers organised in the inner cytoplasmic 
membrane, the peptidoglycan layer and the bacterial outer membrane, as well as in the 
periplasmic and extracellular spaces (100,101). The T3SS is activated upon recognition 
of host cells, and effector proteins secreted by this system can inhibit or modify host 
metabolic pathways in a manner beneficial to the invading microbe (102). The gene 
cluster of the T3SS and the proteins it encodes resemble those involved in the assembly 
of the bacterial flagellum, suggesting some conserved similarities between the two 
systems.  
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The T3SS is one of the main organelles responsible for bacterial pathogenicity. Indeed, 
most pathogenic Gram-negative bacteria are equipped with an active T3SS, which they 
use for infecting plants and to facilitate multiplication in plant tissues (103). The T3SS is 
responsible for the translocation of effector proteins into the host cells resulting in the 
manipulation of the plant cellular mechanisms to the benefit of the pathogen (104–106). 
T3SS are complex nanomachines anchored to bacterial membranes. They contain a pilus-
like structure, which is used as a transport channel for secreting proteins and toxins (107–
109). For the translocation of secreted proteins, a pore-like structure is formed on the 
plant cell membrane, which is called the translocon (110,111). Although the T3SS 
components are secreted from the cell into the space between the bacteria and the plant 
cell for the formation of the T3SS pilus, effector proteins are directly translocated into 
the host cell. This last function depends on a signal usually incorporated in the N-terminal 
end of the protein to be secreted. These signals usually follow a specific amino acid 
pattern, which is recognised by the bacterium and places them at the right location 
(112,113). Except for this pattern, the accurate localisation of effector proteins in the 
bacterial cytosol and the T3SS export gate is crucial and is catalysed by cytosolic 
chaperone proteins, which bind and potentially stabilise T3SS substrates, and as a result, 
promote the recognition of the secreted substrates by the secretion system (114–116).  
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1.8.1.1 T3SS Structure 
The Type III secretion system is structurally characterised by the base, the needle, the 
inner rod, the export apparatus and the soluble cytosolic components. 
1.8.1.1.1 The base 
The part of the T3SS anchored to the inner membrane is called the base. It is also the first 
structure built in a new T3SS complex. The base consists of two inner rings and two outer 
rings connected by the neck (117). The inner rings are assembled from subunits of HrpQ 
and HrcJ, which form two concentric rings with diameters of 27 and 18 nm, respectively 
(118,119). The outer rings and neck are composed of the same protein; HrcC, a secretin 
Figure 1.3: Structural representation of the type III secretion system. Figure based on (23) 
 
 
Figure 1.6: c-di-GMP metabolism in the bacterial cell, GGDEF domains synthesise c-di-GMP and EAL domains 
degrade it. Figure originally published by Urs Jenal and Jacob Malone in Annual Reviews (203).Figure 1.7: Structural 
representation of the type III secretion system. Figure based on (23) 
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family protein. The neck links the inner rings with the outer rings. Once the base is 
completed, it acts as an export machine for the extracellular components of the T3SS (e.g. 
the needle).  
1.8.1.1.2 The needle 
The extracellular part of the T3SS is the needle. The needle is built from multiple subunits 
of HrpA, which are arranged in a helical fashion (120–123). It is 30 to 70 nm long in its 
native state with a width ranging from 10 to 13 nm. Solid-state NMR structure analysis 
has shown that the N-terminal domain of HrpA is orientated to the exterior of the needle 
in contrast to the C-terminus, which faces the lumen. The residues facing the lumen of 
the filament are highly conserved and polar, being positively or negatively charged, 
indicating that this charge distribution may be necessary for substrate transfer through the 
channel (124).  
After the needle is built, it is either capped by a single protein, PcrV in Pseudomonas 
(125,126) or is extended  to a longer structure by EspA, a trait observed in E. coli (127). 
The extension is structurally similar to the flagellum filament made by FliC and forms a 
helical structure more flexible than the T3SS needle filament (128).  
1.8.1.1.3 The inner rod 
The inner rod is the part of the T3SS that connects the needle to the base. It is built of a 
single protein, HrpB (129). HrpB is predicted to share similarities in structure with HrpA, 
with the two proteins having a similar α-helical hairpin shape surrounded by flexible 
regions (130). 
1.8.1.1.4 Inner membrane export apparatus 
The export apparatus consists of five well-conserved inner membrane proteins, which are 
essential for the T3SS function; HrcV, HrcR, HrcS, HrcT and HrcU  (131–136). Recent 
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cryo-EM studies have shown that a number of these proteins are potentially located within 
the T3SS, facilitating the export of substrates through the inner membrane (137). It is still 
uncertain however if these proteins always function as a group or if they can operate 
individually (138).  
1.8.1.1.5 Cytosolic components 
There are a number of cytosolic proteins associated with the T3SS; HrpE, HrcQA, 
HrcQB, HrpO, HrcV and HrcN. These proteins are essential for substrate secretion and 
are highly conserved across all T3SSs (132,139–143). It is well reported that these 
proteins interact with each other, but their organisation is still poorly characterised (144–
146). However, orthologs of some of these proteins exist in the better-characterised 
flagellum and are components of the well-defined C-ring structure, which is known to be 
required for altering the direction of flagellar rotation (147,148). A C-ring structure is 
absent in the T3SS, but there is some preliminary evidence that these proteins may cluster 
to form a complex, which associates with the main export apparatus (144).  
HrcN one of the cytosolic proteins related to the T3SS base, and is a highly conserved 
ATPase with profound structural similarities to both FliI and the F0F1 ATPases (139,141). 
It forms a hexameric ring at the base of the export apparatus located at the bacterial inner 
membrane and provides the initial energy required for the secretion process (149–151) . 
In the human pathogen Salmonella enterica, it has been shown that ATP hydrolysis by 
HrcN is essential for the disassociation of effector proteins from their chaperones, with 
the chaperone-effector complexes shown to interact with the HrcN complex 
(70,74,152,153). It has also been suggested that HrcN may have an active role in the 
unfolding of effectors before they are loaded into the injectisome (70,154,155). In contrast 
to this, it has also been reported that HrcN is not required for the translocation of T3SS-
associated proteins, as animal pathogenic bacteria are still virulent in the absence of a 
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functional ATPase (68,69). In conclusion, based on the latest studies on HrcN, the 
ATPase is responsible for the effective docking of effector proteins to the T3SS export 
gate, whereas the export of these proteins is potentially dependent on PMF (68–
70,153),(156). 
1.8.1.2 T3SS function 
For the effective function of the T3SS, an activating signal is essential. Some studies have 
provided evidence that this signal may come from direct contact of the bacterial cell with 
the host cell (117), (157,158). It is possible that this mechanism exists to ensure that the 
secreted proteins will be delivered directly to the host cells and not the extracellular space. 
The way the bacterial cell senses the interaction is still poorly understood, but some initial 
evidence suggests that the tip complex proteins may be involved in the recognition 
process (109). Experiments with potential tip interacting compounds (e.g. Congo red, bile 
salts) have shown that the T3SS secretion can be activated even without a host cell 
present. The reason for this may be potential conformational changes on the tip of the 
needle, which mimic the contact with the host cell (159–163).  
The signal that is presumably sensed by the tip of the needle is then transduced to the 
remaining components of the secretion machine. This process is potentially mediated by 
conformation changes in the protein components of the needle and the inner rod (109). In 
support of this, previous studies have identified mutations in the needle and inner rod 
protein domains that result in altered secretion patterns (164–167). Following the 
activation of the system, the next step is the deployment of translocase proteins, which 
will open the passage for effector protein translocation (168). As a result, the translocases 
are thought to interact with the T3SS prior to the effectors. Indeed, even prior to 
activation, the only proteins found to interact with the cytosolic components of the system 
are the translocases, and only in their absence can effector proteins be detected (144). 
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1.8.1.3 Effector proteins 
Bacterial pathogenicity depends on the ability of bacteria to infect plants and to be able 
to survive inside the plant tissue. To achieve this, they secrete toxins and toxic protein 
factors (e.g. degradative enzymes), as well as effector proteins that manipulate cell 
behaviour, directly into the host cells (169). Effectors are proteins secreted by bacteria 
using the T3SS in a highly controlled manner, enabling them to effectively manipulate 
host components either structurally or functionally. Plant pathogenic bacteria are known 
to possess a large number of diverse effector proteins. For instance, the P. syringae 
genome sequence revealed that strains in this species are each equipped with up to 39 
effectors (170,171). Deletion of individual effector genes usually produces little or no 
effect on bacterial virulence, indicating that pathogenicity is a bacterial behaviour 
orchestrated by complex and redundant mechanisms. In P. syringae pv. tomato, the 
deletion of 18 different effector genes, which are part of six genomic clusters, are required 
to produce an effect on bacterial growth in planta (172), whereas a minimum of 8 
effectors is needed for the effective suppression of plant resistance mechanisms and to 
promote bacterial virulence (173,174). Recent studies have shown that effector proteins 
in animal pathogens are potentially secreted at different time points to achieve the 
maximum output (76,175–177). For many years, studies have focused on the 
characterisation of effector proteins and their targets in the plant cells, revealing roles of 
effector proteins in the manipulation of signal transduction, protein degradation, 
phytohormone signalling, pathogen-associated molecular pattern (PAMP)-triggered 
immunity and plant gene expression among others (169).  
1.8.1.4 T3SS regulation 
The expression of the T3SS in P. syringae is induced when the bacterium enters the 
apoplastic plant space. This induction is triggered by HrpR and HrpS, two NtrC-family 
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transcriptional regulators, which interact with each other (178). These two regulators 
induce the expression of HrpL, an alternative sigma factor binding to the conserved 
elements of the T3SS promoter regions (179). This positive regulation is inhibited by 
HrpV, a negative regulator, which potentially acts upstream of HrpL and interacts with 
HrpS (180,181). HrpV activity is suppressed by HrpG, a potential T3SS chaperone. The 
activation of the T3SS potentially triggers the release of HrpG from its interaction 
substrate, leading to the interaction with HrpV, and thus inhibiting the negative regulation 
promoted by the latest protein (181).  Another player in the control of T3SS expression 
is the Lon protein, an ATP- dependent serine protease, the role of which is to degrade 
misfolded or unstable protein substrates. In this way, Lon contributes to the correct 
function of the T3SS (182,183). Lon also acts as a negative regulator of T3SS function 
by degrading HrpR (178,184–186). Although the Lon protease is able to degrade 
effectors, these are protected by its proteolytic activity when they are bound to their 
chaperones (187), (108). 
1.8.2 Type VI secretion systems (T6SS) 
The Type VI secretion system (T6SS) is one of the main export systems in bacteria, and 
more specifically is characteristic of Gram-negative proteobacteria, both pathogenic and 
commensal (188). Although the T6SS is more common in pathogens, there are also 
several nitrogen-fixing bacteria and rhizobia that have a functional T6SS (189). 
Pathogenic bacteria employing a T6SS usually pose a high threat to human health, having 
representatives in highly pathogenic categories (e.g. Salmonella typhi, the 
enteropathogenic E. coli, Yersinia pestis, etc.) (189). 
Genetically, the T6SS regulon comprises of 15-25 genes, which were originally identified 
by their importance in the secretion of virulence factors (190–193). Some of these gene 
products are secreted as virulence factors, and others are thought to be either structural 
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components of the machinery or chaperones assisting with the translocation of the system 
components (194,195). One of these components, which is present in most T6SS clusters 
is the  hexameric AAA+ ATPase, which is known to hydrolyse ATP to assist with the 
transportation of the proteins through the export system (196). For instance, in P. 
aeruginosa ClpV1 has been shown to act as an energy source for the secretory apparatus 
(192). 
1.9 Cyclic-di-GMP  
Bis- (3’-5’) cyclic guanosine monophosphate or cyclic-di-GMP (cdG) is a ubiquitous 
second messenger, which is very widespread among different bacterial species. It was 
initially discovered from studies in Gluconacetobacter xylinus that identified its role in 
the regulation of cellulose biosynthesis (197). Today, we know that cdG is a soluble 
molecule associated with signal transduction networks in most bacterial species, where it 
functions as a second messenger. Second messengers transfer an environmental signal 
from the cell surface to the interior of the cell, after amplifying and converting it into a 
Figure 1.4: c-di-GMP metabolism in the bacterial cell, GGDEF domains synthesise c-di-GMP and EAL domains 
degrade it. Figure originally published by Urs Jenal and Jacob Malone in Annual Reviews (203). 
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biochemical response, and can have an enormous impact on the biological processes of 
the cell (198).  
1.9.1 Metabolism 
CdG is synthesised by two guanosine-5'-triphosphate (GTP) molecules in a reaction 
catalysed by diguanylate cyclases (DGCs) and is catabolised into 5’-phosphoguanylyl- 
(3’-5’)-guanosine (pGpG) by specific phosphodiesterases (PDEs) (199). The huge 
importance of this molecule became apparent after the advent of widespread whole 
genome sequencing when it was found that over 80% of bacterial genomes encode 
multiple cdG metabolic enzymes (200). These enzymes have conserved GGDEF and 
EAL domains, which were linked to cdG metabolism in a final contribution by the 
pioneering Benziman lab (201). In P. fluorescens Pf-01, 43 proteins containing GGDEF 
and EAL domains have been found (202), and other P. fluorescens genomes encode 
similar numbers of these enzymes. It was found that overexpression of genes containing 
the above domains modulates the intracellular levels of cdG, leading to the expression of 
different phenotypes. These include biofilm formation and cessation of motility when the 
GGDEF domain is overexpressed and a switch to a motile phenotype when an EAL 
domain is overexpressed (203). A minimal functional model which best describes cdG 
regulation comprises a DGC and a PDE, which synthesise and degrade cdG respectively, 
Figure 1.5: Structural representation of cyclic di-GMP. 
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an effector component which interacts with the cdG molecule, and its downstream 
phenotypic target. This whole system is controlled by alterations in the cellular cdG 
concentration (199). It regulates transcription and post-transcriptional procedures as well 
as allosterically controlling protein function. On the level of the microbial population, 
cdG action has been shown to lead to biofilm formation, secondary metabolite production 
and the switch between a planktonic state to a sessile state of living. Finally, cdG can also 
regulate the production of bacterial virulence factors (204). EAL and GGDEF domains 
are commonly located in multi-domain proteins and co-exist with other signalling 
domains commonly found in bacteria, suggesting a complex system of environmental 
regulation of PDE and DGC activity (205)(206,207). Common cdG-associated sensory 
domains include but are not limited to the following: REC, PAS, HAMP, BLUF and GAF, 
etc., and are responsible for sensing environmental stimuli such as light, oxygen 
availability, redox potential, nutrients, osmolarity, population density and other stimuli 
(208). The high number of different proteins, each with its own characteristic domains, 
reveals the complexity of the cdG regulatory network (209). 
1.9.2 Importance to Pseudomonas plant associations 
CdG plays a crucial role in many aspects of the bacterial lifestyle. For instance, it has 
been associated with the switch between a motile and a sessile way of living, i.e. biofilm 
formation. Biofilm formation has been shown to be essential for efficient plant root 
colonisation and as a consequence plays a major role in the successful establishment of a 
beneficial relationship between plants and bacteria (210). In P. aeruginosa, cdG has been 
shown to regulate biofilm formation via FleQ, a transcriptional regulator, which upon 
binding to cdG, activates the expression of biofilm-related genes such as the Pel and Psl 
exopolysaccharides operons. What is more, FleQ is known to repress the flagellar gene 
expression upon the interaction with cdG. As described previously, the flagellum is also 
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known to facilitate adhesion to surfaces and as a result to enhance biofilm formation 
(84,211). 
Additionally, cdG has been linked to surface attachment in Pseudomonas fluorescens 
SBW25. More specifically cdG has been associated with  the Wsp pathway, which is 
responsible for the aggregative, hyper-adherent wrinkly spreader phenotype (212). This 
phenotype is a result of the overproduction of a cellulosic polymer, a product of the wss 
operon, which is in turn regulated by the Wsp chemosensory pathway and WspR, a CheY-
GGDEF like protein involved in cdG metabolism.  CdG regulation of the system leads to  
cellulose expression and attachment enabling more efficient surface colonisation (213), 
(214).  
To investigate further the role of cdG networks and rhizosphere colonisation Silby et al. 
have identified seven cdG-related genes, by In Vivo Expression Technology (IVET) 
analysis, which are upregulated in the sugar beet rhizosphere environment (215).  
Further studies were carried out to identify genes and pathways related to swimming 
motility repression in Pseudomonas fluorescens F113. As part of the work of different 
labs, SadB was originally identified as a protein related to surface adhesion, which acts 
at the beginning of biofilm formation and represses swarming motility by rhamnolipid 
sensing (216,217). The linkage between SadB and cdG is yet unknown and remains to be 
identified. The Gac system is another system implicated in the repression of swimming 
motility in P. fluorescens F113. GacA/GacS is a two-component system which regulates 
the production of secondary metabolites and secreted proteins, like exoprotease and 
cyanide, through repression of the post-translational regulator RsmA (218,219). Recent 
studies have shown that the Gac system is also related to repression of motility and 
biofilm formation (217), and controls/is controlled by cdG signalling proteins (220–222). 
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1.9.3 Binding 
The molecules that recognise and bind c-di-GMP, and trigger a downstream cellular 
response are called effectors and include both proteins and RNA molecules. Effectors 
differ widely from one another in both structure and function and are characterised by the 
different affinities with which they bind cdG. Previous studies have revealed various cdG 
targets. Currently, known cdG effectors and binding targets include PilZ domain proteins, 
diverse transcription factors, HD-GYP domain proteins, RNA riboswitches and even 
inactive GGDEF and EAL domain proteins (223–225). Through these effectors, cdG 
exerts its role and regulates processes at the transcriptional, post-transcriptional and post-
translational levels (200).   
In the first cdG regulatory circuit identified, cellulose biosynthesis in the alpha-
proteobacterium Acetobacter xylinum (197), cdG was shown to bind to BcsA, a 90-kDa 
PilZ-domain protein, involved in cellulose synthesis complex (226,227). Although it was 
initially thought that BcsA was the sole cdG target, subsequent studies showed that this 
Figure 1.6: Representation of the characteristic c-di-GMP signalling model(3).  Reprinted by permission from 
Macmillan Publishers Ltd: [Nature publishing group] (199), copyright (2009). 
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was not the case. This realisation, together with advances in genome sequencing 
technologies, revealed complex cdG signalling networks of GGDEF and EAL/ HD-GYP 
domain proteins in many different organisms, including several not known for cellulose 
synthesis (205,228). This indicated that cdG was likely to regulate other biological 
processes, and implying the existence of additional receptor proteins.  
The perception for a number of years was that cdG should have a single characteristic 
binding protein or domain, resembling the well-understood cAMP binding protein CAP 
or CRP (200,229), which at the time was the only known cAMP binder. However, 
subsequent biochemical analyses have shown that nothing could be further from the case.  
1.9.3.1 PilZ domain proteins 
Further studies led to the identification of PilZ (230) a one-hundred amino acid protein 
domain first confirmed to bind cdG in Pseudomonas aeruginosa (230). To date, various 
examples of cdG based regulation via proteins containing PilZ domains have been 
identified. For instance, in E. coli, cdG interacts allosterically with the PilZ domain 
protein YcgR, resulting in a conformational change of the protein, enabling it to bind to 
and inhibit the rotation of the bacterium flagellum (231). In P. aeruginosa, cdG binding 
to the PilZ-domain protein Alg44 is suggested to regulate alginate production (232), while 
P. fluorescens contains five known proteins containing PilZ domains. PilZ domain 
proteins are well-characterised cdG effectors, and are widespread in bacterial species 
(233). However, although PilZ domain proteins as a family are known to bind cdG, they 
display significant diversity in cdG binding modes, quaternary structures and 
stoichiometries. In addition, some PilZ domain proteins do not bind to cdG, further 
complicating the picture.  
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1.9.3.2 Degenerate GGDEF/ EAL domain proteins 
Another well-known category of cdG effectors are proteins containing either degenerate 
GGDEF or EAL domains. Whereas early studies on these domains focussed on their role 
in the synthesis and degradation of cdG, nowadays it is known that these domains not 
only metabolise cdG but that they also recognise it as a messenger, triggering in this way 
complex cellular and biochemical processes. In addition to the catalytic active site (A-
site), GGDEF domains also have an allosteric inhibitory site (I site) which can bind c-di-
GMP (234). LapD from Pseudomonas fluorescens is a well-studied example of the 
alternative role of these domains. LapD, despite containing both GGDEF and EAL 
domains, does not show any in vitro enzymatic activity but instead it acts as a receptor of 
cdG. CdG recognition by LapD leads to the maintenance of the outer membrane adhesin 
LapA on the surface of the cell (208,235).  Other degenerate GGDEF/EAL domain 
proteins that bind cdG include PopA in Caulobacter crescentus (236), PelD in 
Pseudomonas, that controls exopolysaccharide production  and Fim, which is involved in 
the regulation of pili function (237).  
1.9.3.3 Binding diversity 
Although the protein categories described above represent well-known cdG targets, in 
recent years more and more unconventional cdG binding proteins have been identified, 
some of them containing completely novel binding clusters. For instance, cdG has been 
recently strongly associated with transcriptional regulation by the identification of DNA-
binding proteins as cdG targets. Some of these include VpsT, BldD, FleQ/ FlrA, VpsR, 
EpsI, LtmA, Bcam1349, MrkH (87,238–246). Several of these proteins employ novel 
ways of interacting with cdG. For example, in the case of MrkH, DNA binding combines 
a previously unknown type of DNA-binding domain with a cdG-binding PilZ domain 
(241). In the case of BldD, binding occurs at the interface between two subunits of the 
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protein, which are linked to a tetrameric cdG cluster in a novel binding site that contains 
no subunit-subunit interactions at all (238). Except for the transcriptional regulators, other 
proteins, in diverse categories, have recently been identified as cdG binding proteins. For 
instance, PgaC/D (247), a membrane-spanning poly-glcNAc synthase was shown to bind 
cdG, as well as the kinase/phosphatase CckA (248). 
The discovery of these novel cdG binding mechanisms indicates the possibility that more 
cdG receptors exist and remain to be identified. In most cases, their prediction through 
bioinformatics approaches is not possible, as cdG binding requires a little more than three 
strategically placed glutamate/arginine residues (229). Identifying binding proteins 
generally requires more sophisticated lab techniques such as pull-down experiments and 
extensive binding tests (249).  
In conclusion, our understanding of the cellular targets of cdG binding is far from 
complete. The discovery of novel, exciting targets is needed in order to understand further 
the mechanisms underpinning cdG metabolism and the processes controlled by this 
molecule in the cell.  
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Chapter 2: Materials and methods 
2.1 Materials 
2.1.1 Antibiotics, enzymes and reagents  
Antibiotics (Sigma) were used at the following concentrations: ampicillin and 
carbenicillin at 100 μg ml-1, kanamycin at 50 μg ml-1, and tetracycline at 12.5 μg ml-1 (in 
80% ethanol). For inducible plasmids, isopropyl β-d-thiogalactopyranoside (IPTG) was 
added to a final concentration 0.5 mM-1 mM as appropriate. Digestions were performed 
with restriction enzymes (New England BioLabs), at 37°C for 2 hours unless otherwise 
stated. Ligations were performed O/N at 16oC with T4 ligase (New England Biolabs) 
according to the manufacturer’s instructions. Polymerase chain reactions (PCR) were 
carried out with Taq (New England BioLabs) and Phusion (New England BioLabs) 
enzymes according to the manufacturer instructions.  
2.1.2 Media and Growth Conditions 
Bacteria were cultured in Luria-Bertani (LB) medium (10 g NaCl, 10 g tryptone, 5 g yeast 
extract), King’s B (KB) medium (10 g glycerol, 20 g Protease Peptone No.3, from BD, 
1.5 g K2HPO4.3H2O, 1.5 g Mg2SO4.7H2O L-1) and M9 minimal medium supplemented 
with 0.4% pyruvate as a carbon source [10 ml M9 salts (10x), 200 μl MgSO4 (1M), 200 
μl CaCl2 (50mM), 2 ml pyruvate (20%) in 100 ml final volume]. Where appropriate, agar 
was added to a final concentration 1.5%. Bacteria were grown O/N in the appropriate 
medium at 37oC for E. coli and 28oC for P. fluorescens under shaking conditions. For 
protein overexpression, Terrific broth (Deionized H2O to 900 mL, 12 g tryptone, 24 g 
yeast extract, 4 ml glycerol, 100 mL of a sterile solution of 0.17 M KH2PO4, 0.72 M 
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K2HPO4) was used. The overexpressions were carried out at 18
oC O/N, under shaking 
conditions. 
2.1.3 Strains and Plasmids 
All the strains and plasmids used in this study are listed in Table 2.1. Primers are listed 
in Table 2.2. 
Table 2.1: Strains and plasmids 
Strains Description Reference 
E. coli BL21-(DE3) SmR, K12 recF143 lacIq lacZΔ.M15, xylA Novagen 
E. coli DH5α endA1, hsdR17(rK-mK+), supE44, recA1, 
gyrA (NalR), relA1, Δ(lacIZYA-argF) U169, 
deoR, Φ80dlacΔ(lacZ)M15 
(250) 
SBW25 Environmental P. fluorescens isolate (251) 
Pto DC3000 RifR derivative of P. syringae pv. tomato 
NCPPB 1106 
(252) 
Salmonella enterica pv. 
typhimurium  
Strain LT2 (253) 
Sinorhizobium meliloti  
 
Strain 1020 (254) 
Plasmids   
pETNdeM-11 KmR, purification vector, N-terminal His6-tag (255) 
pQLinkG2 AmpR purification vector, N-terminal GST tag (256) 
pTYB12 AmpR purification vector, Intein tag (257,258) 
pET42b KmR, purification vector, C-terminal His6-tag Novagen 
pME6032/ wspR19 TetR, overexpression vector Malone lab 
unpublished 
pET42b/ PFLU4401 For the overexpression of PFLU_4401 This study 
pET42b/ PFLU6126 For the overexpression of PFLU _6126 This study 
pET42b/ PFLU0463 For the overexpression of PFLU_0463 This study 
pET42b/ PFLU4320 For the overexpression of PFLU 4320 This study 
pET42b/ PFLU4414 For the overexpression of PFLU 4414 This study 
pET42b/ PFLU4531 For the overexpression of PFLU_4531 This study 
pTYB12/ PFLU1582 For the overexpression of PFLU_1582 This study 
pTYB12/ PFLU4531 For the overexpression of PFLU_4531 This study 
pTYB12/ PFLU4622 For the overexpression of PFLU_4622 This study 
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pETNdeM-11/ PFLU0001 For the overexpression of PFLU_0001 
(DnaA) 
This study 
pETNdeM-11/ PFLU3809 For the overexpression of PFLU_3809 This study 
pETNdeM-11/ PFLU4732 For the overexpression of PFLU_4732 This study 
pETNdeM-11/ PFLU4436 For the overexpression of PFLU_4436 (FliI) This study 
pETNdeM-11/ PFLU4436/ 
Δ1-18 
For the overexpression of PFLU_4436 (FliI) 
truncated version Δ1-18,  
This study 
pETNdeM-11/ PFLU4436/ 
G176A 
For the overexpression of PFLU_4436 (FliI) 
with a point mutation at G176A 
This study 
pETNdeM-11/ PFLU4436/ 
K181A 
For the overexpression of PFLU_4436 (FliI) 
with a point mutation at K181A 
This study 
pETNdeM-11/ PFLU4436/ 
S182A 
For the overexpression of PFLU_4436 (FliI) 
with a point mutation at S182A 
This study 
pETNdeM-11/ PFLU4436/ 
D265A 
For the overexpression of PFLU_4436 (FliI) 
with a point mutation at D265A 
This study 
pETNdeM-11/ PFLU4436/ 
R170H 
For the overexpression of PFLU_4436 (FliI) 
with a point mutation at R170H 
This study 
pETNdeM-11/ PFLU4436/ 
E208Q 
For the overexpression of PFLU_4436 (FliI) 
with a point mutation at E208Q 
This study 
pETNdeM-11/ PFLU4436/ 
R337H 
For the overexpression of PFLU_4436 (FliI) 
with a point mutation at R337H 
This study 
pETNdeM-11/ PFLU4895 For the overexpression of PFLU_4895 This study 
pETNdeM-11/ PFLU4437 For the overexpression of PFLU_4437(FliH),  This study 
pETNdeM-11/ PFLU0343 For the overexpression of PFLU_0343 
(NtrC),  
This study 
pETNdeM-11/ PSPTO1400 For the overexpression of PSPTO_1400 
(HrcN),  
This study 
pETNdeM-11/ PSPTO1400/ 
K181A 
For the overexpression of PSPTO_1400 
(HrcN)  
This study 
pETNdeM-11/ PSPTO1400/ 
S182A 
For the overexpression of PSPTO_1400 
(HrcN) with a point mutation at S182A 
This study 
pETNdeM-11/ PSPTO1400/ 
D265A 
For the overexpression of PSPTO_1400 
(HrcN) with a point mutation at D265A 
This study 
pETNdeM-11/ PSPTO1961 For the overexpression of PSPTO_1961 (FliI 
from P. syringae) 
This study 
pETNdeM-11/ STY2180 For the overexpression of STY_2180 (FliI 
from S. typhimurium) 
This study 
pETNdeM-11/ SMC03025 For the overexpression of SMC_03025 (FliI 
from S. meliloti) 
This study 
pETNdeM-11/ PFLU6025 For the overexpression of PFLU_6025 
(ClpB2),  
This study 
pETNdeM-11/ PSPTO1960 For the overexpression of PSPTO_1960 
(FliH from P. syringae) 
This study 
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pQlinkG2/ PSPTO1960 For the overexpression of PSPTO_1960 
(FliH from P. syringae) 
This study 
pQlinkG2/ PSPTO1961 For the overexpression of PSPTO_1961 (FliI 
from P. syringae) 
This study 
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2.1.4 Oligonucleotides 
Oligonucleotides were ordered and synthesised by Sigma. They were stored at -20 °C in 
deionised water at a final concentration 100 μΜ. They were diluted at 10 μΜ tο be used 
at a final concentration of 0.2 μΜ in PCR reactions. The primers used in this study are 
enlisted in the following table: 
Table 2.2: Primers and expression vectors 
Gene target Description Sequence 
PFLU0001 DnaA Forward CATTAATCATATGTCAGTGGAACTTTGGC 
PFLU0001 DnaA Reverse CTATCTCGAGCGTTGTCAGTGTACGC 
PFLU4401 PFLU4401 Forward CTTAATTCATATGGCCGGCATTCTCGACA
C 
PFLU4401 PFLU4401 Reverse TAAGCTCGAGGGCGGGCACTTCGTC 
PFLU4401 PFLU4401 XhoI site-
directed mutagenesis 
Forward 
GCGTGAAAAACTAGAGGACCCGGTCC 
PFLU4401 PFLU4401 XhoI site-
directed mutagenesis 
Reverse 
GGACCGGGTCCTCTAGTTTTTCACGC 
PFLU6126 PFLU6126 Forward CATTAATCATATGGCCGTCAAGAAACGA
G 
PFLU6126 PFLU6126 Reverse CTATCTCGAGGCGGATGTGAGCAAG 
PFLU6126 PFLU6126 XhoI Site-
directed mutagenesis 
Forward 
ATCGCACGTCTAGAGCAGCGCCTG 
PFLU6126 PFLU6126 XhoI Site-
directed mutagenesis 
Reverse 
CAGGCGCTGCTCTAGACGTGCGAT 
PFLU0463 PFLU0463 Forward CATTAATCATATGCGCGTACTGGTAATC 
PFLU0463 PFLU0463 Reverse CTATCTCGAGGTGCAGCTCCTCAGC 
PFLU4320 PFLU4320 Forward CATTAATCATATGTGCGGATTAGCTGGA
G 
PFLU4320 PFLU4320 Reverse CTATCTCGAGGATTCCTTGTTCGCTG  
PFLU4531 PFLU4531 Forward GTTTAACTTTAAGAAGGAGATATACATA
TGAAAGCGCCCCGCGTTACCCT 
PFLU4531 PFLU4531 Reverse GTGGTGGTGGTGGTGGTGGTGGTGCTCG
AGGGCCTGCCGGGGCGCGGCGA 
PFLU1582 PFLU1582 Forward TTACATCATATGAGCGAACACGAGCGCG 
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PFLU1582 PFLU1582 Reverse AGATTGAATTCTCAGCGCATTTTCAAG 
PFLU4531 PFLU4531 Site directed 
mutagenesis, NdeI site 
Forward 
TCGCCCACCACATGGAGCAGGGC 
PFLU4531  PFLU4531 Site-directed 
mutagenesis, NdeI site, 
Reverse 
GCCCTGCTCCATGTGGTGGGCGA 
PFLU4531 PFLU4531 Forward TTACATCATATGAAAGCGCCCCGCGTTA
C 
PFLU4531 PFLU4531 Reverse AGATTGAATTCTCAGGCCTGCCGGGGC 
PFLU4622 PFLU4622 Forward TTACATCATATGGCTGTCAAAACAAATA 
PFLU4622 PFLU4622 Reverse AGATTGAATTCTTACAGGTGGAAGCG 
PFLU3809 PFLU3809 Forward TTACTTCATATGCCCACCCGCTCGAAGAT
C 
PFLU3809 PFLU3809 Reverse AGATTGAATTCTTACTTCAACTTGGCAAT
CGCCG 
PFLU4732 PFLU4732 Forward TTACTTCATATGTCTACGGGTAATTTGGA 
PFLU4732 PFLU4732 Reverse AGATTGAATTCTTACTTGGCCTGGTAAAT
G 
PFLU4436 PFLU4436 Forward TTACTTCATATGCGCCTTGATCGCACCAG 
PFLU4436 PFLU4436 Reverse ATATTCAATTGTTAGCCGCCCGGCGCG 
PFLU4436  PFLU4436 G176A 
Forward 
CCTGTTCGCCGCTACCGGCGTGG 
PFLU4436  PFLU4436 G176A 
Reverse 
CCACGCCGGTAGCGGCGAACAGG 
PFLU4436  PFLU4436 K181A 
Forward 
CGGCGTGGGTGCGTCGGTGTTGC 
PFLU4436  PFLU4436 K181A 
Reverse 
GCAACACCGACGCACCCACGCCG 
PFLU4436 PFLU4436 S182A 
Forward 
CGTGGGTAAGGCGGTGTTGCT 
PFLU4436 PFLU4436 S182A 
Reverse 
AGCAACACCGCCTTACCCACG 
PFLU4436 PFLU4436 D265A 
Forward 
GTTGCTGATGGCCTCGCTCACGC 
PFLU4436 PFLU4436 D265A 
Reverse 
GCGTGAGCGAGGCCATCAGCAAC 
PFLU4436 PFLU4436 R170H 
Forward 
CGCGGCCAGCATCTGGGCCTG 
PFLU4436 PFLU4436 R170H 
Reverse 
CAGGCCCAGATGCTGGCCGCG 
PFLU4436 PFLU4436 E208Q 
Forward 
CGGGGCCGTCAGGTGAAGGAA 
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PFLU4436 PFLU4436 E208Q 
Reverse 
TTCCTTCACCTGACGGCCCCG 
PFLU4436 PFLU4436 R337H 
Forward 
GACTCGGCGCATGGCGTGCTC 
PFLU4436 PFLU4436 R337H 
Reverse 
GAGCACGCCATGCGCCGAGTC 
PFLU4895 PFLU4895 Forward TTACTTCATATGCGTATCCACGTCAGT 
PFLU4895 PFLU4895 Reverse AGATTGAATTCTCAGGGCTTGTTGGAG 
PFLU4437 PFLU4437 (FliH) 
Forward 
TTACTTCATATGTCGAACAAAGATGAG 
PFLU4437 PFLU4437 (FliH) 
Reverse 
AATCTGAATTCTCAAGGCGCATCGGG 
PFLU4436 FliI Δ1-18 Forward TTACTTCATATGACATCGTTGCCCGGCCA
G 
PFLU0343 NtrC Forward TTACTTCATATGAGCCGTAGTGAAACCG 
PFLU0343 NtrC Reverse AATATCAATTGTCAGCCTTCATCGC 
PSPTO1400 HrcN Forward TTACTTCATATGAACGCCGCACTGAACC
AG 
PSPTO1400 HrcN Reverse AATATGAATTCTTACTCCGGCAGTTGCGA
G 
PSPTO1961  Pto DC3000 fliI Forward TTACTTCATATGCGCCTTGATCGCGTGAG
  
PSPTO1961  Pto DC3000 fliI Rev AATATCAATTGTCAGCCGCCAGGGG 
STY2180  S. typhimurium fliI 
Forward 
TTACTTCATATGACCACGCGCCTGACC 
STY2180  S. typhimurium fliI Rev AATTGAGAATTCTCACACCGTCGGGAAA
AT 
SMc03025  S. meliloti fliI Forward TTACTTCATATGGCACGCGAAGCCGCTG 
SMc03026  S. meliloti fliI Rev AATATCAATTGTCATCCCCTTCCGCGCA 
PFLU6025  SBW25 clpB2 Forward TTACTTCATATGGGTGAAATCAGTCGC 
PFLU6025  SBW25 clpB2 Rev AATATCAATTGTCAATCTGCGTCGC 
PSPTO1400 HrcN K181A Forward CGGTTGCGGCGCGACCACGCTGA 
PSPTO1400 HrcN K181A Reverse TCAGCGTGGTCGCGCCGCAACCG 
PSPTO1400 HrcN S182A Forward GCGGCAAGGCCACGCTGATG 
PSPTO1400 HrcN S182A Reverse CATCAGCGTGGCCTTGCCGC 
PSPTO1400 HrcN D265A Forward GCTGCTGCTCGCCTCCCTGACCC 
PSPTO1400 HrcN D265A Reverse GGGTCAGGGAGGCGAGCAGCAGC 
PSPTO1960 FliH Pto His Forward TTACTTCATATGTCCAGTTCCAATAAAG 
PSPTO1960 FliH Pto His Reverse AATATCAATTGTCAAGGCGCATCGAGAG 
PSPTO1960 FliH Pto GST Forward AATCGAGGATCCATGTCCAGTTCCAAT 
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PSPTO1960 FliH Pto GST Reverse TCGATTGCGGCCGCTCAAGGCGCATCGA
G 
PSPTO1961 
 
FliI Pto GST Forward AATCGAGGATCCATGCGCCTTGATCGCG
TGAG 
PSPTO1961 FliI Pto GST Reverse TCGATTGCGGCCGCTCAGCCGCCAGGGG
CCGG 
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2.2 Methods 
2.2.1 Molecular Biology Procedures 
Cloning was performed according to standard molecular biology techniques. Purification/ 
overexpression vectors based on pET42b were produced by ligating PCR fragments 
between the NdeI and XhoI sites as appropriate. pETNdeM-11 backbone were generated 
by ligating PCR fragments between the NdeI and EcoRI sites of plasmid pETNdeM-11 
(255) as necessary. pQLinkG2-based (Addgene plasmid #13671) overexpression and 
purification vectors were produced by ligating PCR fragments between the BamH I and 
Not I restriction sites (256). pTYB12 was used for the Intein Mediated Purification using 
an Affinity Chitin-binding Tag (New England Biolabs, IMPACTTM kit, N6902S) based 
on the manufacturer’s instructions (257,258). Overexpression vectors based on pTYB12 
were produced by ligating PCR fragments between NdeI and EcoRI sites as appropriate. 
Site-directed mutagenesis by overlap extension  (259) was used to generate the ATPase 
active site (Walker A and B motifs) and the binding site mutations in both FliI and HrcN 
using the appropriate primers (Table 2.2). The constructs were then cloned into the 
appropriate overexpression vectors (Table 2.1). 
2.2.1.1 PCR 
Polymerase chain reaction was carried out in an ARKTIK thermal cycler (Thermo Fisher 
Scientific). A standard 50 μl reaction contained: 10 μl dNTPs (2 mM), 5 μl polymerase 
buffer (10x), 0.5 μl Taq polymerase or 0.5 μl Phusion polymerase, 2.5 μl of each primer 
(10 μΜ), 1 μl DNA template, made up to 50 μl with deionised water. The standard 
protocol followed was based on the polymerase manufacturer’s instructions. Based on 
that, the initial denaturation of the DNA template was carried out in a single step for 3 
min at 95°C. For the amplification of the product of interest, 25 cycles of denaturation for 
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30 sec at 95°C were performed, followed by annealing for 30 sec at the appropriate 
temperature (56°C – 62°C depending on the primer melting temperature, Tm) and strand 
extension for 1-2 minutes at 72°C for 30 sec. A 5-minute extension step at 72°C was 
included before the sample was kept at 4°C. 
2.2.1.2 q-RT PCR 
For the RNA extractions, 100ml of LB were inoculated with the strains of interest and 
were grown O/N at 37oC. For the overproduction of cdG in some of the strains, WspR, a 
cyclase was overexpressed in pME6032 vector by adding 0.5mM IPTG to the cultures 
when they reached an OD of 0.5-0.8 and growing them O/N at 37oC. The cells were 
harvested by centrifugation and the RNA isolations were carried out using the RNeasy 
Mini kit by Qiagen according to the manufacturer’s instructions. For the cDNA 
generation, the QuantiTect Reverse Transcription Kit was used, following a two-step 
approach. The first step towards the cDNA synthesis was the elimination of the genomic 
DNA from the RNA samples. For that, 500 ng of RNA were used and incubated for 2 
minutes at 42oC with the gDNA Wipeout buffer included in the kit. For the second step 
of the reaction, the reverse transcription mix (Quantiscript Reverse Transcriptase, RNase 
inhibitors, RT buffer, RT primer mix) was added to each reaction, and it was followed by 
15 minutes’ incubation at 42oC and then at 95oC for 3 minutes for the inactivation of the 
reverse transcriptase.  The cDNA concentrations were quantified by Nanodrop, and they 
were normalised accordingly.  For the qPCR step, the Bioline SensiFAST SYBR No-
ROX Kit (#98005) was used. 50 μl final volume reactions were used with 100 ng cDNA, 
250nM of the forward and reverse primer and 1x SensiMixTM SYBR® No-ROX 
respectively in each reaction.  
For the analysis, the BioRad CFX96 Touch real-time PCR detection system was used. 
White plates were used (Bio-Rad hard-shell white PCR plates #HSP9601). The thermal 
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cycling conditions followed were 10 minutes at 95oC for the polymerase activation, and 
40 cycles of 95oC for 15 seconds, 55oC for 15 seconds and 72oC for 15 seconds. The 
results obtained were normalised against the expression of the housekeeping gene RpoD, 
encoding for the σ70 factor.  
2.2.1.3 Agarose gels 
Agarose electrophoresis gels were prepared at a final agarose concentration of 0.8, 1 and 
1.2% depending on the size of the DNA fragments for analysis. The gels were prepared 
in 1x TBE buffer (90 mM Tris-HCl pH 8.0, 0.55% boric acid, 2 mM EDTA) and 10 μg 
ml-1 ethidium bromide were added for the visualisation of DNA under ultraviolet (UV). 
The DNA samples were mixed with sample loading buffer (0.25% bromophenol blue, 
0.25% xylene cyanol, 30% glycerol, Sambrook et al. 1989) before loaded onto the gel. 
Gel electrophoresis was carried out in TBE buffer using a PowerPac™ Universal Power 
Supply (BioRad) between 80 and 130 V until the DNA and dye bars were sufficiently 
separated. As a standard, 1 kb DNA ladder (NEB) was run in parallel with the DNA 
fragments for analysis. The gels were visualised using a UV Transilluminator and Gel 
Documentation System (UVP). 
2.2.1.4 Digestion, purification and ligation  
Cloning was performed by standard molecular biology techniques (260). Plasmid DNA 
extractions from liquid cultures were performed using the NucleoSpin® Plasmid 
extraction kits (Macherey-Nagel). DNA fragments generated by PCR were cleaned up by 
the NucleoSpin® Gel and PCR Clean-up (Macherey-Nagel). Ligations were carried out 
either O/N at 16°C or for 10 minutes at room temperature with 0.5 U T4 DNA ligase 
(New England Biolabs) in a final volume of 10 μl, containing ligase buffer and a 3:1 
molar ratio of vector to insert. 
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2.2.1.5 Transformation of chemically competent Escherichia coli cells 
Competent cells were prepared by growing E. coli cultures to mid-log phase in LB 
medium. The cells were harvested by centrifugation at 4,000g for 15 minutes and were 
washed with ice-cold 50 mM CaCl2 buffer. 30 min incubation intervals on ice were carried 
out between the washing steps. Finally, the cells were pelleted and re-suspended in 100 
μl ice-cold 50 mM CaCl2 for storage at -80oC until transformation. For the transformation, 
either plasmid DNA or the ligation reaction mix were mixed with 50 μl of competent cells 
and incubated on ice for 30 min. The transformations were performed by heat-shock at 
42°C for 2 min, incubated on ice for a further 2 min. The cells were left to recover in 1 
ml of LB medium at 37oC for 2 hours before plating onto selective media. 
2.2.2 Protein biochemistry techniques 
2.2.2.1 Protein overexpression and purification 
For the overexpression of proteins, the E. coli BL21-(DE3) pLysS strains were used. The 
strain was transformed with the overexpression vectors, as appropriate for its protein. For 
the overexpression, 5 ml cultures were grown O/N and were used in a 1:100 ratio to 
inoculate the overexpression cultures. The overexpression cultures were then grown at 
37°C to an OD600 of 0.4 before protein expression was induced overnight with 0.5-1 mM 
IPTG at 18°C. Cells were then lysed by sonication on ice, and the soluble protein fraction 
was recovered by centrifugation at 10,000g for 30 minutes.  His6-tagged proteins were 
purified by NTA-Ni chromatography, in 1 ml HiTrap chelating HP columns (GE 
Healthcare). GST-tagged proteins were purified using glutathione pre-packed columns 
(GSTrapTM HP, 1 ml, GE Healthcare). For the purifications, an AKTA Fast Protein Liquid 
Chromatography (FPLC) system was used (AKTA pure chromatography system, GE 
Healthcare, Life Sciences). For the His-tag protein purifications, the columns were 
equilibrated with 10 volumes of washing buffer (20 mM HEPES, 250 mM NaCl, 2 mM 
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MgCl2, 2.5% glycerol pH 7.5). Cell lysates were loaded to the equilibrated columns, 
which were then washed with 10 volumes of washing buffer containing 50 mM imidazole. 
The proteins were eluted using washing buffer containing 500 mM imidazole, in a single 
step elution. For the GST-tagged proteins, the columns were equilibrated with 10 volumes 
of washing buffer (20 mM HEPES, 250 mM NaCl, 2 mM MgCl2, 2.5% glycerol pH 7.5) 
and loaded with cell lysate. Following protein immobilisation, the proteins were eluted 
with a gradient of washing buffer containing 10 mM reduced glutathione. For the intein 
system purifications, chitin resin was used, and the purification was performed following 
the manufacturer’s instructions (New England Biolabs, IMPACTTM kit, N6902S).  
2.2.2.2 SDS-PAGE gels 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was carried 
out in 4% stacking (0.83ml acrylamide (30%), 0.63ml Tris-HCl pH 6.8, 25μl SDS (20%), 
50μl APS (10%), 8μl TEMED and 2.8ml deionised H2O) and 12 % resolving gels (4 ml 
acrylamide (30%), 3.75ml Tris-HCl pH 6.8, 50μl SDS (20%), 100μl APS (10%), 8μl 
TEMED and 2.1ml deionised H2O). The gels were prepared in Mini-PROTEAN® Tetra 
Handcast Systems (BioRad) according to the manufacturer’s instructions. Protein 
samples were mixed in 1:1 ratio with 2 x SDS loading buffer (0.005% bromophenol blue, 
10% glycerol, 2% SDS, 10 mM Tris-HCl pH 6.8) and were incubated for 4 min at 95°C 
to denature proteins before loading. Broad Range Protein Markers or ColorPlus™ 
Prestained Protein Ladder, Broad Range (New England Biolabs) were used as a standard. 
The gel electrophoresis was performed in SDS running buffer (25 mM Tris, 192 mM 
glycine, 1% SDS) at 120-180 V until the dye front reached the bottom of the gel. Gels 
were stained in InstantBlue (Expedeon) for 1 hour with shaking and were destained with 
water for 1 hour.  
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2.2.2.3 Western blotting 
For the preparation of the protein samples to be analysed by Western, 100ml of LB were 
inoculated with the FleQ-bypass mutants and were grown O/N. On the next day, the cells 
were harvested and the growing media was collected for the identification of exported 
flagellin subunits. The proteins in the media were mixed with an equal volume of ice-
cold acetone and were left to precipitate at -20oC O/N. They were then resuspended in 
100μl of protein buffer. The protein concentration is each sample was normalised 
accordingly before the analysis. SDS-PAGE gels were loaded with the proteins of interest 
and ran as described in the previous section. For the Western blotting, no staining is 
required. Proteins were blotted onto an Immobilon-P PVDF membrane (Millipore) using 
a Western blot module (ThermoFisher Scientific) according to the manufacturer’s 
instructions. The membrane was blocked by TBS-Tween20 solution containing 5% milk 
powder O/N at 8oC. It was then rinsed with TBS-Tween20 and incubated with primary 
(1/10,000 dilution in TBS buffer) and secondary peroxidase antibodies (1/3,000 dilution 
in TBS buffer) (1-2 hours each), with washing steps with TBS-Tween20 in between the 
incubations. The rinsed membrane was developed by incubation of 2.5 ml Amersham 
ECL Western Blotting Detection Reagent (GE Healthcare Life Sciences) for 5 minutes. 
The western blots were visualised by using a CCD camera (ImageQuant LAS 500).  
2.2.2.4 Capture compound screen for cyclic di-GMP binding proteins 
The protocol was performed based on the Nesper et al. publication in 2012 (249). For the 
identification of novel cdG targets in P. fluorescens SBW25, bacteria were grown in M9-
pyruvate and M9-pyruvate complemented with CAS aminoacids, KB and LB, to 
stationary phase and mid-logarithmic phase in 250ml cultures. The cells were isolated by 
centrifugation for 30 minutes at 5,000g. 0.5 g-1 g of the pellet was weighed and 
resuspended in 1- 1.5ml protein buffer (20 mM HEPES, 250 mM NaCl, 2 mM MgCl2, 
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2.5% glycerol pH 7.5) complemented with pellets of protease inhibitor and DNaseI 
(Roche) according to the manufacturers’ instructions. Cells were lysed by sonication on 
ice, and the soluble fraction of the proteins was isolated by centrifugation at 100,000 g 
for 1 hour. The analysis was performed on the soluble fraction of the cell lysates. 600 μg 
of the soluble protein fraction were mixed with the capture compound cdG (CC-cdG) at 
a final concentration of 10 μM. To produce the method’s control samples, cdG, at a final 
concentration of 1mM, was pre-incubated with the soluble lysate fraction to be used as a 
reference. The final volume of the reaction was adjusted to 100 μL with protein buffer, 
and the reactions were incubated for 2 hours at 4oC on a rotary wheel. The reactions were 
UV irradiated for 4 minutes using the caproBox (Caprotec Bioanalytics GmbH, Berlin). 
50 μl streptavidin magnetic beads (Dynabeads, ThermoFisher Scientific) were added 
together with 25 μL of 5x wash buffer (250 mM Tris pH7.5, 5M NaCl, 0.1% n-octyl-β-
glucopyranoside). The samples were further incubated for 30-60 minutes at 4oC on a 
rotary wheel. The target proteins, bound to the magnetic beads, were isolated using the 
provided magnet (caproMag) and the samples were washed five- ten times with 200 μL 
of 1x wash buffer. The beads were resuspended in 20 μL SDS loading buffer (0.005% 
bromophenol blue, 10% glycerol, 2% SDS, 10 mM Tris-HCl pH 6.8) and were incubated 
at 95oC for ten minutes. The samples were loaded on a 12% SDS-PAGE acrylamide gel 
and were ran at 100 Volts for ten minutes. The protein bands were cut and analysed by 
Mass Spectrometry.  
2.2.2.5 Gel filtration chromatography 
Soluble protein extracts were prepared in protein buffer (20 mM HEPES, 100 mM NaCl 
pH 7.5). Gel filtration chromatography was performed on a Superdex 200 10/300 GL 
column by FPLC (AKTA pure, GE Healthcare). The column was equilibrated with 3 
volumes of protein buffer. 100 μL injections of 60 μΜ of FliI and FliIΔ1-18 were performed 
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at a flow rate of 0.5 ml/min. ATP and cyclic di-GMP were added to the protein mix at a 
concentration of 500 μM accordingly and were pre-incubated O/N at 4oC on a rotary 
wheel. The results were plotted in Excel, the baseline for the different samples was 
normalised, and the curves were smoothed using GraphPad.  
2.2.3 Binding tests 
2.2.3.1 Differential Radial Capillary of Ligand Assay (DRaCALA) 
The method was performed as previously described by Roelofs et al. (63). The assays 
were conducted by mixing 4 nM radiolabelled cdG with variable concentrations of the 
proteins of interest. For the synthesis of radiolabelled cdG from [γ32-P]- GTP, the well-
characterized DGC protein, PleD* was used. 10 μΜ of PleD* was mixed with 1 μl of 
[γ32-P]- GTP and was incubated at 37oC for 1 hour. The reaction was inactivated by 10 
minutes’ incubation at 95oC, and the radiolabelled cdG was isolated by centrifuging the 
reaction for 5 minutes at 13,000g. For the analysis, each protein was incubated for 2-5 
minutes with 4nM radiolabelled cdG in protein buffer (20 mM HEPES, 250 mM NaCl, 2 
mM MgCl2, 2.5% glycerol pH 7.5). 5 μL of the sample was spotted on nitrocellulose, and 
a phosphorimager was used for the visualisation of the results. As an alternative to [γ-32P] 
cdG, 2′-Fluo-AHC-c-diGMP was used (BioLog 009) at a final concentration of 0.6 μM in 
some of the experiments.  For the DRaCALA nucleotide competition experiments of 
FliIΔ1-18, 1 mM of each nucleotide was mixed with 10 μM of the protein and incubated for 
30 min.  0.6 μΜ of the fluorescent cdG analogue were then added to the reaction and were 
incubated for 2 minutes before spotting 5 μL on a nitrocellulose membrane for the 
analysis. The results were visualised using a charge-coupled device camera. 
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2.2.3.2 Isothermal Titration Calorimetry (ITC) 
ITC experiments were conducted using an ITC200 Calorimeter instrument (MicroCal 
Inc.). The experiments were performed at 25oC in 20 mM HEPES, 150 mM NaCl, pH 8 
buffer. For the FliI experiment, the calorimetric cell was filled with protein at a final 
concentration of 54 μΜ, which was titrated with 1 mM cdG. For the PFLU_1582 
experiment, the cell was filled with protein at a final concentration of 100 μΜ, which was 
titrated with 1mM cdG. A total number of 18 injections were carried out of a volume of 
1 μL for the first, followed by 2 μL injections for the rest. The ITC data was analysed, 
plotted and fitted to a one-site binding model using the MicroCal Origin software. 
Injections were made at 150 seconds intervals with a stirring speed of 1000 rpm. 
2.2.3.3 Surface plasmon resonance (SPR) 
For the cdG binding experiments, the SPR experiments were conducted using a Biacore 
T200 system. 100 nM biotinylated cdG (Biolog B098) were immobilised on a streptavidin 
chip (GE Healthcare) at a final immobilisation level of 50 RU, with a flow rate of 5 μL/ 
min.  An empty cell was used as a reference for subtraction of non-specific interactions 
subtraction. After the immobilisation, the chip was washed with 1 M NaCl, 50 mM NaOH 
for the removal of any unconjugated streptavidin. The protein samples were prepared at 
the required concentrations in SPR buffer (10 mM HEPES, 150 mM NaCl, 0.1% Tween 
20, 2 mM MgCl2) and were injected with a flow rate of 5 μl/min over the chip for 60 sec, 
90 sec or 120 sec until they reached their saturation level. The buffer was then injected 
onto the chip for 60 or 90 seconds for the calculation of the disassociation time of the 
protein from the chip. 1 M NaCl was used after each injection for the chip regeneration. 
For each protein concentration, three replicates were included as appropriate.  
For the FliH/ FliI interaction experiments, N-terminal His-tagged FliH from 
Pseudomonas syringae DC3000 was immobilised on an NTA sensor chip (GE 
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Healthcare, BR100407) at a final 50 RU immobilisation level. N-terminal GST-tagged 
FliI full length at a final concentration of 10 μΜ, from P. syringae DC3000, was injected 
at a flow rate of 5 μl/ min over the reference and the FliH cell for 60 seconds, followed 
by the buffer for 60 seconds. To test the effects of cdG on the interaction, a range of cdG 
concentrations (0, 1, 10, 100, 1000 μΜ) were pre-incubated with FliI O/N at 4oC.  
2.2.3.4 Differential Scanning Fluorimetry (DSF) 
Shifts in the protein melting temperature were measured by DSF. Reactions of a final 
volume of 20 μl were set up. The final protein concentration used was 10 μΜ; SYPRO 
Orange was used as the detection dye at a final concentration of 5x, and the reactions 
were prepared in 20 mM HEPES, 100 mM NaCl, 2 mM MgCl2 pH 8 buffer. For the 
identification of potential shifts in the melting temperature of the proteins in association 
with cdG, a titration of cdG was carried out (0, 10, 30, 100, 300, 1000 μΜ cdG). The 
reactions were set up in a clear bottom 96-well plate, and the experiment was conducted 
using a Biorad CFX96 instrument. The protocol followed was: 10 minutes at 10oC 
followed by 0.5oC increment up to 90oC and the reactions were kept at 4oC. The results 
were analysed using the Biorad CFX Manager 2.1.  
2.2.3.5 Streptavidin UV Precipitation assay (SUPr) 
The method was carried out as described in (261). 5 ml cultures of E. coli strains carrying 
overexpression vectors for EpsI/ Nla24 and SadB were induced with 0.5 mM IPTG for 5 
hours at 28°C. Empty-vector and  non-induced strains were used as controls. The cells 
were collected by centrifugation were resuspended in 400 μl protein wash buffer before 
they were lysed by sonication. The soluble fraction was collected after centrifugation at 
13000g at 4°C for 1 hour and 45μl of it were mixed with biotinylated cdG (BioLog B098) 
at a final concentration of 30 μM. The mix was then incubated O/N on a rotary wheel at 
8°C and was UV cross-linked for the complexes stabilisation, on the next day. The UV 
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cross-linking was performed on ice for 4 minutes in a UV Stratalinker (Stratagene). For 
the isolation of the biotinylated-cdG bound proteins, 25 μl of Streptavidin magnetic beads 
(Invitrogen) were added and incubated for 1 hour on a rotary wheel at 8°C. A magnet was 
used for the isolation of the Streptavidin magnetic beads. To remove any un bound 
proteins, five-ten washing steps were carried out with 200 μl of protein wash buffer (20 
mM HEPES, 250 mM NaCl, 2 mM MgCl2, and 2.5% (v/v) glycerol pH 6.8). The washed 
Streptavidin beads were resuspended in 15 μl wash buffer with 4x SDS loading buffer 
added. The samples were incubated at 95°C for 10 min and were loaded on a 12% SDS-
PAGE protein gel. The gel was then developed using InstantBlue (Expedeon). 
2.2.3.6 Native acrylamide gel shift assays 
10 μΜ of protein were incubated with 120 μΜ of cdG for 15minutes on ice. The mix was 
UV cross-linked for 1 minute in round-bottom 96-well plates, in a UV Stratalinker on ice.  
A protein-only sample was used as a reference to the method. The samples were mixed 
with 2x sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 1% Bromophenol Blue) 
and loaded onto a native acrylamide gel. For the native gel preparation, 10 ml of 12% 
native PAGE separating gel were prepared by mixing 4 ml of Acrylamide/Bis-acrylamide 
(30%/0.8% w/v), 5.89 ml of 0.375 M Tris-HCl (pH 8.8), 100 μL of 10% (w/v) ammonium 
persulfate and 10 μL TEMED. The electrophoresis was performed in 25 mM Tris and 
192 mM glycine running buffer, at 180 V for 1 hour. The gel was stained using 
InstantBlue (Expedeon).  
2.2.3.7 Native Agarose gel shift assays 
The assay was carried out as described in (262). For the identification of protein shifts in 
agarose gels upon the addition of cdG, 5 μΜ final protein concentration was used and 
was incubated with 100 μΜ of cdG for 15 minutes on ice. The protein mix was UV cross-
linked using a Stratalinker for 1 minute on ice. As a reference, a protein-only sample was 
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included. The samples were loaded on a horizontal 0.8% native agarose gel, which was 
prepared in 25 mM Tris-HCl, pH 8.5, 19.2 mM glycine, with the comb placed in the 
middle. The samples were mixed 1:1 with sample buffer (20% glycerol, 0.2% 
Bromophenol blue, 0.12 M Tris base) and were loaded on the gel. The electrophoresis 
was performed at 50 V constant voltage, for 1 hour, at room temperature. The gels were 
stained with 0.12% Coomassie brilliant blue, 45% methanol, 10% acetic acid for 20 
minutes and were then destained with 45% methanol and 10% acetic acid. 
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2.2.3.8 Capture compound competition assay 
For the competition assay, 10 μΜ of FliIΔ1-18 were mixed with 1 mM of cdG, ATP, ADP, 
NADH, cAMP, cGMP, cdA in separate reactions and were incubated for 30 minutes at 
4oC on a rotary wheel. 10 μΜ of the capture compound (chemically modified, biotinylated 
cdG from Caprotec) was then added to the reaction mixes, which were then incubated 
O/N at 4oC on a rotary wheel. On the next day, the reactions were UV-cross-linked for 4 
minutes using the UV Stratalinker (Stratagene) on ice for the stabilisation of the 
interactions. For the isolation of the cdG-protein complexes, streptavidin magnetic beads 
(Invitrogen) were used in a 1:5 ratio with the protein mixture. The samples were then 
washed 5x with protein washing buffer (20 mM HEPES, 250 mM NaCl, 2 mM MgCl2, 
and 2.5% (v/v) glycerol pH 6.8), they were mixed with SDS-protein loading dye, were 
incubated at 95oC for 10minutes and they were analysed on an SDS-PAGE gel.  
2.2.4 Activity analysis 
2.2.4.1 Linked Pyruvate Kinase / Lactate Dehydrogenase (PK/LDH) ATPase activity assay 
The ATPase activity of the proteins of interest was measured indirectly by monitoring 
NADH oxidation. For the analysis, each protein was prepared in ATPase activity buffer 
(50 mM Tris-Cl, 2 mM MgCl2, 1 mM DTT and 10 mM KCl, pH 8.0). For each reaction, 
1μM final protein concentration was mixed with 5 mM NADH in 10 mM NaOH, 80 mM 
phosphoenolpyruvic acid, 1.5 μl PK/LDH (Sigma) and the appropriate concentrations of 
cdG. The reactions were initiated by the addition of suitable ATP concentrations. 
Experiments were carried out in clear bottom 96-well plates (Elkay laboratory products 
(UK) Limited) in a plate reader (BioTek Instruments inc.) and the enzymatic activity of 
each protein was determined by monitoring the absorbance at A340 with 1-minute 
intervals. The results were analysed by plotting the specific activity of the enzyme (nmol 
ATP hydrolysed/ min/ mg of protein) versus ATP concentration, and the kinetic 
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parameters were calculated by non-linear enzyme kinetics modelling (Hill equation) in 
GraphPad Prism. 
2.2.5 Microscopy techniques 
2.2.5.1 Transmission electron microscopy (TEM) 
For the visualisation of FliI full-length complex formation in TEM, 1-3 μg/ml of FliI full 
length from Pseudomonas fluorescens SBW25 were used. CdG was added to the protein 
mix accordingly, at a final concentration of 1 mM and incubated with the protein O/N at 
4oC. For the visualisation of the samples, the protein sample was negatively stained as 
described by Harris and Horne (1991) (263) in 2% aqueous uranyl acetate, pH 4.5, on a 
400 mesh copper grid with a carbon-coated pyroxylin support film.  The grids were 
viewed in a Tecnai 20 transmission electron microscope (FEI, Eindhoven, Netherlands) 
at 200kV and digital TIFF images were taken using an AMT XR60B digital camera 
(Deben, Bury St Edmunds, UK). 
2.2.5.2 Atomic force microscopy (AFM) 
For the visualisation of FliI and FliI alleles complexes using AFM, 1-3 μg/ ml of protein 
in 10 mM HEPES, 3 mM MgCl2 buffer, were used. CdG and ATP were added, where 
needed at 100μΜ final concentration. The protein samples were immobilised on mica 
slides. The samples were analysed in MFP-3D-BIO (Asylum Research, Santa Barbara, 
CA, USA) AFM instrument. Imaging was performed in tapping mode in air in the 
repulsive regime using Olympus AC160TS cantilevers (Olympus, Japan). The cantilevers 
were driven into oscillation at 10% below their fundamental resonant frequency (typically 
around 320 kHz) and the feedback loop operated using amplitude control. The set-point 
was kept at the minimal value (~ 90% of the free amplitude) that enabled stable tracking 
of the sample surface to eliminate any sample damage. The scan rate was 1 Hz. 
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2.2.6 Mass spectroscopy analysis 
2.2.6.1 Mass spectrometry of cross-linked FliI for the peptide shift analysis 
All the MS analysis was carried out by Dr. Gerhard Saalbach. FliI full length was mixed 
with cdG capture compound (Caprotec) in a 1:1 ratio (10 μM final concentration) and 
cross-linked by UV irradiation for 4 minutes on ice, in a Stratalinker.   The cross-linked 
protein molecules were washed with protein wash buffer and were isolated using 
streptavidin magnetic beads and a magnet. The procedure is described in detail in the 
capture compound method above. A non-cross-linked control was included as a reference. 
The two samples were isolated on an SDS-PAGE gel; the protein bands were cut out, and 
the samples were given for MS-analysis. The analysis was carried out using a nanoLC-
MSMS on an Orbitrap Fusion™ Tribrid™ Mass Spectrometer coupled to 
an UltiMate® 3000 RSLCnano LC system (Thermo Scientific, Hemel Hempstead, UK). 
A PepMap™ 100 C18 LC Column (C18, 2 μm, 500x0.75 mm, Thermo) was used to 
separate the peptides, with a gradient of 0.75% min-1 acetonitrile from 6% to 40% in 
water/0.1% formic acid at a flow rate of 0.3 µl min-1 and infused directly into the mass 
spectrometer. The precursor scans were performed in positive ion mode, at 120 K 
resolution over the mass range 350-1800 (m/z) with no quad isolation (Orbitrap). One 
microscan of 50 ms with an AGC target of 2e5 was used. The threshold for MS2 was set 
to 1.5e4, and both CID and HCD were utilised for the fragmentation of the precursor ions, 
with CE=30 and an isolation window of 1.6 Da (quadrupole) using the automatic 
maximum speed option with ion injection for all available parallelizable time. Dynamic 
exclusion was set to 1 count and 30 s. MaxQuant 1.5.2.8 (www.MaxQuant.org) was used 
to generate recalibrated peak lists. Mascot 2.4 (Matrixscience, London, UK) was used to 
compare the merged HCD and CID peak lists against a partial E. coli database, including 
the expected FliI protein sequence. The precursor and the fragment error tolerances were 
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set to 6 ppm and 0.6 Da, respectively. The enzyme was set to trypsin/P, and a maximum 
of two missed cleavages were allowed. Carbamidomethyl (C) was set as fixed 
modification, and oxidation (M) and acetylation (Protein N-term) were used as variable 
modifications. The Mascot search results were imported into Scaffold 4.4.1.1 
(www.proteomsoftware.com) using identification probabilities of 99% and 95% for 
proteins and peptides. 
2.2.6.2 Mass Spectrometry-Peptide Shift Analysis (MS-PSA) 
MS-PSA analysis was performed as described previously in (264). For the analysis two 
different samples were included, the treated (UV-cross-linked with the cdG CC) and the 
untreated (reference sample). Accordingly, many peptides in the treated samples were 
found to have shifts in their size compared to the untreated sample. The most heavily 
modified peptide after the treatment with cdG CC was identified to be the 
NVLLLMDSLTR peptide. More specifically, the following MS-PSA parameters were 
used for both analyses: num = 8 pmr = 0.001 t1 = 5 t2 = 100 fmr = 0.5 mnds = 2 clusterq 
= True signif = 1 tol = 1 outl = 0.1 nmfp = 20 mofp = 9 mnspg = 2 csf = 2 peakfreq = 2 
nummods = 1 pwss = 4 cp = 3 qual1 = 0.2 qual2 = 0.2 qual1pl2 = 0.5 mrms = 150 maxdev 
= 1.  
2.2.7 Structural analysis 
2.2.7.1 Crystallisation trials 
For the crystallisation experiments, N-terminally His-tagged FliIΔ1-18 at a concentration 6 
mg/mL was used. The protein was crystallised by sitting-drop vapour diffusion in 96-well 
crystallisation plates (Swissci) by mixing 0.3 μl well solution with 0.3 μl protein solution. 
The plates were set up by using either an OryxNano or an Oryx8 crystallisation robot 
(Douglas Instruments). The crystal optimisation experiments were performed manually 
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in 24-well plates (Hampton Research) by the hanging-drop vapour diffusion technique by 
varying the composition of the precipitant solution to improve crystal quality. The best 
FliIΔ1-18 crystals were obtained from 20% (w/v) PEG 4000, 40% (v/v) Glycerol, 0.1 M 
Bicine/ Tris pH 8.5, 0.3 M magnesium chloride and 0.3 M calcium chloride in the 
presence of 1 mM cdG and 1 mM ADP. The crystals were harvested and flash-cooled in 
liquid nitrogen using LithoLoops (Molecular Dimensions). Additional cryoprotection 
was not required due to the presence of glycerol in the crystallisation solution. They were 
then transported to the Diamond Light Source (Oxfordshire, UK), in Unipuck cassettes 
(MiTeGen), where they were maintained at -173°C with a Cryojet cryocooler (Oxford 
Instruments) during data collection. A Pilatus 6M hybrid photon counting detector 
(Dectris) was used for the recording of the X-ray diffraction data on either beamline I02 
or I03, which were then integrated using XDS (265), and scaled and merged using 
AIMLESS (266) via the XIA2 expert system (267). The structure was solved by 
molecular replacement with PHASER (268) starting from the known FliI structure (PDB 
accession code 2DPY) using a dataset collected to 2.4 Å resolution for FliIΔ1-18, in the 
presence of cdG and ADP.  
The protein model and the electron density maps were generated by COOT (269).  The 
model was built manually by altering it to fit in the electron density until the observed 
and calculated data were assessed to have the closest possible match with the data set by 
monitoring the Rfactor and Rfree values.  For the refinement of the protein, structure 
REFMAC was used (270). The water molecules were fitted and refined by ARP/wARP 
(271).  
2.2.7.2 Homology Model Production 
The homology model of the hexameric FliI from P. fluorescens SBW25 was based on the 
published crystal structure of FliI from S. enterica (Protein Databank accession code: 
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2DPY) (272). The two proteins share 63% sequence similarities, and the model was 
created by the Phyre2 server (273).  The model prediction was based on the broad 
structural similarities between FliI and the a and β subunits of the F0F1 ATP synthase. 
The hexameric model was generated by superposing six copies of the monomeric 
structure onto each of the a and β subunits of the bovine F0F1 ATP synthase complex 
(Protein Data Bank accession code: 2JIZ) (274), using the secondary structure matching 
algorithm (275), in the COOT software (269). The structural figures were all generated 
using CCP4 mg (276). 
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Chapter 3: Identification of novel cdG binding proteins  
3.1 Introduction 
CdG is a widespread bacterial second messenger, which regulates growth and behaviour 
in both Gram-positive and negative bacteria. CdG is well known to trigger the switch 
between a motile lifestyle and a sessile one. It has also been associated with biofilm 
formation, one of the leading causes of chronic infections caused by pathogenic bacterial 
strains (e.g. Pseudomonas aeruginosa) (277). An increasing number of cellular processes 
controlled by cdG are emerging, such as the synthesis and export of exopolysaccharide 
(EPS), synthesis of secondary metabolites, different ways of regulating bacterial motility, 
cell cycle control, etc. (224,277,278). As described in the introduction, cdG has various 
binding targets in the bacterial cell. To be able to predict and analyse the pathways and 
processes that are triggered and regulated by cdG, it is imperative to identify these targets. 
Although we have a good understanding of cdG metabolism, surprisingly little is 
currently known about the downstream targets of this molecule.  
In recent years more and more cdG binding proteins have been discovered. While many 
of the established cdG targets have been identified following bioinformatics approaches, 
it is becoming increasingly clear that cdG networks contain many more target proteins 
whose nature cannot be determined bioinformatically. To further understand the 
mechanisms underpinning cdG metabolism and the processes controlled by this molecule 
in the cell, it is essential to identify these missing cdG targets. Although there have been 
some previous attempts that aimed to determine cdG targets from whole cell lysates using 
cdG immobilised to sepharose and affinity chromatography (279,280), there were major 
problems with the physical stability of the sepharose beads, and limited availability 
rendering it difficult to carry out large-scale experiments. 
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For the identification of cdG targets in complex bacterial cell lysates, Urs Jenal’s group 
developed a global approach in 2012 (249). His group introduced a novel tri-functional 
capture compound screen (cdG-CC) as a tool for the effective identification of cdG targets 
from a complex mixture of cell lysates. CdG-CC is a chemically modified cdG molecule 
(Figure 3.1), which has a biotin group attached to it for sorting purposes, and a UV 
reactivity group for the stabilisation of the complexes formed.  
The capture compound is incubated with a crude extract of bacterial cells, and protein-
cdG complexes are stabilised by UV cross-linking. Finally, for the isolation of the 
complexes, streptavidin magnetic beads are employed. The analysis of the bound proteins 
is achieved by Mass Spectrometry (MS) analysis. To reduce the number of false positive 
binders, various nucleotides are incubated with the cdG-CC and whole cell lysates and 
are used as controls for the method. For the evaluation of the method, it is important that 
some known cdG binding proteins can be detected following MS/MS. In both of the 
Figure 3.1: CdG capture compound as described in (249). Reprinted by permission from Elsevier.   
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publications describing the method, as well as in the experiments carried out here, several 
known cdG binding proteins were identified. 
3.2 Aims 
1. To identify novel cdG binding targets by performing pull-down screens. 
2. To select the most interesting targets, and confirm binding using a selection of 
biochemical tools. 
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3.3 Results 
3.3.1 Identification of novel cdG targets 
To identify novel cdG binding proteins in Pseudomonas fluorescens SBW25, a cdG 
capture compound screen was performed in multiple media conditions. The bacteria were 
grown in the following media; M9-pyruvate, M9-pyruvate complemented with CAS 
amino acids, KB and LB to logarithmic and stationary growth phases. The experiment 
was repeated twice per condition and samples pre-incubated with an excess of cdG were 
included as controls. A merged list of potential binding targets, which resulted from the 
different experimental conditions, are presented in the following table 3.1.  
Interestingly, three of the 17 identified potential targets are already known to interact with 
cdG (i.e. PFLU_4738, 1582, 1571). All three are known PilZ domain proteins. The other 
PilZ domain proteins encoded in the P. fluorescens genome are membrane proteins and 
could not be identified in this experiment, as only water soluble fractions were studied. 
Among the identified PilZ proteins, PFLU_4738 is a homolog of E. coli YcgR, the 
flagella brake protein, and a well-established cdG target in E. coli (281). A YcgR homolog 
in P. putida  (FlgZ) has also been characterised (282). 
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Table 3.1: Merged list of potential cdG binding targets as emerged by the different screen 
conditions. 
Protein name Predicted function 
PFLU_0001 Chromosomal replication initiation protein DnaA 
PFLU_0017 Methionyl-tRNA formyltransferase 
PFLU_0022 Quinone oxidoreductase 
PFLU_0142 Uncharacterised- putative membrane protein 
PFLU_0251 Predicted oxidoreductases  
PFLU_0290 glucose-1-phosphate thymidylyltransferase 
PFLU_0355 Fructose bisphosphatase 
PFLU_0463 Lipopolysaccharide heptosyltransferase-1 
PFLU_0667 Adenosine deaminase 
PFLU_0760 Sulphate adenylyltransferase subunit 2 
PFLU_0771 4-Hydroxy-3-methylbut-2-enyl diphosphate reductase IspH 
PFLU_0840 30s ribosomal protein S9 
PFLU_0879 Hypothetical protein 
PFLU_0998 ATP-dependent RNA helicase RhlB 
PFLU_1164 DNA mismatch repair protein MutS 
PFLU_1327 Hypothetical protein- outer membrane 
PFLU_1454 Uncharacterised protein 
PFLU_1571  PilZ domain protein- cdG binding 
PFLU_1582 PilZ domain protein- cdG binding 
PFLU_1597 Hypothetical protein- ppGpp synthetase- RelA/SpoT family 
PFLU_1667 Putative aminotransferase- cell wall biogenesis 
PFLU_2160 Putative dehydrogenase 
PFLU_3017 Two-component system protein 
PFLU_3199 3-oxoacyl-ACP synthase II 
PFLU_3406 Cysteine synthase(only in one) 
PFLU_3481 Hypothetical- AAA 
PFLU_3796 Siroheme synthase 
PFLU_3809 Isocitrate dehydrogenase 
PFLU_4144 Phenylalanyl-tRNA synthetase subunit alpha 
PFLU_4320 Putative asparagine synthetase 
PFLU_4401 Putative Chemotaxis protein 
PFLU_4436 Putative flagellum ATPase 
PFLU_4531 LysR family transcriptional regulator 
PFLU_4578 DNA polymerase III subunits gamma and tau 
PFLU_4589 Cell division protein ZipA 
PFLU_4622 Transcriptional regulator 
PFLU_4738 PilZ domain protein- c di-GMP binding 
PFLU_4874 16S rRNA uridine-516 pseudouridylate synthase 
PFLU_4895 Putative regulatory protein 
PFLU_4900 Cold shock 
PFLU_4908 Translocation protein 
PFLU_4974 Uncharacterised 
PFLU_5043 GMP synthase 
PFLU_5427 Gamma-glutamyl phosphate reductase 
PFLU_5543 Biotin protein ligase 
PFLU_5615 Biotin synthase 
PFLU_5772 tRNA (guanine-N(7)-)-methyltransferase 
PFLU_5828 GlycolatePutative oxidase 
PFLU_5932 Putative uroporphyrin-III C-methyltransferase 
PFLU_6001 Putative exported 
PFLU_6122 Proton-transporting ATP synthase activity, rotational mechanism 
PFLU_6126 Putative chromosome partitioning protein ParB 
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3.3.2 Target selection and analysis 
Following the identification of potential cdG targets (table 3.1), it was necessary to 
confirm that the proteins identified in our screens were indeed specific cdG binding 
proteins. To do this, key targets from the screen were selected (highlighted in bold, table 
3.1), cloned into overexpression vectors, and purified. These were: the chromosomal 
replication initiation protein DnaA (PFLU_0001), the lipopolysaccharide 
heptosyltransferase protein PFLU_0463, the previously unidentified PilZ domain protein 
PFLU_1582, the isocitrate dehydrogenase PFLU_3809, the putative asparagine 
synthetase PFLU_4320, the putative chemotaxis protein PFLU_4401, the flagellum ATP 
synthase PFLU_4436, the LysR transcriptional regulator PFLU_4531, a second 
transcriptional regulator (PFLU_4622), the putative regulatory protein PFLU_4895, and 
the chromosome partitioning protein, PFLU_6126.  
The target genes were cloned into either pET42b, pETM-NdeI-11 or pTYB12 vectors, 
resulting in the attachment of an C-terminal His tag in each case. They were purified using 
an AKTA FPLC system with anti-His Nickel columns. The purifications were optimised 
for each protein, to achieve high purity products that remain soluble and active in solution. 
3.3.3 Binding testing 
In order to test the purified proteins, it was essential to develop and optimise simple and 
rapid assays that would allow the simultaneous examination of a large number of proteins 
for cdG binding. 
The first assay used was the Differential Radial Capillary Action of Ligand Assay 
(DRaCALA). In DRaCALA, radiolabelled cdG is mixed with the protein, or the lysate 
overexpressing the protein of interest, and binding is indicated by the formation of an 
inner ring in the middle of the spot on a nitrocellulose membrane (283). 
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Initially, E. coli whole cell lysates overexpressing PFLU_0001, PFLU_4401, 
PFLU_6126, PFLU_0463 and PFLU_4320 were tested. PleD* was used as a positive 
control. This protein is a phosphorylation-independent, constitutively active form of the 
PleD diguanylate cyclase (284). Strong, unambiguous binding could not be detected for 
any of the selected proteins (Figure 3.2). However, in some cases, there was a hint of an 
inner ring, which encouraged us to investigate further by testing the purified proteins 
instead of the lysates.  The most promising targets were examined with a series of 
additional assays to confirm that the results were reproducible.  
 
  
Figure 3.2: DRaCALA on whole cell lysates overexpressing a selection of potential cdG targets identified in the capture 
compound screen. PleD* was used as a positive control for binding. Non-induced whole cell lysates were used as a 
negative control. The lysates were incubated with the radiolabelled cdG either for 5 or 45 seconds.  
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3.3.4 Method evaluation using the cdG-binding protein, PleD* 
The first protein tested for evaluating the methods was PleD*, a known cdG binding 
protein. Firstly, the overexpression and purification of the protein were optimised to 
achieve a high protein yield (Figure 3.3- A). The purified protein was then tested for 
binding by DRaCALA, where a clear inner, binding ring was formed, strongly indicating 
binding (Figure 3.3- B-II). Once PleD* binding had been confirmed by DRaCALA, the 
next assay carried out was Differential Scanning Fluorimetry (DSF) (285), a method 
measuring changes in the melting temperature of the protein upon addition of a ligand. 
An increase in the melting temperature of PleD* was demonstrated upon the addition of 
increasing concentrations of cdG (Figure 3.3- C). This directly indicates the effect cdG 
has on the conformation of PleD*, which leads to changes in the stability of the complex 
and as a result on the Tm of the protein. 
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Figure 3.3: Purification and analysis of PleD* as a positive control for cdG binding. A. Protein purification fractions. The 
protein was purified using an FPLC-AKTA system to high quantities and extra purity. B. DRaCALA assay. Negative, non-
binding control. PleD* (3 μΜ) binding spot C. Differential Scanning Fluorimetry (DSF). The melting temperature of the 
protein increases as the cdG concentration raises (0 μΜ, 1 μΜ, 3 μΜ, 10 μΜ, 30 μΜ, 100 μΜ), indicating a role of cdG in 
the conformation of the protein. 
 
 
 
 
 79 
 
3.3.5 Testing putative binding targets 
3.3.5.1 Lipopolysaccharide heptosyltransferase (PFLU_0463)  
PFLU_0463 is a lipopolysaccharide heptosyltransferase-1, an enzyme known to transfer 
heptoses in lipopolysaccharides. PFLU_0463 is homologous to E. coli and Salmonella 
rfaC, mutations in which were shown to produce an LPS core free of oligosaccharides, 
This, in turn, resulted in reduced motility and the absence of functional flagellum 
filaments, suggesting that oligosaccharides attached to the LPS core are essential for both 
the assembly of the flagellum and for protein secretion (286). 
The protein was purified in high amounts and purity (Figure 3.4- A) and tested for binding 
using DRaCALA. As indicated in Figure 3.4- C, an inner ring was observed for the 
protein sample, indicating binding to cdG. To test if the cdG binding was condition-
dependent, P. fluorescens whole cell lysates were added to the mix, although this did not 
trigger any profound change in binding. Different reagents were also added such as ATP 
and chromosomal DNA, but no changes in binding intensity were observed. In DSF 
(Figure 3.4- B), a mild shift of the melting temperature was observed upon the addition 
of increasing concentrations of cdG. The final binding test carried out was a gel shift 
assay (GSA), an assay monitoring potential size shifts on the protein upon the addition of 
cdG, when analysed on an agarose gel. This assay is differentiated from the native gel 
shift assay, as the proteins are analysed both based on their size and their isoelectric point 
(see Materials and Methods for the description of the assay). In the case of PFLU_0463, 
a clear shift of the protein size was observed upon the addition of raising cdG 
concentrations, strongly indicating binding.  
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Figure 3.4: Purification and analysis of PFLU_0463 for cdG binding. A. Protein purification fractions. The protein was purified 
using an FPLC-AKTA system to high quantities and extra purity. B. Differential Scanning Fluorimetry (DSF). A mild change in 
the melting temperature of the protein was observed upon the addition of increasing concentrations of cdG. C. DRaCALA assay 
- PleD*and BldD (238) were used as positive controls (3 μΜ of each), PFLU_0463 (3 μΜ) gave a positive binding spot, additions 
of Pseudomonas whole cell lysates (0.5 mg/ml) didn’t produce a binding ring, addition of the lysate to the protein didn’t change 
the binding profile, addition of ATP (10 μΜ) didn’t change the binding profile. D. Gel shift assay (GSA), upon the addition of 
increasing concentrations of cdG (0μΜ, 100 μΜ, 200 μΜ, 400 μΜ, and 750 μΜ), shift in the size of the protein is observed.  
C 
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3.3.5.2 PilZ domain hypothetical protein (PFLU_1582)  
The next protein tested was the PilZ domain protein PFLU_1582. PilZ domain proteins 
are known cdG binders. However, not every protein containing a PilZ domain binds to 
cdG. PFLU_1582 is a previously unidentified PilZ domain protein with no previous 
association with cdG binding, so it was necessary to biochemically test binding for this 
protein.  
Once again, the overexpression and purification parameters of the protein were optimised 
(Figure 3.5- A) and the protein was tested in DRaCALA. As presented in Figure 3.5, the 
formation of an inner ring is evident in the DRaCALA assay (Figure 3.5- B- III).  To 
further confirm binding, a DSF experiment was carried out, in which it is evident that 
upon the addition of increasing concentrations of cdG the melting temperature of the 
protein increases (Figure 3.5- C). Finally, the GSA assay was used to confirm cdG 
binding. In this assay the addition of cdG led to a shift in the size of PFLU_1582, 
indicating cdG binding to the protein leading to its conformational change.  Lastly, the 
protein was incubated with 120 μΜ of cdG and was analysed on a native gel, under non-
denaturing conditions. However, there was no effect on the size of the protein after the 
addition of cdG.    
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Figure 3.5: Purification and analysis of PFLU_1582 for cdG binding. A. Protein purification fractions. The protein was 
purified using an FPLC-AKTA system to high quantities and extra purity. B. DRaCALA assay, I. Negative, non-binding 
control, II. PleD* binding spot (3 μΜ), III. PFLU_1582 binding spot (3 μΜ) C. Differential Scanning Fluorimetry (DSF). 
The melting temperature of the protein increases as the cdG concentration raises (0 μΜ, 10 μΜ, 30 μΜ, 100 μΜ, 400 μΜ, 
500 μΜ), indicating a role of cdG in the conformation of the protein. D. Gel shift assay (GSA) on PFLU_1582 (5 μΜ), 
upon the addition of 100 μΜ of cdG, a shift in the size of the protein is observed. E. Native gel of PFLU_1582 (6 μΜ) 
without cdG and upon the incubation with 100 μΜ cdG. No shift in the size of the protein was observed. 
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At this stage, we decided to use an analytical binding assay to PFLU_1582, to acquire 
more information about the nature of the interaction (e.g. the stoichiometry). Isothermal 
Titration Calorimetry (ITC) was employed to probe the cdG-protein interaction (Figure 
Figure 3.6: Isothermal titration calorimetry result showing the interaction between PFLU_1582 and cdG. 
Data collected is shown on the top and the affinity fit on the bottom. The KD was calculated to be ~322nM 
and the stoichiometry of the interaction was calculated to be 1:1. MicroCal Origin software was used to fit a 
single-site fit model. 
KD: ~ 0.322 μM 
N: 0.740 ± 0.0270 sites  
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3.6). Through these experiments, the KD of the PFLU_1582 interaction with cdG was 
determined to be ~322 nM. One molecule of protein was shown to interact with one 
molecule of cdG.  
3. 3.5.3 Flagellum-specific ATP synthase FliI (PFLU_4436) 
The next protein tested was the flagellar ATPase PFLU_4436. PFLU_4436, or FliI, is a 
well-conserved protein among flagellated microorganisms, which forms hexamers at the 
base of the bacterial flagellum and hydrolyses ATP to provide the system with the initial 
energy required for the export of proteins through the flagellum export gate.  
PFLU_4436 was purified in high amounts and purity (Figure 3.7- A). It was first tested 
with DRaCALA, where an inner binding ring was formed, indicating cdG binding (Figure 
3.7- B- III). However, no shift in the melting temperature of the protein was observed in 
DSF (Figure 3.7- C) and also no change in the size of the protein was seen in GSA (Figure 
3.7- D). 
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Figure 3.7: Purification and analysis of PFLU_4436 for cdG binding. A. Protein purification fractions. The protein 
was purified using an FPLC-AKTA system to high quantities and extra purity. B. DRaCALA assay, I. Negative, non-
binding control, II. PleD* binding spot (3 μΜ), III. PFLU_4436 binding spot (2.5 μΜ) C. Differential Scanning 
Fluorimetry (DSF). No change in the melting temperature of the protein was observed upon the addition of increasing 
concentrations of cdG (0 μΜ, 1 μΜ, 3 μΜ, 10 μΜ, 30 μΜ, 100 μΜ, 300 μΜ and 1 mM). D. Gel shift assay (GSA), 
upon the addition of 100 μΜ of cdG, no shift in the size of the protein was observed.  
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Similarly to PFLU_1582, and based on the positive DRaCALA result, the PFLU_4436 
protein was examined further by ITC to confirm binding and find out more about the 
nature of the dinucleotide interaction (Figure 3.8).  
Figure 3.8: Isothermal titration calorimetry result showing the interaction between PFLU_4436 and cdG. Data 
collected is shown on the top and the affinity fit on the bottom. The KD was calculated to be ~3.4 μΜ and the 
stoichiometry of the interaction was calculated to be 2:1. MicroCal Origin software was used to fit a single-site fit 
model. 
KD: ~ 3.4 μM 
N: 0.407 ± 0.0758 sites  
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The KD of PFLU_4436 (FliI) interaction with cdG was determined to be ~3.4 μΜ. The 
stoichiometry of the reaction was calculated to be Ν~ 0.4. This stoichiometry either 
implies that two molecules of the protein are needed for binding of 1 molecule of cdG 
(assuming that N is closer to 0.5), or that the binding happens in a 3:1 protein: cdG ratio 
(assuming that N is closer to 0.3).  A possible interprantation is discussed at the end of 
this chapter. 
3. 3.5.4 False positive targets- Isocitrate dehydrogenase (PFLU_3809) 
Although the proteins described above were proven to be positive binding targets, this 
was not the case for all of the initially selected proteins. PFLU_0001, PFLU_4401, 
PFLU_4531, PFLU_4895, PFLU_6126 as well as PFLU_3809, were shown to be false 
positives (more examples in Appendix 1). For instance, although PFLU_3809 (isocitrate 
dehydrogenase), came up in the capture compound screen as a strong positive target, 
when tested with DRaCALA, DSF and GSA, we saw no indication of cdG binding 
(Figure 3.9).   
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Figure 3.9: Purification and analysis of PFLU_3809 for cdG binding. A. Protein purification fractions. The protein was purified 
using an FPLC-AKTA system to high quantities and extra purity. B. DRaCALA assay, I. Negative, non-binding control, II. PleD* 
binding spot (3 μΜ), III. PFLU_3809 spot (25 μΜ), not binding was observed. C. Differential Scanning Fluorimetry (DSF). No 
change in the melting temperature of the protein was observed upon the addition of increasing concentrations of cdG. D. Gel shift 
assay (GSA), upon the addition of 100 μΜ of cdG, no shift in the size of the protein was observed.  
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3.4 Discussion 
CdG has been known to function as a second messenger for many years. However, it has 
recently become apparent that its importance to bacterial behaviour is broader than 
initially thought. This small molecule has been associated with changes in bacterial 
lifestyle, lipo/exopolysaccharide production and virulence but recently it has also been 
linked to unexpected functions such as the control of Streptomyces development (238).  
To further unravel its importance in bacteria, it is essential to identify novel cdG binding 
targets in the cell. To do so, Pseudomonas fluorescens SBW25 was selected as a model 
organism for the identification of novel cdG targets. P. fluorescens is a biocontrol agent, 
which promotes plant growth by fighting pathogenic microorganisms in the soil, and by 
secreting growth hormones and other beneficial molecules.  
To identify novel cdG binding proteins in P. fluorescens, a series of pull-down 
experiments were carried out based on the cdG capture compound screen, initially 
developed by the Jenal group (249). By carrying out the capture compound screen in 
multiple conditions, many potential cdG targets were identified. However, it was essential 
for these proteins to be tested further by biochemical tools to confirm binding to cdG. To 
do so, the potential targets were cloned, overexpressed and purified in E. coli and tested 
using various biochemical assays. The first assay used was the capillary-action 
radiolabelled assay, DRaCALA. The reason for selecting this assay first was because of 
its simplicity and its speed. DRaCALA simply involves the incubation of radiolabeled 
cdG with the protein of interest, or even with whole cell lysates overexpressing the protein 
of interest before spotting onto a nitrocellulose membrane. Being a quick and easy method 
for the identification of cdG binding proteins, this assay was the ideal initial screening 
tool to test multiple potential binding candidates. Unfortunately, after testing multiple 
proteins of interest, it became evident that results obtained with the DRaCALA assay 
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were inconsistent and prone to false negative results.  For these reasons, it was necessary 
to test the potential targets using alternative biochemical assays, in order to give more 
reproducible and consistent results and to support the initial DRaCALA data. One of the 
assays selected was DSF, a straightforward and precise assay producing consistent and 
reproducible results. DSF gives information about potential alterations in the 
conformation of the protein, and as a result its melting temperature (Tm), upon the addition 
of increasing concentrations of cdG. Although DSF is a valuable tool for the indirect 
identification of protein-ligand interactions, getting positive results from this assay 
requires the addition of the ligand, in this case, cdG, to have a direct effect on the 
conformation of the protein and as a result to cause a change in melting temperature. 
Unsurprisingly, not every protein-ligand interaction leads to an alteration in the protein 
folding and as a result, getting a negative result in DSF doesn’t mean that the protein does 
not interact with the ligand of interest. 
Both DRaCALA and DSF are simple, rapid assays that act as a first indication to confirm 
cdG binding.  However, these methods are both highly dependent on the nature of the 
interaction of the protein with cdG. Based on the idea that an interaction between cdG 
and the potential binding proteins will lead to a multimerization effect of the protein or a 
change in folding that would cause it to behave differently in a native gel environment, 
native gel shift assays were proposed as an alternative binding test. However, no changes 
in the multimerization state of the protein were observed for any of the proteins tested, so 
this method was not pursued further. An easier and simpler assay, which was optimised 
for the proteins of interest was the Gel Shift Assay (GSA), an assay conducted in agarose 
gels. The aim of this assay is similar to the Native gel assay. However, it produces more 
consistent and reproducible results, in a shorter time than native gels.   
 91 
 
PleD* was used as a positive control in all these experiments. This protein is a response 
regulator, which is required for the pole development of Caulobacter crescentus during 
its cell cycle (82). During the Caulobacter cell cycle, PleD is specifically localised to one 
pole of the cell, a procedure which is coupled by the activation of the C-terminal GGDEF 
domain of the protein via the phosphorylation of its N-terminal domain (284). As a 
cyclase, PleD* binds cdG with a high affinity and it is well reported that the condensation 
of GTP to cdG requires the dimerization of the protein (287), making this a highly suitable 
positive control. 
All the assays described above worked nicely for the initial stages of testing as they are 
quick and easy and give multiple options for testing a number of proteins simultaneously 
in various different conditions. However, they do not provide any information about the 
nature of the interaction between the protein and cdG, or the affinity of binding. To further 
characterise proteins of interest, several other tools were employed to more closely probe 
the nature of the cdG-interaction. The first of these was Isothermal Titration calorimetry 
(ITC), which allowed the determination of a cdG binding affinity for PFLU_1582 in the 
low μΜ range (~0.322 μΜ). ITC was also used to confirm further and characterise cdG 
binding to PFLU_4436. In this case, the KD of the reaction was a little higher than for 
PFLU_1582, but was again in the low μM range (~3.4 μΜ), well within the range of 
physiologically relevant binding affinities (288). The stoichiometry of the reaction was 
calculated to be ~0.4. This value can either represent a stoichiometry of 3:1 protein: cdG, 
if closer to 0.3 or a stoichiometry of 2:1 protein: cdG if closer to 0.5. There are a variety 
of reasons why the exact value could not be calculated. For example, changes in the 
conformation and multimerisation state of the protein upon the addition of cdG may 
introduce a consistent inaccuracy in the data, making it impossible to calculate the 
physiological value. It seems more probable that binding happens in a 2:1 ratio, as FliI in 
vivo is frequently present as a dimer; the only possible ratios for binding to this form 
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being 1:1 or 2:1 (289). Although ITC provides lots of information about the nature of the 
interaction, it has high concentration requirements for both protein and ligand. For this 
reason, it is not an ideal method to examine unstable or low-abundance proteins. This was 
a factor for PFLU_4436, which easily precipitates in high concentrations, making it tough 
to test and produce consistent results for this protein with ITC. 
After testing all the proteins described in this chapter, PFLU_4436 (FliI) was selected for 
more detailed analysis. FliI represents an exciting and highly important new cdG target, 
with implications for both the survival and the control of pathogenicity of pseudomonads. 
Although no effects were observed for FliI in the conformation change based assays 
(Figure 3.6- B, C, and D), the DRaCALA binding result was strong and consistent, and 
the initial positive ITC results were encouraging enough to warrant further analysis of 
this protein.  
All the proteins tested are summarised in the following table (Table 3.2). 
Table 3.2: List of proteins tested for cdG binding and outcome in different assays. (+) indicates a positive outcome, (-
) indicates a negative outcome. Absence of a (+)/ (-) symbol indicates that the protein was not tested with the specific 
assay. Positive cdG binders are highlighted in bold.  
Locus  Name DraCALA DSF GSA N-PAGE ITC Outcome 
PFLU_0001 DnaA - -  - - Negative 
PFLU_0463 - + + + -  Positive 
PFLU_1582 PilZ + + + - + Positive 
PFLU_3809 - - - - - - Negative 
PFLU_4320 - - - - -  Negative 
PFLU_4401 - - - - -  Negative 
PFLU_4436 FliI + - -  + Positive 
PFLU_4531 - - -  -  Negative 
PFLU_4622 - - -  -  Negative 
PFLU_4895 - - - -   Negative 
PFLU_6126 ParB - - - -  Negative 
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Chapter 4: FliI binding to cdG, characterisation and 
universality 
4.1 Introduction 
The bacterial flagellum is one of the most important organelles for efficient host 
colonization by both commensal and pathogenic species. P. fluorescens flagella-mediated 
motility is crucial during both the initial stages of plant root colonization as the flagellum 
helps the bacterium to move through the soil towards plant roots, and during later stages 
where the bacterium colonizes plant surfaces, and further migrates into the apoplastic 
space (15).  
Assembly of the bacterial flagellum is a complex process starting from the export of 
extracellular subunits via the flagellum export gate (28,37,290). The AAA+ ATPase FliI 
interacts with FliH and FliJ and forms the soluble, cytosolic fraction of the flagellum 
machinery (67,291). FliI and FliH associate in a heterotrimer (FliH2-FliI) in vivo, which 
acts as a chaperone for the transfer of substrates from the cytoplasm to the flagellum 
export gate. There, FliI forms a hexameric ring and hydrolyses ATP to provide the initial 
energy required for export via the flagellum gate (68). Although it is well reported that 
the majority of the energy needed for flagellum formation is provided by the proton 
motive force (PMF), FliI ATPase activity is essential for the initiation of the export 
process (292,293). 
FliI is a very well-conserved protein among different bacterial species, characterised by 
homologs in every bacterium species equipped with a flagellum. FliI homologs are found 
in major plant pathogens such as Pseudomonas syringae, major human pathogens such 
as Salmonella enterica pv typhimurium and plant symbionts such as Sinorhizobium 
meliloti. In addition to FliI homologs in different species, FliI has well-conserved 
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orthologs in different export systems, such as the closely related Type III secretion system 
(T3SS) and even the more distantly related Type VI secretion system (T6SS). Although 
FliI orthologs among these systems do not share huge similarities, they all form hexamers 
or even dodecamers at the cytoplasmic basal body of the organelle, and have the same 
broad function; to catalyse the hydrolysis of ATP to provide energy for the initial export 
of substrates. 
CdG has been linked several times with the regulation of the bacterial flagellum. For 
example, the expression of the flagellar gene cluster is controlled by the cdG-binding 
transcriptional regulator FleQ (84,87). The control of flagella function has also been 
associated with cdG, which binds to YcgR and FlgZ, basal body-associated proteins, 
leading to reduced flagellar rotation speed in both Escherichia coli and Pseudomonas 
putida, respectively (231,282). 
 The flagellar export ATPase FliI (PFLU4436), was among the proteins positively 
identified in the capture compound screening experiment and subsequently confirmed as 
a cdG binding protein with a KD in the low micromolar range. Due to its widespread 
nature, and the importance of Pseudomonas colonisation and infection, FliI was selected 
from the binding targets identified in chapter 3, and subjected to in-depth biochemical 
analysis.  
After having confirmed cdG binding by DRaCALA and ITC, Surface Plasmon Resonance 
(SPR) was used to further characterise the interaction. SPR is an assay using biotinylated 
cdG immobilised on a streptavidin chip to monitor changes in the resonance of the system 
upon the addition of the protein of interest. When the protein is a positive binder, the 
addition of increasing levels of the protein should result in higher responses until a 
saturating level is achieved. The responses are then plotted against the injected 
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concentrations of protein, and an affinity curve is formed, giving more information about 
the stoichiometry of the reaction. 
4.2 Aims 
1. To biochemically characterise the interaction between cdG and FliI. 
2. To examine the extent to which cdG binding is conserved among FliI proteins from 
different bacterial species, and orthologs in different secretion systems. 
3. To determine the effect of cdG binding on the ATPase activity of FliI. 
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4.3 Results 
4.3.1 Biochemical characterisation of FliI-cdG binding  
4.3.1.1 Confirmation of FliI binding by DRaCALA  
To further characterise the interaction between FliI and cdG, a set of assays was used with 
the aim to produce more consistent and reproducible results. To complement the 
previously results, a DRaCALA assay was performed using a series of different 
concentrations of FliI assayed against a stable concentration of cdG. As shown in Figure 
4.1, the higher the concentration of FliI, the more pronounced the binding results were 
seen for cdG.  To confirm that the results obtained with DRaCALA are specific to cdG, 
the experiment was repeated with radiolabelled GTP and no binding was observed (Figure 
4.1).  
Figure 4.1: DRaCALA FliI titration experiment, FliI full length was added in raising increasing concentrations in 
the assay with a stable radiolabelled-cdG concentration at 4nm. Radiolabelled GTP was also included in the 
assayed but gave no positive binding for FliI. Positive (10 μM PleD*) and negative (10 μM BSA) binding controls 
were included. FliI lacking the first 18 amino acids (FliIΔ1–18) was also included in the assay (10μΜ) giving a 
positive binding spot for cdG but not for GTP. Figure adapted from (326). 
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To overcome the problem of FliI protein aggregate formation, a truncated version of the 
protein lacking the first 18 amino acids was produced. This modification affects FliI 
multimerization, with the truncated allele unable to form hexamers in vitro (294).  
4.3.1.2 FliI binding to cdG is specific 
To further complement these results, a variety of nucleotides (cyclic di-GMP, ADP, ATP, 
NADH, cAMP, cGMP, and cyclic di-AMP), some of which closely resemble the cdG 
structure, were added to the DRaCALA assay to try and outcompete cdG binding. As 
shown in Figure 4.2, cdG was only out-competed when cold cdG was added. In any other 
case, no effect on the binding pattern was observed. To complement these results, a pull-
down experiment, using the chemically modified cdG used in the capture compound 
screen, was carried out in parallel. This was incubated with the purified FliI protein, and 
various nucleotides were added to the mix (cyclic di-GMP, NADH, ADP, ATP, cAMP, 
cGMP, and cyclic di-AMP) to outcompete the capture compound. The same procedure 
used for the capture compound screen was followed, starting with normalised 
concentrations of the protein. After washing the unbound proteins off the capture 
compound, the samples were analysed on an acrylamide gel. The results were in 
agreement with the DRaCALA results, showing that competition is only present in the 
case of externally added cdG.   
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Figure 4.2: A. DRaCALA competition experiment performed on FliIΔ1–18. A variety of nucleotides were included in 
the reaction to test the specificity of cdG binding. B. SDS-PAGE gel showing protein bound to the capture compound 
after pre-incubation with different nucleotides. Figure adapted from (326). 
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4.3.1.3 Testing the FliI-cdG interaction using Surface Plasmon Resonance (SPR) 
As described in chapter 1, ITC was initially used to define the biochemical parameters of 
cdG binding to FliI. This technique showed tight cdG binding with a KD of ∼3.4 μΜ. 
However, it was not possible to refine the ITC protocol sufficiently to produce 
reproducible data. Consequently, surface plasmon resonance (SPR) was employed, 
producing positive, tight binding data with a KD of 2.4 ± 0.2 μM (Figure 4.3).  
Having confirmed that full-length FliI binds to cdG, the FliIΔ1-18 allele was purified and 
tested for binding, resulting in a positive DRaCALA result (Figure 4.1) and an even 
tighter binding affinity (KD: 0.8 ± 0.03 µM) when tested in SPR (Figure 4.4). 
Figure 4.3: A. SPR sensorgrams showing affinity measurements for FliI full-length protein binding to 
biotinylated cdG. A range of FliI concentrations was used (0.312, 0.625, 1.25, 2.5, 5, 10, 20, and 40 μM), with 
three concentration replicates per concentration, included as appropriate. Buffer only and BSA were included 
as negative controls. B. Affinity fit for FliI-cdG binding. The binding response for each concentration was 
recorded 4 s before the end of the injection. The KD values for FliI binding to cdG (2.4 ± 0.2 μM) were 
calculated using by GraphPad Prism. Figure adapted from (326).  
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Figure 4.4: A. SPR sensorgrams showing affinity measurements for FliIΔ1–18 binding to biotinylated cdG. A range of 
protein concentrations was used (0.078, 0.156, 0.3125, 0.625, 1.25, 2.5, 5, and 10 μΜ with three concentration 
replicates per concentration, included as appropriate. Buffer only and BSA were included as negative controls. Β. 
Αffinity fit for FliIΔ1–18-cdG binding. Binding responses were measured 4 s before the end of the injection, and the KD 
values for FliIΔ1–18 binding to cdG (0.8 ± 0.03 μΜ) were calculated by GraphPad Prism. Figure adapted from (326). 
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4.3.2 FliI –cdG binding universality 
4.3.2.1 FliI homologs from other species 
To examine the degree of conservation among FliI proteins from different bacterial 
species, The FliI homologs from Pseudomonas syringae, Salmonella enterica pv 
typhimurium, and Sinorhizobium meliloti were selected for examination by SPR. If these 
diverse homologs bind to cdG, this will go a long way towards establishing this 
interaction as a universal trait among flagella. The fliI genes from the three species were 
Figure 4.5: A- Ι, A-II, SPR sensorgrams and resulting affinity fit for FliIPto binding to biotinylated cdG. B-I and B-II, 
SPR sensorgrams and affinity fit for FliISeT binding to biotinylated cdG. C-I and C-II, SPR sensorgrams and affinity fit 
for FliISm binding to biotinylated cdG. In all three cases, a range of protein concentrations was used (0.625, 1.25, 2.5, 
5, 10, and for FliIPto/FliISeT 20 μM) with three concentration replicates per concentration, included as appropriate. 
Buffer only and BSA were included as negative controls.  The protein binding and dissociation phases for all sensorgrams 
are shown. For the affinity fits, binding responses were measured 4 s before the end of the injection, and KD values for 
each protein were calculated by GraphPad Prism. Figure adapted from (326). 
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cloned into overexpression vectors, and the proteins were overexpressed, purified and 
analysed by SPR. In each case, this resulted in positive binding results (Figure 4.5). 
4.3.2.2 FliI orthologs from the type III and type VI secretion systems  
Next, FliI orthologs from the T3SS as well as the T6SS were selected and tested for 
binding. More specifically, the T3SS ortholog HrcN from P. syringae DC3000 and the 
T6SS ortholog ClpB2 from P. fluorescens SBW25 were chosen. Once again, the genes 
encoding the proteins of interest were cloned, purified and subjected to SPR analysis. 
Figure 4.6: A-I and A-II, SPR sensorgram and resulting affinity fit for HrcN (type III export ATPase) binding to 
biotinylated cdG. B-I and B-II, SPR sensorgram and resulting affinity fit for ClpB2 (Type VI export ATPase) binding to 
biotinylated cdG. In both cases, a range of protein concentrations was used (0.625, 1.25, 2.5, 5, and 10 μM), with three 
concentration replicates per concentration, included as appropriate. Buffer only and BSA were included as negative 
controls. The protein binding and dissociation phases for all sensorgrams are shown. For the affinity fits, binding 
responses were measured 4 s before the end of the injection, and KD values for each protein were calculated by 
GraphPad. Figure adapted from (326). 
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Tight, concentration-dependent binding to cdG was confirmed by SPR in each case 
(Figure 4.6). 
4.3.3 FliI activity and the role of cdG 
4.3.3.1 CdG binding inhibits ATPase activity 
FliI and its orthologs are active ATPases in the cell, being responsible for the hydrolysis 
of ATP when associated with the export gate of the flagellum or the base of the T3SS / 
T6SS. To test the effect of cdG addition on the activity of these enzymes, the pyruvate 
kinase/ lactate dehydrogenase (PK/LDH) linked assay was used. It was observed that FliI 
is an active ATPase (with a Vmax at 1262 ± 54.46 nmol ATP/min/mg), characterised by a 
sigmoidal ATPase activity curve, which could potentially indicate cooperative binding of 
ATP. Addition of 50 μΜ cdG resulted in a significant drop in FliI ATPase activity (Vmax 
dropped noticeably at 867.2 ± 51.65 nmol ATP/min/mg) (Figure 4.7).  
In order to evaluate the scale of the inhibition observed, a cdG titration was conducted 
for the ATPase assay and the IC50 value for the competition calculated (Figure 4.7). The 
Figure 4.7: A, ATPase activity for FliIHis ± 50 μM cdG. FliIHis specific activity (nmol ATP hydrolysed/min/mg protein) is 
shown under increasing ATP concentrations. CdG addition causes a decrease of the Vmax of FliIHis ATPase activity. B, 
IC50 curve for FliIHis ATPase activity upon addition of increasing cdG concentrations. A constant concentration of ATP 
(1 mM) was included alongside 1 μg of FliIHis protein. Figure adapted from (326). 
log [cyclic di-GMP] μΜ 
+ 50μΜ cdG 
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ATPase activity of FliI was progressively inhibited by rising concentrations of cdG, and 
the IC50 of the interaction was calculated to be 36.7 ± 1.13 μM (Figure 4.7). 
Following the ATPase results for FliI, the T3SS protein HrcN was selected for further 
analysis. HrcN was active in solution giving a Vmax of 1183 ± 68.2 nmol ATP/min/mg. 
Upon the addition of 50 μΜ of cdG a similar reduction in activity to FliI was observed 
(to 832.4 ± 119.7 nmol ATP/min/mg (Figure 4.8). A cdG titration experiment was then 
performed to characterise the interaction further and led to an IC50 calculation of 25.11 ± 
1.14 μM. 
4.3.3.2 ATPase activity and cdG-binding can be decoupled 
Following the ATPase inhibition results, the question to be addressed was whether cdG 
binding occurs at the same site as ATP, and if so, does cdG-binding competitively inhibit 
ATPase activity? To test this, the residue positions essential for the ATPase activity 
(Walker A motif positions G176 and K181 and the Walker B motif position D265) were 
mutated by overlap extension mutagenesis. The mutated genes were cloned in pETNdeM-
Figure 4.8: A. ATPase activity for HrcN ± 50 μM cdG. HrcN specific activity (nmol ATP hydrolyzed/min/mg protein) 
is shown under increasing ATP concentrations. CdG addition causes a decrease of the Vmax of HrcN ATPase 
activity. B. IC50 curve for HrcN ATPase activity upon addition of increasing cdG concentrations. A constant 
concentration of ATP (1 mM) was included alongside 1 μg of HrcN protein. The IC50 curve also includes results for 
GTP titration showing no ATPase inhibition. Figure adapted from (326). 
+ 50μΜ cdG 
log [cyclic di-GMP, GTP] μΜ 
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11 expression vector and were overexpressed. The proteins were purified and tested for 
both ATPase activity and cdG binding. Their activity was tested using the PK/LDH linked 
assay, and cdG binding was tested by SPR (Figure 4.9). 
The results obtained showed that whereas in the K181A and D265A mutants, the ATPase 
activity was completely abolished, the mutants still bound to cdG with affinities close to 
the WT. In the case of G176A (a mutant not essential for ATPase activity), a small drop 
in the ATPase activity was observed, whereas the affinity curve produced by SPR was 
indicative for non-specific binding (Figure 4.9). 
Figure 4.9: A, Affinity fit for cdG binding to different FliI alleles (FliIHis, Δ1–18, K181A, D265A, and G176A). 
Sensorgrams obtained using biotinylated cdG were used to calculate the KD values for FliI binding to cdG. At each 
protein concentration, the responses were recorded 4s before the end of the injection. B, ATPase activity for different 
FliI alleles. Protein specific activity in each case (nmol ATP hydrolyzed/min/mg protein) is shown for increasing ATP 
concentrations. Figure adapted from (326). 
Δ1-18 
Δ1
-
18 
Protein concentration (μΜ) 
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4.4 Discussion 
In this chapter, I provide further evidence that the second messenger cdG binds to the 
bacterial flagellum export ATPase FliI. Binding was confirmed by surface plasmon 
resonance and shown to occur in the same physiological range as other characterised cdG 
binding proteins. Binding specificity was confirmed by two independent competition 
assays, providing evidence that binding is not only tight but is also highly specific to cdG.  
FliI is a protein that naturally forms dimers, hexamers or even higher order complexes in 
solution. This effect is even more pronounced at higher concentrations of the protein and 
leads to a non-uniform solution making it hard to use the full-length protein for analytical 
biochemistry. To overcome this problem, a truncated version of the protein lacking the 
first 18 amino acids was produced. It is well reported that the N-terminal end of the 
protein is responsible for the multimerization of the protein (294). As a result, the 
truncated version of FliI cannot form multimers and remains in a uniform, monomeric 
population in solution. 
Having established SBW25 FliI binding to cdG, the next step was to test the universality 
of binding. FliI is a very well-conserved protein among different bacterial species, with 
homologs in every microorganism equipped with a flagellum. FliI homologs from 
multiple bacterial species were tested showing strong, concentration-dependent binding 
activity upon the addition of cdG in surface plasmon resonance. Excitingly, when the 
closely related type III secretion system ortholog HrcN from P. syringae DC3000 and the 
much more distantly related Type VI ATPase ClpB2 from P. fluorescens SBW25 were 
tested, I was able to determine cdG binding at physiologically relevant (low micromolar) 
affinities in each case. These findings are a first indication that cdG may be involved in 
the direct regulation of export via the flagellar, the T3SS as well as the T6SS for a range 
of pathogenic and beneficial bacterial species. 
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To begin to unravel the role of the cdG interaction on protein function, the ATPase 
activity of both FliI and HrcN was measured to determine the effect of cdG on the 
enzymatic function of the protein. Interestingly in the case of FliI, the activity curve 
follows a sigmoid pattern, suggesting positive cooperative binding of ATP. This result 
implies that one molecule of ATP enhances the binding of the next molecule. It was also 
observed that the activity of both proteins is suppressed by the addition of cdG. In this 
respect, the relationship between cdG and the export ATPase proteins resembles binding 
to the transcriptional motility regulators FleQ and FlrA (87,245). These proteins are both 
active AAA+ ATPases and are known binders of cdG, which has been shown to bind 
close to the Walker A motif of the protein. However, this is apparently not the case for 
the export ATPases, as the ATPase activity could be effectively uncoupled from cdG 
binding. FliI/HrcN K181A (Walker A motif) mutants were shown to bind to cdG, in 
affinity levels close to the wild type but lost their ATPase activity, whereas the G176A 
mutant, although it showed severely compromised cdG binding, retained substantial 
ATPase activity. 
Recent studies have shown that energy produced by the enzymatic activity of FliI is only 
required for the initial stages of export and the majority of the energy for protein export 
is provided by the proton motive force (293). My biochemical data shows that the ATPase 
activity of FliI and HrcN is suppressed in the presence of increased cdG levels. CdG may, 
therefore, exert a direct inhibitory effect on the export activity of these proteins. The 
allosteric suppression of AAA+ ATPases by cdG would be consistent with the wider 
literature (87). The fact that the IC50 inhibition value is much higher than the expected 
cdG concentration in the cell (199), indicates that there may be a missing piece in this 
interaction. For instance, it is possible that the ATPase inhibition value may drop to a 
physiological range at the presence of one of FliI/ HrcN’s protein partners in the cell. 
Another possibility is that maybe at a local level, cdG concentrations may reach a higher 
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level, that could be closer to the calculated IC50 value. To date, the highest reported 
concentrations of cdG levels in bacteria have been monitored to be in the low μΜ range 
(1-10μΜ) (199). However, at the moment it is impossible to monitor the local cdG 
concentrations in the cell to prove this point, due to the lack of a suitable method and the 
nature of the molecule itself (easily diffusible in the cytoplasm or bound to metabolising 
or receptor proteins).  
The presence of FliI is essential for the efficient export of protein substrates through the 
flagellum and also plays a gatekeeper role, providing the basal body with the energy 
required to initiate protein export (292). At this stage, it is unclear what the biological 
role of cdG binding is in this system. Based on my results, which showed well-conserved 
FliI binding among diverse bacterial species with a relatively high affinity in each case 
(implying a regular interaction between cdG and the protein in vivo), I propose that cdG 
binding may play a very fundamental role in the control of flagellar function and 
assembly. For example, cdG binding may be required at a basal level for the initiation of 
protein export, perhaps via the promotion of multimerization or the imposition of 
rotational asymmetry to the FliI hexamer (295). It has been reported that basal levels of 
cdG are required for flagella synthesis in both S. enterica and Caulobacter crescentus 
(296,297). In both cases, deletion of all the cdG synthesis proteins resulted in a strain 
unable to produce cdG and led to the loss of flagella-driven motility. In the Salmonella 
cdG- strain, increased expression of flagellar basal body genes was observed, but the 
export of the flagellum filament subunit FliC was severely compromised (297). It is 
unclear at this point whether the mechanism of cdG control at the flagellum would be the 
same for the T3SS and the T6SS but considering that the two systems are reversely 
regulated (222) , it is unlikely for both to be controlled in the same way by cdG.  
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CdG has been associated with flagellar regulation at multiple levels of control. For 
instance, it is known that flagella gene expression in Pseudomonas sp. is controlled by 
FleQ, a known cdG binder, which binds to multiple flagellar loci. FleQ-cdG binding 
results in the abolition of flagella gene expression (84). Flagella rotation is also likely to 
be associated with cdG control in both P. fluorescens and P. syringae, which both contain 
close homologs to the P. putida flagellum brake protein, FlgZ (282). Swarming motility 
in P. aeruginosa is also a behaviour controlled by cdG interference with the two different 
stator complexes; MotAB and MotCD (298). Indirect effects on flagellar construction and 
motility are also caused by exopolysaccharide production and pili biosynthesis, which are 
both regulated by cdG (84,299–302).  
CdG has also been associated with the control of the P. aeruginosa type III and type VI 
secretion systems. However the regulatory pathways, in this case, are less well 
understood. Studies have shown that cdG mediates the switch between the production of 
type III and the type VI secretion pathways by the sRNAs RsmY and RsmZ, via 
interactions with the small translational regulatory protein RsmA (222). RsmA controls 
the translation of both flagella and type III mRNAs in P. aeruginosa (220) and is part of 
a complex regulatory cdG signalling network (221,303). 
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Chapter 5: Structural analysis of FliI and cdG binding site 
determination 
5.1 Introduction 
In chapter 4, the relationship between the hexameric export ATPase, FliI and cdG was 
established. It was shown that cdG binds to FliI and its homologs, as well as FliI orthologs 
in the Type III and Type VI secretion systems both tightly and specifically. To fully 
understand the relationship between cdG binding and the FliI complex, it is essential to 
identify and characterise the cdG binding site.  
Although certain cdG binding proteins have characteristic binding sites, which are 
conserved among many other cdG targets, recent studies have shown that cdG can bind 
to certain target proteins via novel binding motifs, which are not always possible to 
predict in silico (238). The structural diversity of cdG is one of the potential reasons that 
cdG binding motifs can be so different from one another. CdG is a flexible molecule that 
adopts a variety of conformations depending on the specific target. These conformations 
range from a fully stacked form to an extended monomer, through adjustments around 
the glycosidic bond. The guanine base of cdG, being hydrophobic can interact with an 
arginine or a phenylalanine/tyrosine residue, further increasing the range of its interaction 
partners. An interesting characteristic of cdG is also its capacity to oligomerise. CdG has 
been found in a monomeric, dimeric and even the recently-identified tetrameric form 
(238). CdG in the dimeric form is a very versatile molecule, which can adopt even more 
conformations; for instance, the guanine bases can be stacked together or stacked 
partially, and the remaining de-stacked guanine residues to be free to interact with 
available hydrophobic regions in target proteins (229).  
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Determination of the FliI cdG binding site is crucial for the identification of the role of 
this interaction. Although a FliI crystal structure has been resolved for Salmonella 
enterica pathovar typhimurium (272), the interaction of FliI to cdG was unknown when 
this structure was resolved. Nonetheless, this study was of crucial importance as it pointed 
out similarities between the F0F1 ATP synthetase and FliI, by modelling FliI as a hexamer. 
The model was based on the F0F1 structure composed of the α3β3γ subunits. The two 
proteins share similarities at the main chain structures in the interface between the two 
subunits, whereas they are very different when it comes to the outer surface of the 
hexameric ring. The results generated by this study imply a co-evolution of the two 
proteins as, although their function is different, they share similarities in their mechanism 
of action (272). Determination of the binding site not only will it give insights about the 
role of this interaction but also will potentially unravel a new mechanism of cdG binding, 
broadening our understanding of cdG signalling mechanisms. 
5.2 Aims 
1. To structurally characterise the FliI-cdG complex. 
2. To identify and analyse the binding site of cdG to FliI. 
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5.3 Results 
5.3.1 Crystallisation trials 
The first step towards the determination of the binding site was the initiation of 
crystallisation trials in P. fluorescens SBW25.   
The FliI full-length protein has been extensively studied, and it is well-reported for the 
formation of higher order complexes in solution, making it not suitable for crystallisation 
purposes. For that reason, the truncated version of FliI (Δ1-18) from P. fluorescens 
SBW25 was selected for crystallisation purposes as it is unable to form hexamers and 
remains soluble in high concentrations. However, although the protein is highly soluble 
and stays in a monomeric form, it could not be crystallised when it was added to a number 
of different commercial screens. In addition to commercial screening attempts, the 
published crystallisation conditions for the Salmonella protein were applied but again did 
not result in protein crystals. 
Having confirmed cdG binding in a number of different species, my next crystallisation 
efforts focused on the FliI homolog from Salmonella enterica (FliISeT). Although this 
crystal structure is already published (272), the aim was to co-crystallise the protein with 
cdG to determine the binding site. For this reason, the FliIΔ1-18 mutant was used and was 
applied to a number of different commercially available screens. The protein was finally 
crystallised in the Morpheus screen under 20 % w/v PEG 4000, 40% v/v Glycerol, 0.1 M 
Bicine/ Tris pH 8.5, 0.3 M magnesium chloride and 0.3 M calcium chloride, in the 
presence of 1 mM cdG and 1 mM ADP. The crystals had a needle-like structure and in 
order to be diffracted, they needed to grow further in size. To achieve this, a series of 
optimisation experiments were carried out, which gave crystals of a nice size and shape 
(see Figure 5.1).  
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Figure 5.1: A-B. Orthogonal view of mounted crystal (top panels). C-D. Example of diffraction pattern for the best 
FliIΔ1-18 crystal (bottom panels). Crystals were obtained from S. enterica in complex with ADP. Inset highlights the 
weak and diffuse diffraction spots. 
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The FliIΔ1-18 crystals were analysed on beamlines I02 and I03 at the Diamond Light 
Source. Generally, the X-ray diffraction was weak and gave diffuse spots indicative of 
poorly ordered crystals (Figure 5.1). Nevertheless, a number of datasets were collected to 
a maximum resolution of 2.4 Å from crystals of the protein alone, as well as crystals that 
had been soaked with ATP and cdG. All datasets were processed in space group P21 with 
approximate cell parameters of a = 95 Å, b = 73 Å, c = 126 Å,  = 90,  = 94,  = 90, 
these being very similar to those obtained for the deposited structure of FliIΔ1-18 (PDB 
accession code 2DPY) in the same space group (a = 48 Å, b = 73 Å, c = 126 Å,  = 90, 
 = 94,  = 90). The doubling of the a-axis with respect to the deposited structure led to 
a doubling of the unit cell volume and an expected increase from two to four copies of 
the protein monomer in the asymmetric unit (ASU) while retaining the same solvent 
content of 47%. The structure was solved with PHASER using one subunit from 2DPY 
Figure 5.2: A. Overview of the asymmetric unit of FliIΔ1-18 showing, as a cartoon representation, the four copies of the 
subunit in different colours and arranged as a pair of parallel dimers. Also shown as van der Waals spheres are the 
two bound ADP molecules (one per dimer). B. Close-up of the ADP binding site showing the residues involved in 
binding the nucleotide together with their associated electron density (calculated at 2.6 Å resolution and contoured at 
~1.0 σ).  
 
 
A B 
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as the search template. This was successful in placing four copies of the subunit in the 
ASU that were arranged as two dimers (Figure 5.2).  
 
In the soaked crystal, only ADP was visible in the electron density plot, with a single 
ADP molecule bound equivalently to one subunit of each FliIΔ1-18 dimer (Figure 5.2). Due 
to the poor data quality, refinement of the ligand-free and ADP-bound structures was less 
than satisfactory. As the resulting models did not provide any additional biological 
insights beyond those given by the published structure, this aspect of the project was 
suspended at this point.  
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Table 5.1: X-Ray Data Collection and Refinement Statistics for FliIΔ1-18 
Values in parentheses are for the outer resolution shell. a Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl). b Rmeas = ∑hkl 
[N/(N  1)]1/2 × ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl), where Ii(hkl) is the ith observation of reflection hkl, I(hkl) is the 
weighted average intensity for all observations i of reflection hkl and N is the number of observations of reflection hkl.c 
CC½ is the correlation coefficient between equivalent symmetry intensities from random halves of the dataset. d The 
data set was split into "working" and "free" sets consisting of 95 and 5% of the data respectively. The free set was not 
used for refinement. e The R-factors Rwork and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/| Fobs | x 100, 
where Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. f Not fully refined.   
 
Ligand-free ADP-bound 
Data collection   
 Beamline I02 I03 
 Wavelength (Å) 0.9795 0.9795 
 Detector Pilatus 6M Pilatus 6M 
 Resolution range (Å) 53.14 – 2.40 (2.46 – 2.40) 78.08 – 2.60 (2.67 – 2.60) 
 Space Group P21 P21 
 Cell parameters (Å) a = 94.6, b = 72.6, c = 125.6 
 = 90.0,  = 94.0,  = 90.0 
a = 94.9, b = 72.7, c = 126.2 
 = 90.0,  = 93.6,  = 90.0 
 Unique reflections 66398 (4871) 52797 (3846) 
 Multiplicity 5.7 (5.7) 4.2 (4.4) 
 Mean I/(I) 7.8 (1.2) 7.2 (1.0) 
 Completeness (%) 99.5 (99.1) 99.4 (98.9) 
 Rmergea 0.177 (1.555) 0.178 (1.537) 
 Rmeasb 0.195 (1.714) 0.204 (1.746) 
 CC½c 0.996 (0.509) 0.994 (0.465) 
Refinement   
 Reflections: working/freed 63093/3304 50138/2659 
 Rwork/ Rfreee, f 0.261/0.288 0.261/0.291 
 R.m.s. bond distance deviation (Å) 0.012 0.011 
 R.m.s. bond angle deviation ()  1.61 1.51 
 Asymmetric unit contents 4 x FliIΔ1-18 4 x FliIΔ1-18 + 2 x ADP 
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5.3.2 Biochemical and in silico analysis of the cdG binding site 
5.3.2.1 Peptide shift analysis 
Since it was not possible to co-crystallise FliI with cdG, a combination of biochemical 
and in silico analysis experiments was carried out to determine the FliI cdG binding site.  
The first experiment was a novel peptide-shift analysis (264), which was conducted in 
collaboration with Dr Thomas Wilhelm from the Institute of Food Research (IFR). For 
this assay, the chemically modified cdG used in the capture compound screen (cdG-CC) 
was incubated and cross-linked to purified FliI Δ1-18. A sample of the cross-linked protein, 
alongside the unmodified protein as a reference, were digested with trypsin. The digested 
samples were analysed by Mass Spectrometry (MS) and differences between the profiles 
of identified peptides were analysed to provide clues as to the location of the cdG binding 
site. Comparison of the treated sample (cross-linked to cdG-CC) and the untreated 
FliIHis as a reference resulted in the identification of many spectra relations corresponding 
to modified peptides (Figure 5.3).  
One single peptide came back as the most densely modified after UV-cross-linking with 
the cdG-CC (residues 259–269, peptide sequence NVLLLMDSLTR). For this peptide, 
52 spectra relations were identified where the heavier modification was >150 Da larger 
than the unmodified peptide. The identified peptide forms the central strand of a β-sheet 
in the centre of the SBW25 FliI homology model. Interestingly, the C-terminus of the 
same β-strand contains the conserved aspartate (Asp-265) of the Walker B motif. 
Importantly, the identified peptide is facing towards the interface between the two 
monomeric FliI subunits (Figure 5.5- A). 
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5.3.2. 2 Analysis of highly conserved residues 
A second round of in silico analysis was performed to complement the previous results, 
in collaboration with Dr David Lawson. This analysis was based on the conserved amino 
acid residues found in every cdG binding ATPase protein (Figure 5.4), which were then 
mapped on a homology model of FliI from SBW25, constructed based on the published 
Salmonella enterica crystal structure (Figure 5.5).  
The peptide identified from the previous in silico analysis as the most heavily modified 
upon the UV-cross-linking with the cdG-CC emerges close to the cluster of the identified 
highly conserved residues. Together, these two in silico analysis techniques present a 
plausible candidate for the cdG binding pocket, which is potentially formed by residues 
from two FliI subunits, as shown in the model illustrated in Figure 5.5. 
Figure 5.3: Mass Spectrometry Peak Shift Analyses for treated (i.e. cross-linked to cdG) vs untreated. A. The 
particularly dense clusters of related spectra in both analyses correspond to the most densely-modified peptides 
following cdG-capture compound crosslinking. B. The denser network corresponds to the most highly-modified 
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Figure 5.4: Clustal alignment of conserved residues between FliI homologs from other species and orthologs from other 
export systems (HrcN, and ClpB2). Residues similarities between all proteins are marked with asterisks (*), and 
similarities across all six with periods (.) or colons (:). The FliI Walker A/B residues are marked in red while in blue is 
highlighted the capture compound-binding NVLLLMDSLTR peptide, in purple is marked the position of the conserved 
cdG binding arginine in FlrA (Arg-176), and in green are the conserved residues of the proposed cdG binding. Figure 
adapted from (326). 
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Figure 5.5: Homology model of the predicted hexameric SBW25 FliI, based on the published crystal structure of FliI 
from S. typhimurium (Protein Data Bank code 2DPY). A. Interface between two FliI subunits, marked in green is the 
identified NVLLLMDSLTR peptide, implicated in cdG capture compound binding and marked in pink is the conserved 
Walker B aspartate (Asp-265) B. Marked in red are the conserved residues between the six cdG-binding proteins tested 
in this study (based on the conserved residues analysis), ADP is included in the structure, shown to bind at the interfaces 
between the individual FliI subunits. Figure adapted from (326). 
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5.3.3 Mutagenesis of ‘binding’ residues (R, E, G) and subsequent cdG-binding and 
ATPase activity assays 
Following the identification of the potential binding site from the in silico analysis 
described above, some of the key residues identified as part of the potential binding site 
were mutated and tested to confirm their importance in cdG binding. To do this, specific 
amino acid substitutions were introduced (R170H, E208Q, and R337H) in the FliIΔ1–18 
background; then the purified proteins were examined for cdG binding and ATPase 
activity (Figure 5.6). 
The binding ability of the mutants to cdG was monitored by SPR, and it was observed 
that binding was heavily compromised in all three cases (R170H, E208Q, and R337H) as 
the KD of the interaction was beyond the method’s detection limit and could not be 
accurately determined (Figure 5.6- A). The mutants were also tested for their ATPase 
activity (Figure 5.6- B) and were found to be enzymatically inactive.  
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Figure 5.6: A. SPR affinity fit for cdG binding to FliI alleles with amino acid substitutions (FliIΔ1–18, FliIΔ1–
18 R170H, FliIΔ1–18 E208Q, and FliIΔ1–18 R337H). B. ATPase activity for different FliI and the mutated alleles. 
Specific activity for each protein (nmol ATP hydrolysed/min/mg protein) was monitored under increasing ATP 
concentrations. Figure adapted from (326). 
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5.4 Discussion 
To identify the cdG binding site of FliI, crystallisation trials were carried out firstly on 
FliI full length from P. fluorescens SBW25 and then on the truncated allele FliIΔ1-18.  After 
several failed attempts, the crystallisation efforts were refocused on the FliI homolog from 
Salmonella enterica, the crystal structure of which has already been published (272). 
Although the protein was crystallised in the presence of cdG, it was not possible to resolve 
the cdG molecule in the protein structure. However, our crystals could only be generated 
in the presence of cdG, strongly suggesting that cdG may be essential for crystallisation 
of the protein under the specific conditions tested. Although it was not possible to resolve 
cdG structure in the crystals obtained, this may indicate that cdG was indeed present as 
crystals couldn’t be obtained without it but in not a high enough concentration to produce 
a dense enough electron density that would allow the structure to be resolved. 
To identify the cdG binding site and get more information about the nature of binding, 
two independent in silico analyses were employed; the first was a recently developed 
method for the identification of unknown peptide modifications, the peptide shift 
analysis. This analysis resulted in one single peptide, which was identified as the most 
heavily modified upon the addition of cross-linked cdG. The peptide identified consisted 
of 11 amino acid residues (NVLLLMDSLTR) and is located in the core of the SBW25 
FliI homology model. The end of the peptide emerges at the interface created by the two 
FliI subunits and in close proximity to a cluster of highly conserved residues, as identified 
by the seconds in silico analysis. To focus more on the cdG binding site, a predicted model 
was built based on the published FliI structure from Salmonella enterica, with the 
quaternary structure of the complex based on the hexameric F1F0 ATPase, which shares 
many structural similarities with FliI. FliI homologs and orthologs share a small number 
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of highly conserved residues including several glutamate and arginine residues, which are 
known to be required for cdG binding (234) (Figure 5.4). 
As part of this second analysis, the conserved residues among the FliI homologs were 
identified and were mapped on the model. Interestingly the residues were all facing 
towards a pocket formed between the two FliI subunits. These results complemented the 
first in silico analysis, which showed that the end of the modified peptide is also directed 
to the same pocket. The conserved pocket identified contained two arginines (Arg-170 
and Arg-337) from the first subunit and a glutamate (Glu-208) from the second. Both 
arginine and glutamate residues are known to be highly important for cdG binding in 
previously characterised cdG binding proteins (234,238). Residues R170, E208, and 
R337, were mutated and tested for both binding and activity. The residues substitutions 
led to a heavily compromised binding and a loss in ATPase activity. 
 The mutated proteins, except for the loss of cdG binding, they also lost their ATPase 
activity. However, this does not come as a surprise since the amino acid substitutions 
were located in the interface between the two FliI subunits. By mutating these residues, 
it is possible that the active site of the protein was altered because of multimerization 
changes. Another possibility is that these mutations may have direct effects on the folding 
of the protein causing it to lose its activity. The fact that the mutations did not cause the 
protein to precipitate, neither did they lead to a different behaviour when tested by AFM 
(see chapter 6), gives a strong indication that the proteins remained soluble and the loss 
of binding was specific to the residue change in each case. 
 The fact that the binding site was shown to be at the interface between the two FliI 
subunits could have great implications on the role of cdG binding in this class of ATPases. 
For instance, this strategic binding position may serve as a catalyst for cdG to control the 
function of the protein by altering its multimerization state.  
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Chapter 6: Towards the in vivo characterisation of FliI-cdG 
binding  
6.1 Introduction 
FliI is an active ATPase, hydrolysing ATP to provide the initial energy required for the 
export of the flagellar subunits and as a result the construction of a functional flagellum. 
However, it is still unclear how the chemical energy acquired from ATP hydrolysis is 
converted to the mechanical energy required for protein export. Sharing broad structural 
similarities with the F0F1 ATP synthase (272), FliI forms a homo-hexameric complex that 
docks on the export gate of the flagellum, where it exerts its activity. Although the role 
of FliI in protein export is well-reported, recent studies have shown that FliI null mutants 
can still export their substrates via the flagellum export gate, using the proton motive 
force (PMF) alone (68).  
In addition to its role as an ATPase during protein export, FliI also forms heterotrimers 
in the bacterial cytoplasm with another protein, FliH. Together they act as chaperones for 
flagellar subunits, which they then direct to the export gate. FliH also acts on anchoring 
the FliI hexamer to the export gate, where it exerts its full enzymatic activity (304).   
The recent identification of FliI as a cdG binder creates numerous questions concerning 
the in vivo role of this binding. CdG signalling networks are highly complex and 
characterising the interaction of FliI to the cdG molecule in vivo could prove to be a hard 
task. CdG is known to be involved in flagella biosynthesis and function at various 
regulatory levels. To begin with, cdG controls the flagella gene expression by directly 
interacting with the master transcriptional regulator FleQ. The next level of regulation by 
cdG comes at the post-translational level, by the direct interaction of the molecule with 
the flagellar brake protein, YcgR. This leads to a conformational change in the protein, 
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enabling it to bind to, and inhibit the rotation of, the bacterial flagellum (231,281). Finally, 
a newly discovered mechanism of regulation is through cdG interaction with the flagella 
stator complexes (298). The MotCD stator is responsible for swarming motility in 
Pseudomonas aeruginosa, whereas the MotAB stator does not support swarming. When 
cdG levels are increased in the bacterial cell, swarming motility is repressed by the 
MotAB stator. It has been shown that introducing mutations in these stator proteins 
recovers cdG-mediated repression of swarming.  
All these different levels of regulation by cdG, create lots of questions about the newly-
identified role of cdG regulation via FliI. To approach this matter and investigate it 
further, I looked at some common roles of FliI (e.g. flagellar genes expression, export via 
the flagellum) and investigated how these may be affected by increased cdG levels. 
Having proposed that cdG binding occurs at the interface between the two FliI subunits, 
and given that FliI is a protein known to exert its maximum activity and role via 
multimerising in higher order complexes, in this chapter, I focused on the characterisation 
of cdG effects on the multimerization state of the protein. 
6.2 Aims 
1. To investigate the effect of cdG on the flagellar gene expression and protein export. 
2. To examine how cdG addition affects the multimeric state of FliI.  
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6.3 Results 
6.3.1 Effect of cdG on the flagellum genes expression and export via the flagellum 
The first step towards the biological characterisation of FliI binding to cdG was to test if 
this interaction has a direct effect on the export of the flagellum subunits via the export 
gate. The first step towards this goal was to investigate whether the expression levels of 
the flagellum genes are affected by increasing levels of cdG in the recently-published 
FleQ-bypass mutants (305). In the FleQ-bypass mutants, the flagellum genes transcription 
is no longer under the FleQ control but under the control of NtrC, a transcriptional 
regulator in the same family as FleQ. The reason for using these mutants was to overcome 
the well-known cdG-dependent transcriptional control of flagella expression exerted by 
FleQ.   
Quantitative RT-PCR experiments were carried out to monitor the expression of FliC, 
FliI and NtrC in the presence of low and high levels of cdG in the cell accordingly (Figure 
6.1- A). The results presented in Figure 6.1 were normalised against the expression of the 
σ70 factor, RpoD. Overproduction of cdG in the cells was mediated by overexpression of 
the WspR cyclase. As shown in Figure 6.1- A, fliC expression was abolished in the ΔfleQ 
mutant, as expected by the lack of the transcriptional regulator. The overproduction of 
cdG in the wild-type background also led to heavily compromised fliC expression, due to 
the FleQ-cdG interaction. However, in the FleQ-bypass mutants, no cdG-mediated effect 
was observed, proving that cdG has no longer an effect on the expression of the flagellum 
genes.  
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FliI expression occurs at much lower levels in the cell compared to FliC. Furthermore, 
FliI expression is not significantly affected by cdG overproduction in the cell. NtrC 
expression is much higher in the FleQ-bypass mutants with no effect from cdG 
overproduction. However, a significant increase in its expression was observed in the 
wild-type background when the levels of cdG were increased. 
Having established that cdG has no other effect on the expression of the flagellum genes 
in the FleQ bypass mutant, the next step was to test whether increasing cdG levels have 
an effect on FliC export via the flagellum. To test this, a Western blot was performed 
monitoring the levels of the exported FliC in the FleQ-bypass strain overproducing cdG 
in comparison to a strain with basal cdG levels.  To monitor the exported levels of 
Figure 6.1: A. q-RT PCR data monitoring the expression levels of FliC, FliI and NtrC in the wild type background, 
ΔfleQ background, wild type strain overproducing cdG, FleQ bypass mutant and FleQ bypass mutant overproducing 
cdG. The data obtained was normalised against the expression of the housekeeping sigma factor gene, q-RT. B. Western 
blot monitoring the flagellin (FliC) export levels. The exported levels of flagellin were monitored in the media, where 
the bacteria were grown, as described in the Materials and Methods relevant section. I. FleQ bypass mutant, II. FleQ 
bypass mutant overproducing cdG by the overexpression of the WspR cyclase. 
 
Figure 6.1: A. q-RT PCR data monitoring the expression levels of FliC, FliI and NtrC in the wild type background, 
ΔfleQ background, wild type strain overproducing cdG, FleQ bypass mutant and FleQ bypass mutant overproducing 
cdG. B. Western blot monitoring the flagellin (FliC) export levels: I. Wild type strain, II. FleQ bypass mutant 
overproducing cdG 
 
Figure 6.1: A. q-RT PCR data monitoring the expression levels of FliC, FliI and NtrC in the wild type background, 
ΔfleQ background, wild type strain overproducing cdG, FleQ bypass mutant and FleQ bypass mutant overproducing 
cdG. B. Western blot monitoring the flagellin (FliC) export levels: I. Wild type strain, II. FleQ bypass mutant 
overproducing cdG 
 
Figure 6.1: A. q-RT PCR data monitoring the expression levels of FliC, FliI and NtrC in the wild type background, 
ΔfleQ background, wild type strain overproducing cdG, FleQ bypass mutant and FleQ bypass mutant overproducing 
cdG. B. Western blot monitoring the flagellin (FliC) export levels: I. Wild type strain, II. FleQ bypass mutant 
 I       II 
 
 I       II 
 
 I       II 
 
 I       II 
 134 
 
flagellin, the media where the bacteria were grown O/N was collected and the proteins 
present in it were concentrated by acetone precipitation before being analysed further. As 
presented in Figure 6.1- B, the export of FliC is heavily compromised in the presence of 
high cdG levels. This implies that cdG may play a direct role in controlling protein export 
via the flagellum machinery.  
6.3.2 Effects of cdG on the multimerization state of FliI 
6.3.2.1 Size exclusion chromatography 
Having acquired some first indications about cdG involvement in protein export via the 
flagellum, the next step was to test if alterations at the export levels of the flagellum are 
due to changes in the multimerization state of FliI, and as a result a loss of activity.  
To test this, and to monitor the effects that cdG has on the conformation of the protein, a 
series of gel filtration experiments were carried out. As presented in Figure 6.2- A, full-
length FliI runs mostly in the void volume with only a small percentage of the protein 
population running as a dimer. The addition of ATP to the protein had no effect on the 
running size of the complexes. However, when cdG was added, a peak corresponding to 
a dodecameric state was formed (Figure 6.2- A). The truncated version of the protein was 
also used for the identification of potential conformational changes upon the addition of 
cdG and ATP. As expected, this allele is unable to form hexamers by itself and runs as a 
monomer in the size exclusion chromatography column. CdG addition had no effect on 
this allele of the protein in contrast to ATP, the addition of which leads to higher order 
complex formation (dimers and hexamers) (Figure 6.2- B). 
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Figure 6.2: A. Size exclusion chromatography on FliI full length, cdG and ATP nucleotides were added at a 
concentration of 500 μM accordingly. B. Size exclusion chromatography on FliI Δ1-18, cdG and ATP nucleotides 
were added at a concentration of 500 μM accordingly. 
 
Figure 6.2: A. Size exclusion chromatography on FliI full length, cdG and ATP nucleotides were added at a 
concentration of 500μM accordingly. B. Size exclusion chromatography on FliI Δ1-18, cdG and ATP nucleotides 
were added at a concentration of 500μM accordingly. 
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6.3.2.3 Transmission electron microscopy 
To expand on the gel filtration data, two complementary imaging approaches were 
conducted. First, Transmission Electron Microscopy (TEM) was carried out. The TEM 
experiments showed that the FliI full-length protein forms higher order complexes as 
expected. However, these  corresponded to units of a larger size than would be expected 
from the hexameric complexes described in the literature (150). The protein complex 
population was uniformly distributed, and no precipitation was observed (Figure 6.3- A). 
Surprisingly, the addition of cdG caused the protein complexes to cluster together, 
forming distinct ring-like structures (Figure 6.3- B).  
 
Figure 6.3: Transmission electron microscopy (TEM) experiments on FliI full length from P. fluorescens SBW25. 
A. Purified FliI full-length was analysed by TEM. Multimers of 20 nm-50 nm were observed corresponding to 
hexamers, dodecamers and higher order complexes. B. TEM analysis of full length FliI upon the addition of 1 mM 
cdG, ring like structures were observed upon the addition of cdG consisting of FliI higher-order multimers.  
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A. Purified FliI full-length was analysed by TEM. Multimers of 20nm-50nm were observed corresponding to 
hexamers, dodecamers and higher order complexes. B. TEM analysis of full length FliI upon the addition of 1mM 
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6.3.2.4 Atomic force microscopy (AFM) 
The second approach followed for the visualisation of FliI complexes was AFM. 
Similarly to the TEM assays, the AFM experiments revealed the formation of higher order 
complexes of distinct shape and size for FliI full-length (Figure 6.4- A). It was observed 
that FliI full-length population was distributed among hexamers, dodecamers and higher 
order complexes.  As expected, in the case of the truncated version of the protein, which 
is unable to form higher order complexes, no protein clusters were observed as the size 
of the protein in the monomeric and dimeric form is much smaller than the detection limit 
of AFM (Figure 6.4- B). The addition of 100 μΜ cdG led to clustering of the hexamers 
and the formation of circular structures (Figure 6.4- C), dependent on the addition of cdG 
specifically, as no clustering was observed when ATP was added to the protein solution 
(Figure 6.4- D). The FliI G176A mutant, which maintains its ATPase activity but is no 
longer sensitive to cdG, was then tested by AFM. This mutant was able to form higher 
order complexes, as observed in the wild-type background. However, an unexpected 
effect was also noted, the hexameric FliI hexamers accumulate around the bigger FliI 
complexes, creating a ‘halo-like’ effect (Figure 6.4- E). This effect was only observed for 
this specific mutant, whereas the other mutants, introduced in Chapter 5, behaved in a 
similar manner to the wild type (Figure 6.4- F).  
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Figure 6.4: Atomic Force Microscopy (AFM) experiments for the determination of FliI multimerization state. 
A. FliI full length forms hexamers, dodecamers and higher order, regular-sized complexes. B. FliI Δ1-18, the 
truncated protein forms monomers and dimers, which are below the detection limit of the method. C. 100 μΜ 
cdG were added to the FliI full length mix, resulting in the formation of ring like structures, comprising of the 
hexameric/ dodecameric complexes of the protein. D. 100 μΜ ATP were added to the FliI full length mix with 
no obvious results on the multimerization state of the protein. E. FliI full length G176A mutant, accumulation 
of the hexameric and dodecameric complexes was observed around the higher order complexes. No cdG or ATP 
were added. F. FliI full length R337H mutant, forming higher order complexes in a similar to the WT way. No 
cdG or ATP were added.   
 
Figure 6.4: Atomic Force Microscopy (AFM) experiments for the determination of FliI multimerization state. 
A. FliI full length forms hexamers, dodecamers and higher order, regular-sized complexes. B. FliI Δ1-18, the 
+ 100 μΜ cdG  + 100 μΜ ATP  
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6.3.3 FliI interaction with FliH 
FliI is part of a complex system in vivo, being closely associated with its protein partners, 
FliH and FliJ. To test how FliI-FliH interaction is affected by cdG addition, a series of 
SPR experiments were carried out in which the proteins were introduced in turn to the 
assay. FliH with an N-terminal His tag was immobilised on a nickel SPR chip and the 
association with FliI was monitored by flowing purified GST-tagged FliI over the chip. 
CdG was also added in increasing concentrations to the FliI mixture and was pre-
incubated with it before passing it through the FliH chip. It was observed that FliI interacts 
with FliH, filling almost 88% percent of the chip’s capacity (Figure 6.5). The chip’s 
capacity was calculated by subtracting FliI’s binding response by the maximal number of 
binding sites (Rmax) on the SPR chip, which was calculated based on FliH molecules 
bound to the chip. 
Upon the addition of cdG the responses obtained were greater than 100% and even 
reached 450% of the FliI-only response (Figure 6.5). These results strongly indicate that 
cdG causes FliI to multimerize, and for that reason, the response is much greater than the 
capacity of the SPR chip, even if a maximal 1:2 ratio of FliH-FliI is assumed.   
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Figure 6.5: Surface plasmon resonance monitoring the interaction between FliI and FliH. The percent of FliI binding 
to the FliH chip was calculated in increasing cdG concentrations. CdG addition to the FliI solution led to 
multimerization of the protein resulting in higher percentages of binding on the FliH chip.  
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6.4 Discussion 
CdG is a small signalling molecule that is involved at multiple levels of regulation of the 
bacterial flagellum. As part of this study, a previously unknown mechanism of regulation 
was identified; direct interaction of cdG with the main flagellum ATPase, FliI. After 
having established the nature of this binding, the next step was to determine the biological 
role of this interaction. As cdG control of flagellar expression and function is complex 
and pleiotropic, this presented some technical challenges. The most important one was 
the cdG-dependent FleQ-mediated transcription of the flagellum genes. To overcome 
that, we were kindly provided specific FleQ-bypass mutants (305). In these mutants, the 
regulation of the flagellum genes is no longer controlled by the master transcriptional 
regulator FleQ but are constitutively expressed under the control of another 
transcriptional regulator, NtrC. 
The initial working hypothesis was that cdG may have a direct effect on the export of 
flagellin (FliC) subunits via the flagellum. To test this, the expression of flagellin (FliC) 
was monitored by q-RT-PCR in the FleQ-bypass mutants, and no change in the level of 
the protein was observed upon the overproduction of cdG in the cells. However, when the 
export of FliC was monitored by Western blotting, the FliC export was shown to be 
significantly reduced in the strain overproducing cdG. This result presents a first 
indication that cdG may have a role in the inhibition of the export via the flagellum export 
gate. FliI expression levels, on the other hand, were much lower and didn’t change 
significantly upon the overexpression of cdG in the cells. This can easily be explained as 
fewer copies of the protein are required for the export, compared to FliC, which is the 
major subunit of the flagellum filament and is required in high abundance. 
The next step was to investigate the reason that FliC export levels dropped by increasing 
levels of cdG. Having established that the binding happens at the interface between the 
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two subunits, we examined the possibility that the effects observed may be due to changes 
in the multimerization state of the protein. A size exclusion chromatography (gel 
filtration) experiment was performed to characterise the multimeric state of the protein as 
well as potential changes in its running pattern. FliI full length, as it is well reported in 
the literature, tends to form higher order complexes, and this was verified by gel filtration 
experiments. The largest part of FliI full length runs above the detection limit of the 
column (>600 KDa) with a minority of the protein running as a dimer. However, the 
addition of cdG led to the formation of complexes corresponding to a dodecameric 
complex. This result gives a first indication that cdG may indeed have a direct effect on 
the multimerization state of the protein. The truncated version of the protein, lacking the 
first 18 amino acids is unable to multimerize to a hexamer and runs in the monomeric 
form. However, the addition of ATP led the protein to multimerize and form dimers and 
hexamers, whereas the addition of cdG had no obvious results.  
Although the full-length protein runs in the void volume, it was found to have fully active 
ATPase activity, and no obvious precipitation was observed in solution. What is more, it 
binds cdG tightly, in the low μΜ range. This suggests that the protein doesn’t form 
inactive aggregates as originally thought, but higher order complexes, which are still 
active and functional. To test this, TEM and AFM experiments were carried out to 
visualise the conformation of the protein in solution. In TEM, it was observed that the 
protein indeed forms higher order complexes corresponding to sizes greater than the 
hexameric size. In AFM, formation of regular-shaped higher order complexes was also 
observed. Interestingly, no precipitation of the protein was observed in any of these 
techniques, confirming that FliI multimerizes in a controlled manner, in contradiction to 
what was originally believed. These complexes tend to cluster together, forming ring-like 
structures when cdG is added to the protein mixture. This observation was backed up by 
the results obtained by AFM, which showed that cdG addition leads to clustering of FliI 
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hexamers or dodecamers into ring-like structures. This effect was specific to cdG as no 
effects were observed when ATP was added to the mix. These results may have no 
physiological role, but they give the first indication that cdG does, in fact, have a role in 
the clustering of FliI complexes. An unexpected and exciting result came from the 
analysis in AFM of the G176A mutant. This mutant is active but insensitive to cdG. 
Although the regular-shaped and sized complexes were still formed, interestingly the 
structures corresponding to hexamers or dodecamers accumulated around the bigger 
complexes, creating a halo-like effect. This effect was unique to the specific mutant as it 
was not observed in any of the other mutants tested by this method, which behaved like 
the wild-type protein. Further tests need to be carried out to better characterise this unique 
conformation of the specific mutant.  
Finally, the effect of cdG on the multimerization state of the protein was confirmed when 
FliI interaction to FliH was tested. The interaction of the two proteins was tested in the 
presence of increasing cdG concentrations, and it was observed that pre-incubation of 
cdG with FliI leads to higher binding responses when tested against FliH, indicating the 
formation of larger FliI complexes interacting with FliH.  
Based on the results presented in this chapter, there are strong indications leading to the 
conclusion that cdG does indeed have an effect on the multimerization state of the protein, 
potentially leading to inhibition of FliC export via the flagellum export gate. However, 
further investigation is required to establish the biological role of cdG interaction with 
FliI.   
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Chapter 7: Towards the determination of novel cdG targets 
7.1 Introduction 
As part of the work presented in this study, the importance of nucleotide-protein binding 
was emphasised and more specifically the importance of identifying novel targets of the 
small second messenger cdG. Although the metabolism of this molecule has been 
extensively studied, surprisingly little is known about its downstream targets. One of the 
reasons for that is that there is significant variation among cdG targets, which makes it 
impossible to predict them bioinformatically.  
Following the Capture compound screen (described in Chapter 3), it was essential to test 
a large number of proteins to identify the true cdG targets and exclude false positives. 
The established cdG binding assays used by the field, although useful for certain proteins, 
did not give consistent results for all of them and are lacking in specificity and selectivity. 
To overcome this problem, an arsenal of biochemical tools was developed, which allowed 
the identification and characterisation of novel cdG targets. These tools not only helped 
with the identification of previously unknown cdG targets (e.g. the export ATPases) but 
also contributed to the characterisation of binding for a number of different proteins for 
international labs. 
In this chapter, the testing and identification of four novel cdG binders are described: 
7.1.1 EpsI/ Nla24 
The first protein tested is EpsI/ Nla24, a transcriptional regulator protein, which is part of 
the NtrC-like transcriptional regulator family. EpsI/Nla24 controls the transcription of the 
EPS synthesis genes in Myxococcus xanthus and is essential for EPS production in this 
species. EpsI/Nla24 is associated with the regulation of EPS gene transcription both at 
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the developmental stage and also at the vegetative growth stage (306). It is structurally 
composed of three distinct domains; a receiver domain, part of a two component system, 
located at the N-terminal end of the protein, a AAA+ ATPase domain, and a helix-turn-
helix (HTH) DNA-binding domain.  
In many bacterial species, the regulation of EPS synthesis is directly associated with cdG 
levels in the cell (307). The regulation of EPS synthesis by cdG can either occur at the 
transcriptional or the post-translational level. Two of the most well-studied regulation 
mechanisms at the transcriptional level are the FleQ-mediated regulation of EPS gene 
expression in Pseudomonas aeruginosa and VpsR regulation in Vibrio cholerae (84,246). 
Binding of cdG to FleQ releases its binding to the pel operon, responsible for the EPS 
production, and as a result, it activates EPS expression. On the other hand, VpsR is able 
to bind to its cognate promoters even at the absence of cdG, but it only exerts its activity 
when bound to cdG. 
EpsI/ Nla24 has a similar function to FleQ in M. xanthus, and after having established the 
effects of cdG perturbation on M. xanthus cells (308), the protein was tested for cdG 
binding. EpsI/ Nla24 was first tested by DRaCALA but did not give a positive response. 
However, as this protein shares similarities in structure and function, as well as some of 
the key cdG binding residues of FleQ, it remained a likely cdG binding target. 
Consequently, I tested EpsI/ Nla24 cdG binding using both SPR and a novel, benchtop 
cdG binding assay, whose development is described in this thesis.  
7.1.2 ToxR 
ToxR/ RegA is a transcriptional regulator that has been associated with regulating the 
expression of an important virulence factor in Pseudomonas aeruginosa, exotoxin A 
(309,310). ToxR positively regulates exotoxin A production, as overproduction of the 
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ToxR protein in trans increases the production of the toxin. ToxR has also been associated 
with pyocin uptake and cell viability via positive regulation of the tol-oprL operon (311) 
as well as the regulation of a 42kDa iron protein (312).  
Recent research conducted by Professor Miguel Camara’s group at the University of 
Nottingham identified a new role of ToxR in the regulation of swarming, polysaccharide 
synthesis and biofilm formation in P. aeruginosa PAO1 (unpublished data). These 
phenotypes are well known to be very closely associated with cdG, so it was decided to 
further investigate ToxR’s association with cdG. ToxR was shown to be a previously 
uncharacterised EAL domain protein (cdG diguanylate phosphodiesterase). Although it 
lacks the conserved catalytic residues responsible for the phosphodiesterase activity, it is 
possible that ToxR may be a cdG effector-like its closely related homologs LapD (235) 
and FimX (313). To confirm this, the first step was to test if toxR deletion has an effect 
on cdG levels in the cells. Indeed, when the levels of cdG were monitored in the cell, the 
toxR null mutant shows elevated dinucleotide concentrations compared to the wild type.  
7.1.3 SadB 
SadB has been associated with surface attachment and biofilm formation in P. aeruginosa 
PA14. This finding established the SadB protein as essential for surface monolayer 
formation (216). SadB was also found to be implicated in affecting swarming motility by 
exerting a direct effect on rhamnolipid sensing (314). The protein has also been linked to 
swarming motility in a FleQ-dependent manner (217). In P. fluorescens, SadB has been 
associated with the Gac system, which negatively regulates flagella-mediated motility 
(315). Finally, SadB is known to be involved in the Type IV pilus (T4P) biogenesis, as it 
acts upstream of the Pil-Chp chemotactic cluster (316,317). Structurally, SadB contains 
an HD(N)-GYP at the C-terminus, which does not exhibit any phosphodiesterase activity, 
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and a Ybak domain at the N-terminus. Both of these domains are required for function 
(216,315,316).  
Although the exact function of SadB is not yet clear, it is well-established that the protein 
acts downstream of SadC in the cdG signalling cascade (221). However, there are a lot of 
hypotheses on how the protein may act. It was considered that SadB may assist SadC to 
its phosphodiesterase activity, acting upstream of cdG synthesis (221). 
Another hypothesis is that SadB could act as a cdG effector, and form part of the 
signalling network responsible for transmitting the cdG signal to its downstream targets. 
Based on this hypothesis, SadB was tested as a potential cdG target in collaboration with 
Professor Rafael Rivilla’s group (data not published). 
7.1.4 RimK  
RimK is an α-L-glutamate ligase enzyme, which catalyses the addition of glutamate 
residues to the C-terminal end of the ribosomal 30S subunit protein RpsF (318). Although 
the function of this protein has been well-documented, it has only recently been shown 
that the activity of this enzyme leads to alterations in ribosomal protein levels. It has also 
been demonstrated that deletion of the rimK gene has direct effects on bacterial behaviour 
in Pseudomonas species (319). RimK is part of an operon encoding for two more proteins; 
RimB and RimA, which tightly control its activity (319). RimA is an active 
phosphodiesterase involved in cdG metabolism, providing a potential link between RimK 
and cdG signalling.  
7.2 Aims 
1. To test previously uncharacterised proteins for cdG binding using the novel tools 
developed in this study. 
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7.3 Results 
7.3.1 Identification of EpsI/ Nla24 transcriptional regulator as a cdG binder 
To test EpsI/ Nla24 binding to cdG, the novel Streptavidin UV Precipitation (SUPr) assay 
was developed and employed. For this assay, whole cell lysates overexpressing the 
protein of interest were incubated with biotinylated cdG; then UV cross-linked before 
streptavidin magnetic beads were used to select and pull-down the proteins bound to the 
biotinylated-cdG. The bound proteins were then analysed on an SDS gel (Figure 7.1- A). 
Non-binding protein controls were included as appropriate (data not shown). As presented 
in Figure 7.1, EpsI/ Nla24 was selectively pulled down from the cell lysate.  
Having established that cdG interacts with EpsI/ Nla24, the protein was then tested by 
SPR, to characterise the interaction better. In SPR, EpsI/ Nla24 gave a clear positive, 
concentration-dependent response confirming cdG binding (Figure 7.1- B). The SPR 
responses for different cdG concentrations were then plotted, producing an affinity curve 
(Figure 7.1- C) from which the binding affinity was calculated to be 0.53 ±0.06 μM, 
which is physiologically relevant for cdG binding proteins in Myxococcus (261). 
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Figure 7.1:  A. Streptavidin UV Precipitation (SUPr) assay on EpsI/ Nla24. Biotinylated cdG was used to pull down EpsI/ 
Nla24 from a complex protein mix. Non-induced lysate was used as a reference. B: SPR sensorgrams showing affinity 
measurements for EpsI/ Nla24 binding to biotinylated cdG. A range of EpsI/ Nla24 concentrations was used (ranging 
from 62.5 nM -lowest curve to 4 μM- highest curve), for each concentration 3 replicates were included. Buffer only and 
BSA controls were also included as negative controls. C. Affinity fit describing EpsI/ Nla24-cdG binding. Binding 
responses was recorded 4 s before the end of the injection for each concentration, the KD value for EpsI/ Nla24 binding 
to cdG was calculated to be 0.53 ± 0.06 μM and the analysis was carried out on BiaEvaluation software and confirmed 
by GraphPad Prism. Figure adapted from (261). 
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7.3.2 Identification of the transcriptional regulator ToxR as a cdG binder 
To test the possibility of ToxR being a cdG binder, the binding was tested using the well-
established SPR method.  
Although the ToxR was rather unstable in solution and exhibited a rapid degradation rate, 
it was possible to purify it and test it by SPR in the first few hours after purification. As 
presented in Figure 7.2, it was possible to detect concentration-dependent responses in a 
series of SPR experiments. The KD of the interaction was calculated to be 2.36 ± 0.7 μΜ, 
which is biologically relevant for a cdG binding protein in P. aeruginosa (Figure 7.2- B).   
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Figure 7.2: A. SPR sensorgrams showing affinity measurements for ToxR binding to biotinylated cdG. A range of 
ToxR concentrations was used (ranging from 78.125 nM -lowest curve to 5.0 µM - highest curve), for each 
concentration 3 replicates were included. Buffer only and BSA controls were also included as negative controls. B. 
Affinity fit describing ToxR -cdG binding. Binding responses were recorded 4 s before the end of the injection for 
each concentration, the KD value for ToxR binding to cdG was calculated to be 2.36 ± 0.7 μΜ and the analysis was 
carried out on BiaEvaluation software and confirmed by GraphPad Prism. 
 
 
Figure 7.2: A. SPR sensorgrams showing affinity measurements for ToxR binding to biotinylated cdG. A range of 
ToxR concentrations was used (ranging from 78.125 nM -lowest curve to 5.0 µM - highest curve), for each 
concentration 3 replicates were included. Buffer only and BSA controls were also included as negative controls. B. 
Affinity fit describing ToxR -cdG binding. Binding responses were recorded 4 s before the end of the injection for 
each concentration, the KD value for ToxR binding to cdG was calculated to be 2.36 ± 0.7 μΜ and the analysis was 
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7.3.3 Identification of the transcriptional regulator SadB as a cdG binder 
To test SadB for cdG binding, the protein was first tested by the SUPr assay. Whole cell 
lysates overexpressing SadB were used. The lysates were incubated and cross-linked with 
biotinylated cdG for the stabilisation of the complex formation. The complexes were then 
isolated by streptavidin magnetic beads and the fractions were analysed on SDS-PAGE 
gels. As presented in Figure 7.3- A SadB was clearly isolated from the complex protein 
mixture. Non-induced cell lysates and non-binding protein controls were used as negative 
controls for the pull-down experiment.  
To further characterise the cdG interaction with SadB, SPR was employed. The protein 
gave positive concentration-dependent responses, strongly indicating binding to cdG 
(Figure 7.3- B). To calculate the affinity of this interaction the responses for each 
concentration were plotted to produce an affinity curve (Figure 7.3- C). The KD of the 
interaction was calculated to be 0.23± 0.034 μΜ, which again is biologically relevant in 
Pseudomonas cdG binders.  
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Figure 7.3: A. Streptavidin UV Precipitation (SUPr) assay on SadB. Biotinylated cdG was used for the isolation of 
SadB from a complex mix of proteins. Non-binding proteins as well as non-induced cell lysates were included as 
negative controls (data not shown) B: SPR sensorgrams showing affinity measurements for SadB binding to 
biotinylated cdG. A range of SadB concentrations was used (ranging from 78.125 nM -lowest curve to 10 μΜ - highest 
curve), for each concentration 3 replicates were included. Buffer only and BSA controls were also included as 
negative controls. C. Affinity fit describing SadB-cdG binding. Binding responses was recorded 4 s before the end of 
the injection for each concentration, the KD value for SadB binding to cdG was calculated to be 0.23± 0.034 μΜ and 
the analysis was carried out on BiaEvaluation software and confirmed by GraphPad Prism. 
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7.3.4 Identification of the L-glutamate ligase RimK as a cdG binder 
In this project, RimK proteins from P. fluorescens and E. coli were tested for binding. 
Each protein was first tested for cdG binding by the SUPr assay. Whole cell lysates 
overexpressing RimK were incubated with biotinylated cdG, cross-linked and isolated 
with streptavidin magnetic beads, before being analysed on an SDS-PAGE gel. As 
presented in Figure 7.4- A RimK could be isolated from the complex whole cell lysate 
mix. Cell lysates from non-induced cultures were used as a negative control. 
SPR was the next assay employed to further characterise the interaction, resulting in 
positive concentration-dependent responses, which strongly indicate binding to cdG 
(Figure 7.4- B). The affinity of the interaction in each case was calculated by an affinity 
curve (Figure 7.4- C). The KD of the interaction for RimK from P. fluorescens was 
calculated to be 1.0 μM and for E. coli the KD was 3.8 μM.  
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Figure 7.4: A. Streptavidin UV Precipitation (SUPr) assay on RimK. Biotinylated cdG was used for the isolation 
of RimK from E. coli overexpression cell lysate, the b-cdG pull down is loaded alongside B, D: SPR sensorgrams 
showing affinity measurements for RimK binding to biotinylated cdG (for RimK from P. fluorescens and E. coli 
respectively). A range of RimK concentrations was used (ranging from 156 nM -lowest curve to 10 μΜ - highest 
curve for P. fluorescens and 1.25 μΜ -lowest curve to 40 μΜ - highest curve for E. coli). For each concentration 3 
replicates were included. Buffer only and BSA controls were also included as negative controls as appropriate. C, 
E. Affinity fit describing RimK -cdG binding (for RimK from P. fluorescens and E. coli respectively). Binding 
responses was recorded 4 s before the end of the injection for each concentration, the KD value for RimK from P. 
fluorescens and from E. coli were 1 μΜ and 3.8 respectively. The analysis was carried out on BiaEvaluation 
software and confirmed by GraphPad Prism. Figure adapted from (319).  
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7.4 Discussion 
In recent years, it has become clear that the mechanisms underpinning cdG regulation 
networks are much more complicated than originally thought. In response to this 
realisation, there has been a constant effort to identify novel cdG targets and characterise 
them to get a better understanding of how cdG-mediated signalling is regulated. The 
limiting factor, however, is the lack of highly efficient screens and biochemical tools to 
characterise the potential binders.  
In this chapter, I describe two new cdG analytical tools, developed as part of this study 
and applied to different proteins to test them and characterise their cdG binding 
behaviour. The first protein tested was the transcriptional regulator EpsI/ Nla24, from 
Lotte Søgaard-Andersen’s group, in Germany. Although these were strong experimental 
indications that the protein may act as a cdG binder, the lack of effective biochemical 
assays for nucleotide-protein interactions, prevented the characterisation of this protein’s 
association with cdG. Here, a dual approach was followed that allowed the efficient 
characterisation of this interaction. The first method used to test binding was the novel 
Streptavidin UV Precipitation (SUPr) assay, which I developed as part of this study. This 
assay is highly specific, resulting in consistent and reproducible results. It is also ideal for 
screening of multiple targets simultaneously, which makes it an invaluable tool for the 
analysis of ‘big-screening’ targets. When the SUPr assay was applied to EpsI/ Nla24, it 
was possible to specifically isolate this protein from a complex cell lysate, strongly 
indicating binding to cdG. As a negative control for the method, non-induced lysates were 
used where no isolation of EpsI/ Nla24 was detected.  
Although SUPr is a very efficient assay for rapid binding detection, it doesn’t provide any 
information about the nature of the interaction or its affinity. To complement this method 
and further characterise the interaction between EpsI/ Nla24 and cdG, SPR was used, 
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following its effective application to FliI and HrcN. EpsI/ Nla24 binding to cdG has 
significant implications for our understanding of cdG signalling networks in M. xanthus.  
This result strongly indicates that EPS synthesis in this bacterium is controlled at the 
transcriptional level by EpsI/ Nla24, via direct regulation from cdG (261). 
A second example of a previously unidentified cdG binding protein presented in this 
chapter is the transcriptional regulator ToxR. ToxR is a previously unidentified EAL 
domain protein, which lacks cdG phosphodiesterase activity. However, it is not 
uncommon for a degenerate EAL domain protein to be a cdG binder. Results from 
Professor Miguel Camara’s group showed that the deletion of this protein leads to 
increased levels of cdG in the cell, indicating a role of ToxR in the cdG-controlled 
regulatory network. To test binding of cdG to the protein, the SPR approach was followed 
as the protein was rather unstable and exhibited a fast degradation rate, which made it 
unsuitable for the SUPr assay. However, in SPR the protein demonstrated positive 
concentration-dependent responses to increasing levels of cdG, indicating binding with a 
KD in the low μΜ range. Since similar cdG regulatory pathways have previously been 
identified in Xanthomonas campestris (320) and E. coli (321), this result suggests that 
cdG regulation at the transcriptional level may be a common trait among different 
bacterial species. 
The third protein tested was SadB, a protein that has been implicated many times in 
common bacterial behaviours associated with cdG but has not previously been linked to 
cdG binding. A similar approach was used for this protein; binding of the protein to cdG 
was firstly shown by SUPr, where the protein was very efficiently separated from the 
complex protein mixture. The interaction was then tested further by SPR resulting in a 
KD for the interaction in the low μΜ range. Although the interaction of SadB to cdG has 
been previously hypothesised, it was first shown experimentally as part of this study. 
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Another previously unknown cdG binder, identified in this study is RimK. Binding was 
tested both in E. coli and P. fluorescens giving affinities in the low μΜ range, implying 
that the binding may be widespread among RimK homologs. CdG binding to RimK was 
shown to boost its glutamate ligase activity (319). RimA, which is part of the same operon 
as RimK, is an active phosphodiesterase, making it likely that it may hydrolyse cdG under 
certain conditions to alter RimK activity. This study unravelled a novel regulatory 
pathway linking cdG binding proteins to the ribosome function and proteome remodelling 
(319). 
The identification of these novel cdG binding proteins gives a good indication of how 
complex cdG networks are, and how important is to be able to rely on efficient 
biochemical tools to characterise these targets. Here I present two valuable new analytical 
tools for the study of cdG binding proteins in bacteria and demonstrate their utility to the 
examination of different signalling systems in a variety of bacterial species.   
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Chapter 8: General Discussion 
8.1 Summary 
The wider aim of this study was to identify and characterise novel cdG binding proteins 
in P. fluorescens SBW25. To this end, an array of pull-down screens were performed 
(249), which led to the identification of a number of potential cdG targets. Several of the 
most biologically interesting targets were then selected and biochemically tested for 
binding. Among these targets, the flagellum main ATPase FliI was identified as a novel 
cdG binder. Molecular biology and biochemistry techniques were employed to 
characterise the nature of cdG binding to FliI, to examine the degree of conservation of 
cdG binding among FliI homologs and to determine the effect of binding on the protein’s 
activity. Determination of the binding site at the interface between the two FliI subunits 
opened the path to further investigate the physiological role of binding, and the effects 
that this has on the multimerization state of the protein. Finally, the important biochemical 
tools developed and optimised in this study were used to identify more protein targets for 
cdG binding, expanding our understanding on how cdG signalling networks operate.     
8.2 Discussion  
To identify novel cdG binding proteins, the capture compound pull-down screening 
experiment (249) was performed in various media and growth conditions. The reason for 
repeating the screen in these different experimental conditions (described in detail in 
Chapter 3) was to compensate for the well-reported characteristic of bacteria to express 
genes both conditionally and transiently, to meet the immediate needs of the organism in 
a specific growth condition (322). For instance, FliI was identified as a potential candidate 
only in the stationary phase in LB. The isolation of the protein at this stage could 
potentially be due to experimental variation or due to the absence of other cdG binders at 
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this growth phase, which made it possible for FliI to interact with cdG. The cells exhibited 
a motile phenotype at the stationary phase, when observed under the microscope, which 
indicates a strong presence of FliI, together with the rest of the flagellum components at 
this growth phase. Minimal media (M9-pyruvate) was used to induce the expression of 
genes that may be required to survive in poor growth conditions, and that would not be 
expressed in rich media.  
Although the pull-down screens led to the identification of a number of potential cdG 
targets, many of these were shown to be false positives when tested using the biochemical 
assays available at the beginning of this study. However, I strongly believe that the lack 
of more sophisticated and precise tools at this early stage of the project may have led to 
the mis-characterisation of some of these targets. In my opinion it would be well worth 
testing some of these proteins again, using the novel tools developed in the course of this 
study (e.g. by SUPr or SPR).  
Strikingly, FliI ATPase was identified as one of the stronger binding proteins in the 
capture compound screen, and when tested by DRaCALA gave strong concentration-
dependent responses. To further characterise cdG binding to this protein, I performed 
several state-of-the-art biochemical techniques such as ITC and SPR. These techniques 
provided a deep insight into the nature of binding. For instance, ITC provided information 
about the stoichiometry of the interaction, which was found to be a ratio of 2:1 protein to 
cdG. This result was a first indication that two molecules of the protein are needed for 
binding to one molecule of cdG, and that cdG binding may therefore occur at the interface 
between two protein subunits. The binding affinity was calculated by SPR in the low μΜ 
range, a physiologically relevant affinity for cdG binders (229). Excitingly, binding was 
also confirmed for FliI homologs from other organisms. These homologs were 
strategically selected to cover a wide range of organisms from distinct categories (plant 
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pathogen, plant symbiotant and human pathogen). Confirming binding in all these three 
categories shows how widespread the binding is and implies that cdG binding to FliI is a 
universal trait.  
The next step after confirming and characterising the nature of binding, was to identify 
the exact binding site. Knowing the location of the FliI-cdG binding site is a very 
important step towards the identification of the role of binding to the protein. Knowing 
the exact binding location allows not only to generate specific mutants and perturb protein 
function in vivo but also it enables the prediction of cdG binding proteins having the same 
sharing domains. To achieve this, several attempts to crystallise FliI from SBW25 were 
carried out. Unfortunately, however, these yielded no promising results. Finally, FliI from 
S. enterica was crystallised in the presence of cdG and ADP. Unfortunately, the location 
of cdG could not be resolved in the FliI structure. Since its presence in the trials was 
essential for crystals to be produced, it is possible that the molecule was present, but only 
in a percentage of the available binding sites of the protein, resulting in a too-low electron 
density to enable the resolution of its structure. Another possibility is that the binding 
pocket could not be formed properly because the truncated version of the Salmonella 
protein was used for crystallisation. This truncated allele is well-reported as being unable 
to form multimers higher in order than dimers (323). As a result, the binding site may not 
be available when the truncated protein is crystallised in the monomeric state as it may 
only occur in the hexameric state of the protein. Another possibility is that given that it 
was shown that the binding occurs at the interface between the two FliI subunits, with 
specific amino acid contributions from each subunit, it may be that FliIΔ1-18 crystallises in 
a way, which doesn’t allow for these residues to come together and form the binding 
pocket.  
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Despite the lack of a crystal structure of FliI bound to cdG, the importance of determining 
the binding site led me to look for other methods and tools to achieve it. Two 
complementary in silico analyses were performed (described in detail in chapter 5), both 
pointing to a conserved binding site at the interface between the two FliI subunits. This 
binding site was subsequently confirmed by producing the mutated protein analogues by 
site-directed mutagenesis, purifying them and testing them for binding by SPR. The 
determination of the binding site at the interface between the two subunits strongly 
indicates, given the way FliI functions, that cdG binding may affect the multimerization 
state of the protein and thus, its function in the wider flagellar context.  
The specific in vivo role of the FliI-cdG interaction remains to be unravelled, and at this 
stage we can only speculate as to what it may be. The first hypothesis is that it may act as 
a fine control of the export via the flagellum by altering the multimerization state of the 
protein. Indeed, preliminary data, presented in chapter 6, shows that the flagellin export 
levels drop when cdG concentration in the cells increases. However, although I eliminated 
the FleQ cdG-dependent transcriptional control mechanism (see Chapter 6), we cannot 
rule out the possibility that another, as yet uncharacterised cdG-dependent flagellar 
control mechanism may exist. Another hypothesis, is that given that cdG binding occurs 
at the interface between the two FliI subunits, it may lead to an asymmetry in the 
hexameric complex, facilitating the association and dissociation of ATP at the enzyme 
active sites. Although our ATPase activity results suggest an inhibition of ATPase activity 
by cdG, the IC50 values are far from physiological, making it unlikely that this represents 
the actual role of cdG binding in vivo. A third theory is that cdG binding to FliI may 
influence the direction of rotation of the protein, affecting protein export as a consequence 
of this. Finally, it is also possible that cdG is required for the rapid disassembly of the 
filament of the flagellum in circumstances where the bacterium needs to detection by the 
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host, given that flagellin is well-reported to be triggering the innate immune response of 
host cells (324). 
The role of cdG binding to the T3SS and T6SS export systems is very uncertain and needs 
further characterisation. However, it is well-known that these two systems are 
reciprocally regulated by cdG (222) during the switch between acute and chronic 
infection, and it is possible that cdG triggers the rapid switching between these two 
systems. In this model, HrcN and ClpB2 would facilitate the assembly and disassembly 
of the needle structures of the two organelles in response to cdG binding. Another 
hypothesis is that cdG interaction with FliI may be a control mechanism for the export of 
structural subunits the effector proteins exported by the secretory complexes. In this 
model, cdG binding to the T3/6SS would play a similar role to that observed for the 
flagellum (Chapter 6).   
The initial aim of this study was to expand our understanding of cdG signalling 
mechanisms by the identification of novel targets of the molecule. The development of 
novel biochemical tools for the characterisation of binding targets, together with the 
optimisation of existing assays worked towards this direction. During the course of this 
study, I developed and pioneered the use of novel tools for the examination of protein-
nucleotide interactions (e.g. the SUPr assay), which proved to be valuable assets for the 
investigation for novel cdG targets. In chapter 7, I describe how these tools were used for 
the characterisation of binding to four previously unknown cdG targets (EpsI/Nla24, 
ToxR, SadB and RimK). 
8.3 Implications  
CdG binding to FliI and its orthologs is a discovery with great implications. Although the 
export ATPases have been extensively studied, binding to a new ligand, which potentially 
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alters their function and multimerization state, make the existing models of hexameric 
export ATPases incomplete.  Additionally, our perception of the flagellum organelle 
assembly and function change in light of this discovery as it was shown that are controlled 
by cdG, something previously unknown. Finally, modifications in the function of the 
ATPases as well as in the organelle assembly, lead to direct effects of cdG in motility and 
virulence, implying that existing models describing how these behaviours function are 
now incomplete and need to change in light of this discovery.  
Furthermore, new tools developed in the course of this study will advance and speed up 
cdG research and can also expand into other nucleotide second messengers. 
Finally, the identification of a new class of cdG receptors, the export ATPases, together 
with the characterisation of binding for a number of different transcriptional regulators as 
well as the ribosomal modification protein RimK, changes what we know so far for cdG 
binding. Through the course of this study, more diverse cdG binding proteins were 
discovered, broadening the existing knowledge about cdG binding protein diversity.  
8.4 Future directions of research 
By carrying out a number of screening experiments aimed at the identification of novel 
cdG binders, an exhaustive database of potential cdG targets was produced. In this study, 
only a small number of the proteins was tested for binding. Hence, an obvious starting 
point for future analysis would be to start testing some of the most exciting targets using 
the tools developed in the course of this study.  
My attempts to co-crystallise cdG with the truncated version of FliI were unsuccessful. 
Nonetheless, it would be reasonable to return to this by attempting to crystallise the full-
length protein and its orthologs, HrcN and ClpB2. Using the full-length proteins will 
certainly be a harder task for the purposes of crystallisation because of the higher order 
 167 
 
formation and aggregation of the proteins in higher concentrations. It is also possible that 
one of the orthologs from the T3SS or the T6SS may be more amenable to crystallisation.  
To investigate the biological role of the FliI-cdG interaction further, the first obvious step 
would be to chromosomally introduce the mutations of the binding site into the fliI gene 
and test the resulting mutants for export, flagellum assembly, and rotation. We could also 
examine the impact of cdG perturbation on motility in the mutant background. In this 
case, the mutations would need to be introduced in the FleQ-bypass background to avoid 
the cdG-dependent regulation of flagellar transcription by FleQ.  
To test protein export via the flagellum, a similar approach to the one described in Chapter 
6 would be followed, in which the levels of exported flagellin subunits would be 
monitored by Western blotting. For the evaluation of flagella assembly, TEM could be 
employed to look for extracellular forming structures on the cells. Lastly, the flagellar 
rotation could be tested by artificially re-building the FliI-FliJ system in vitro, then 
monitoring rotation by the detection of the rotation speed of a fluorescently labelled actin 
filament, attached to FliJ. This method was previously carried out for the F0F1 ATPase 
(325). Rotary ATPase proteins are central players in control of bacterial virulence and 
motility. This work establishes a fundamental role for the second messenger cdG in the 
function of these proteins.  
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Appendix 1: False-positive capture compound screen proteins  
Chapter 3: 
Negative binding results from proteins tested as part of the capture compound screen 
verification. Binding assays used are described more fully in Chapter 3.  
Putative regulatory protein (PFLU_4895) 
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LysR family transcriptional regulator (PFLU_4531) 
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